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Abstract 
During development of the mammalian cerebral cortex, precursor cells in the 
ventricular zone sequentially produce neurons and glial cells. This process clearly 
involves a complex interplay between intrinsic cellular machinery and extrinsic cues. 
Remarkably, embryonic cortical precursor cells isolated at the onset of neurogenesis, 
and cultured under serum-free conditions, will mimic the temporal differentiation 
pattern observed in vivo, producing neurons first, and then glia. In the studies 
presented here, l have used this system to identify critical components of the 
intracellular machinery that co-ordinately control two essential steps in neuronal 
differentiation, exit from the cell cycle (via the retinoblastoma family) and induction 
of neuronal gene expression (via the basic helix-Ioop-helix transcription factors). l 
then demonstrate that endogenously produced neurotrophins are crucial 
autocrine/paracrine extracellular factors that regulate the precursor-to-neuron 
transition by promoting precursor survival (through the PI3-kinase-Akt signaling 
pathway) and neuronal differentiation (through the MEK-ERK pathway). Finally, l 
identify the nature of the "cortical timer mechanism" for sequential generation of 
neurons and glial cells: increasing levels of cytokines are produced by newly born 
neurons, which act to instruct the remaining precursors to produce glial cells. This 
neuron-based feedback mechanism was verified by using in utero electroporation to 
alter levels of cytokine signaling components within the developing cortex, and by 
analysing mice deficient for the cytokine cardiotrophin-l, which in both cases 
impaired the onset of gliogenesis. Taken together, our findings have led to a better 
molecular understanding of cortical precursor biology and cortex development, which 
could ultimately lead to the design of novel therapeutic strategies for 
neurodegenerative disorders. 
11 
Résumé 
Lors du développement du cortex cérébral des mammifères, les précurseurs 
cellulaires de la zone ventriculaire produisent successivement des neurones et des 
cellules gliales. Ce processus implique des intéractions complexes entre la machinerie 
intrinsèque intracellulaire et les signaux extracellulaires. De façon remarquable, les 
précurseurs corticaux embryonaires cultivés en absence de sérum peuvent reproduire 
la séquence temporelle de différentiation observée in vivo, produisant tout d'abord les 
neurones, puis les cellules gliales. Dans la série d'expériences présentée dans cette 
thèse, j'ai utilisé ce système afin d'identifier des composants critiques de la machinerie 
intracellulaire qui contrôlent la coordination de deux évènements essentiels à la 
différentiation neuronale: l'arrêt du cycle cellulaire (via la famille de la protéine 
retinoblastoma) et l'induction de l'expression de gènes neuronaux (via la famille des 
facteurs de transcription hélice-loupe-hélice). J'ai également démontré que les 
neurotrophines endogènes sont des facteurs extracellulaires cruciaux qui agissent de 
manière autocrine/paracrine pour réguler la transition précurseur/neurone en 
promouvant la survie des précurseurs (via la cascade de signalisation PI3-kinase-Akt) 
et la différentiation neuronale (via la cascade de signalisation MEK-ERK). 
Finalement, j'ai caractérisé la nature du «mécanisme de chronomètre cortical» qui 
régule la génération successive de neurones et de cellules gliales: un niveau croissant 
de cytokines est produit par les neurones nouvellement formés, incitant ainsi les 
précurseurs restants à se différencier en cellules gliales. J'ai validé ce mécanisme 
rétrocontrole neuronal en utilisant l'électroporation in utero pour altérer les niveaux 
des composants de la cascade de signalisation des cytokines durant le développement 
du cortex et en analysant des souris déficientes pour la cytokine cardiotrophin-l. Ces 
deux approches ont résulté en une gliogenèse altérée. Globalement, ces résultats ont 
conduit à une meilleure compréhension moléculaire de la biologie des précurseurs 
corticaux et du développement du cortex, un préalable indispensable à la création de 
nouvelles stratégies thérapeutiques contre les maladies neurodégénératrices. 
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Rational 
During embryonic cerebral cortex development, 
sequentially differentiate to generate neurons and glial cells. 
cortical precursors 
Elucidation of the 
molecular mechanisms underlying this developmental process will enable a better 
understanding of neural precursor biology, which will be of further use for the design 
of novel therapies for neurodegenerative diseases and neuronal injuries. The present 
studies were aimed at defining such mechanisms regulating cortical precursor 
proliferation, survival and differentiation. 
Objectives and hypothesis 
The first aim was to identify the mechanism coupling terminal mitosis and 
expression of neuronal genes during cortical precursor-to-neuron transition. 1 
hypothesized that the cell cycle regulator pRb and the neuronal transcription factor 
bHLH proteins, cooperate to induce neuronal differentiation, through the common 
regulater Id2. 
The second set of studies aimed at examining the role of extracellular factors 
during neuronal differentiation of cortical precursors. 1 focused on the neurotrophin 
family of growth factors, which are weIl characterized as regulators of neurons, but 
which are also highly expressed within the developing ventricular zone, where their 
potential effects on cortical precursors were unknown. 1 hypothesized that 
endogenously produced neurotrophins regulate precursor differentiation and survival 
through activation of distinct downstream signaling pathways. 
The final aim was to characterize the mechanism by which cortical precursors 
sequentially generate neurons and glial cells. Although several putative gliogenic 
factors have been identified, the exact nature of the gliogenic timing mechanism and 
the in vivo source of such factor(s) during embryonic cortex development have been 
unclear. 1 hypothesized that newly born neurons secrete accumulating levels of 
gliogenic factors, which then instruct remaining precursor cells to generate astrocytes. 
xv 
CHAPTER 1: Literature Review 
The aim of this chapter is to familiarize the reader with the current knowledge 
of the molecular mechanisms regulating the development of the cerebral cortex. To 
allow a better understanding of the work presented in this the sis, known intrinsic 
components and extracellular signaling pathways involved in cortical precursor 
biology are presented in detail. 
I. Embryonic cerebral cortex development 
The cerebral cortex is the center of higher human cognitive functions, such as 
integration and processing of sensory information, memory and behaviour. Its 
increased complexity and size correlates with the evolution of higher vertebrate 
species, and despite the highly variable morphologies of adult cortices across 
vertebrate species, the embryonic development of the cerebral cortex is governed by 
conserved processes. Establishing the molecular basis of embryonic cortical 
development will ultimately lead to a better understanding of both human 
developmental disorders and neurodegenerative diseases. 
A. Formation of the cerebral cortex during embryogenesis 
The CNS is derived from neuroepithelial ceIls forming the neural plate, which 
is patterned in an anterior-posterior axis by several factors during early embryonic 
development (reviewed in Bayer et al., 1991b; Wilson and Rubenstein, 2000; 
Schuurmans and Guillemot 2002). The telencephalon is derived from the anterior 
neural ridge, where a single ceIl sheet of neuroepithelial ceIls folds and fuses at the 
midline around E9 in the mouse. The telencephalic cortical vesicles arise from dorsal 
and lateral expansion of this neuroepithelial sheet by E Il. Dorso-ventral patterning of 
the telencephalon by local signaling events gives rise to the pallium (dorsal) and sub-
paIlium (ventral) structures, which constitute the cerebral cortex and basal ganglia, 
respectively. At this early stage of cortex development, cortical precursor ceIls 
undergo extensive proliferation through symmetric division, increasing the precursor 
pool within the ventricular zone (VZ). At the onset of the neurogenesis period (EI2-
13 in mouse), precursor division becomes mostly asymmetric generating the first 
neurons. Precursor ceIl division is accompanied by an interkinetic nuclear migration, 
where precursor nuclei move away from and towards the ventricular surface during 
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DNA-replication (S-phase) and mitosis (M-phase), respectively. The orientation of 
the division plane is indicative of the type of division, where symmetric divisions are 
parallel and asymmetric divisions are vertical to the ventricular surface (Bayer et al., 
1991a; Lu et al., 2000a). As neuronal production proceeds, the ventricular zone 
recesses and contributes to the formation of a second germinal zone, the 
subventricular zone (SVZ), which becomes the main source of precursor cells during 
late embryonic and early post-natal periods. The adult cortex comprises six layers that 
are formed sequentially from the precursors within the germinal zone (VZ and SVZ) 
(Figure 1.1). The tirst newly bom neurons, or the so-called pioneer neurons, leave the 
VZ and form the preplate (PP), which is subsequently split into the more superficial 
layer, the marginal zone (MZ, layer I) and the subplate (SP) by the accumulation of 
the cortical plate neurons (CP, layers II-VI). Developing afferent fibres form the 
intermediate zone (1Z), which lies between the germinal zone and the cortical plate. 
Two modes of neuronal radial migration occur during cortical development: somal 
translocation utilized by the pioneer neurons, and radial fibre-guided migration 
utilized by subsequently bom cortical neurons (reviewed in Pamavelas, 2000; 
Nadarajah and Pamavelas, 2002). Most of the cells forming the PP and MZ are Cajal-
Retzius cells which express reelin, an important molecule for CP migrating neurons 
and the radial glial fibre scaffold. Cajal-Retzius cells are a transient cortical neuronal 
population, as the vast majority die at the end of cortex development (reviewed in 
Soriano and Del Rio, 2005). Cortical neurons populate the CP in an "inside-out" 
sequence, where the deeper layers (V-VI) are generated before the more superficial 
ones (II-IV). Layer specificity is regulated at least in part by the neuron birth date, as 
precursors forced to maintain an undifferentiated fate for longer periods will adopt 
later-bom neuronal phenotypes upon differentiation (Caviness, 1982; Mizutani and 
Saito, 2005), while expression of specifie transcription factors, such as the 
homeodomain proteins Pax6 and Tlx and the bRLR neurogeninl-2, results in specifie 
higher and lower laminar fate loss, respectively (Reins et al., 2002; Schuurmans and 
Guillemot 2002; Schuurmans et al., 2004; Campbell, 2005). Finally, the cortex is 
populated sequentially by different neural cell types: neurons appear first (between 
E12 and E17-18 in the mouse), followed by astrocytes, which are mainly generated 
perinatally, and oligodendrocytes, which are produced throughout the first month of 
life (Figure 1.1). Neurons are believed to be mostly derived from VZ precursors, 
while SVZ derived precursors form later-bom neurons and glial cells. 
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B. Origin of cortical neurons and glial cells 
An exception to this sequential production of neurons and glia is formation of 
radial glial celIs. These celIs appear at the onset of neurogenesis, have a celI body 
located in the VZ, and processes spanning the thickness of the developing cortex that 
are thought to provide a scaffold for newly born migrating neurons (reviewed in 
Nadarajah and Parnavelas, 2002; Ever and Gaiano, 2005). The reference to a.glial 
lineage is based on the observation that these celIs express sorne glial markers (such as 
GLAST and BLBP) and that they mostly differentiate into mature astrocytes post-
natally. Recently, a series of in vitro and in vivo studies have provided compelling 
evidence that these radial glial celIs themselves represent a significant fraction of the 
cortical precursor celI population, and can generate both neurons and glial celIs 
(reviewed in Gotz et al., 2002; Ever and Gaiano, 2005; Gotz and Barde, 2005). 
Moreover, it was demonstrated that these radial glial cells can simultaneously fulfilI a 
neuronal precursor and neuronal migration scaffold function. Therefore, radial glial 
cells should be considered and renamed "radial precursors" which also suggests that 
neuron production occurs before all mature glial cell formation in the developing 
cortex. These findings, along with analysis of the differential expression pattern of 
several markers within the cortex germinal zones, have highlighted the heterogeneous 
nature of cortical precursor celIs (Hartfuss et al., 2001). 
The cortex contains two major classes ofneurons: the glutamatergic projection 
pyramidal neurons and the GABAergic interneurons. While the former are produced 
10calIy from cortical VZ precursor celIs, the majority of interneurons are derived from 
the ventral telencephalon (Nadarajah and Parnavelas, 2002). The diversity of 
interneurons in terms of their morphology, gene expression and electrophysiological 
properties is impressive, but three main classes of cortical interneurons have been 
identified based on the differential expression of the calcium binding proteins, 
parvalbumin, calbindin and calretinin (reviewed in Plames and Marin, 2005). Cortical 
interneuron identity is probably dependent on the migration route into the cortex (MZ, 
1Z or SVZ) along with the site of origin within the ventral telencephalon (lateral, 
medial or caudal ganglionic eminence) and time of birth. Another ventralIy derived 
cell population that migrates into the developing cortex is oligodendrocytes. During 
the development of the CNS, oligodendrocyte precursors have been shown to arise 
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from defined regions, such as the ventral spinal cord, diencephalon and telencephalon 
(reviewed in Miller, 2002). A direct evidence for ventral telencephalon-derived cells 
contributing to the developing cortex cornes from the low production of both 
interneurons and oligodendrocytes from dissociated cortical tissue prior to tangential 
migration (E12 in the mouse) in comparison to age matched ventral telencephalon 
tissue (He et al., 2001). 
C. A model to study cortical precursor cell differentiation 
A complex interplay between intracellular factors and external cues is likely to 
occur during embryonic cortex development in vivo. In order to study these molecular 
mechanisms under defmed in vitro conditions, several groups have developed a 
cortical precursor culture system (Davis and Temple, 1994; Ghosh and Greenberg, 
1995; Qian et al., 1997; Williams et al., 1997). Dissociated cortical precursor cells 
isolated at the onset of neurogenesis (E12-E13 and E14-15 in the mouse and rat, 
respectively) survive and differentiate in serum-free conditions, and they are 
responsive to mitogenic and differentiating factors (as discussed in depth below). 
Surprisingly, cultured cortical precursor cells reproduce the differentiation pattern 
observed in vivo: neurons are generated upon plating for approximately the first five 
days in vitro (DIV) followed by a gliogenesis period where astrocytes are produced 
few days before oligodendrocytes (Qian et al., 2000) (Figure 1.1). Using clonaI 
analysis, it was further demonstrated that the sequential production of neurons and 
glial cells by cortical precursors reflects a change in their potential over time, rather 
than a random process (Qian et al., 2000). Together, these findings validate the 
cortical precursor system as a useful model to study mechanisms regulating neuronal 
differentiation and the transition from neuron-to-glia cell fate of cortical precursor 
cells. 
Classical techniques to study embryonic cortex development in an in vivo 
context inc1ude retrovirus based gene expression delivered in ulera or in cortical 
explants (for-example see Burrows et al., 1997). Recently, the use of in utero 
electroporation of expression plasmids has gained interest, where plasmids injected in 
E13-15 lateral ventricle get internalized by VZ cortical precursor cells upon 
application of a series of electrical pulses (for example see Ohtsuka et al., 1999). This 
technique eliminates the need for virus work and yields an impressive transfection 
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efficiency. Moreover, directed electroporation techniques can be combined with the 
newly discovered small interfering RNA (siRNA) gene silencing technique, which 
directs degradation of mRNA containing homologous sequences (Calegari et al., 
2004; Tijsterman and Plasterk, 2004). Using a whole-embryo culture system, 
electroporation of siRNA was shown to successfully inhibit the expression of both 
overexpressed and endogenously produced proteins (Calegari et al., 2002). In 
addition to being less time-consuming and costly than classical transgenic methods, in 
utero electroporation also allows targeting of a specifie cell population in a mosaic 
manner. Therefore, the in utero electroporation technique enables powerful loss or 
gain-of-function studies of the developing cortex in vivo. 
II. Intracellular players during cortical neurogenesis 
The hypothesis of Chapter 2 is the presence of a molecular link that allows co-
ordination of terminal mitosis and expression of neuronal genes during cortical 
precursor neuronal differentiation. Here, l review our current understanding of the 
intracellular protein families that regulate cortical precursor proliferation, 
differentiation and survival. 
A. Regulators of the cel! cycle 
Regulation of precursor cell proliferation is essential for proper nervous 
system development, controlling the resulting number of differentiated cells. 
Moreover, neuronal differentiation involves permanent withdrawal from the cell 
cycle. The notion that neuronal differentiation and terminal mitosis are intimately 
coupled mechanistically is supported by several findings. SpecificaIly, early neuronal 
markers are expressed within hours of terminal mitosis of both retinal ganglion cells 
and cortical neurons (McLoon and Barnes, 1989; Waid and McLoon, 1995; Gloster et 
al., 1999); laminar fate correlates with the number of cell cycles undergone by cortical 
precursor ceIls; transplanted precursors differentiate similarly to ho st neurons if they 
undergo terminal mitosis upon implantation (McConnell and Kaznowski, 1991; 
Caviness et al., 1995); and finally, failure to exit the cell cycle leads to impaired 
neurogenesis (as described below; Clarke et al., 1992; Jacks et al., 1992; Lee et al., 
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1992; Lee et a1., 1994). The ceIl cycle machinery and its main regulators will be 
presented here, with a focus on their role during cortical neuronal differentiation. 
The cell cycle is a highly regulated process that is driven by adynamie 
apparatus composed of three main families of proteins: the cyclins, the cyclin-
dependant kinases (CDKs) and the cyclin-dependant kinase inhibitors (CKIs) 
(reviewed in Sherr, 1994; Liu and Greene, 2001; Nguyen et a1., 2002). CDKs 
promote progression through the ceIl cycle by phosphorylating serine/threonine 
residues on their targets, such as the pRb family (see below). The activity of the 
CDKs depends on the expression of their activating subunits, the cyclins, which are 
dynamically regulated throughout the different phases of the ceIl cycle. Specifically, 
D-type cyclin expression triggers the entrance in G liS phase, activating the cdk4 and 
cdk6, while cyclin E/cdk2 complex promotes the later G liS phase. The S/G2 
transition is mediated by cyclin A/cdkl and cdk2 complexes and the progression from 
G2 to M phase is promoted by cyclin B/cdkl complex (Figure 1.2). CDK progressive 
promotion of the cell cycle is negatively regulated by two classes of CKIs: the Kip 
family of inhibitors (including p21, p27 and p57) and the INK4 family of inhibitors 
(including p16 and p19). Both these CKI families negatively regulate CDK activity, 
where the Kip family binds to and inhibits cdklcyclin complexes and INK4 family 
specifically binds to cdk4 and cdk6 and prevents their association with cyclins. The 
major target of CDKs is the pRb family of proteins. 
The retinoblastoma (Rb) gene was the first tumor-suppressor gene to be cloned 
and has been extensively studied as a ceIl cycle, tumor growth, and differentiation 
regulator (Liu and Greene, 2001; Classon and Harlow, 2002; Claudio et a1., 2002). 
The pRb family comprises three members, pRb, p107 and p130, also referred to as the 
"pocket proteins", after their conserved pocket region, which mediates binding to 
other proteins. For example, DNA tumor viruses, such as adenovirus ElA, SV40 T 
antigen and the E7 proteins of human papillomaviruses bind to the pocket domain and 
inactivate pRb family members. AlI three pRb family members can inhibit cell 
growth, primarily by interacting with and repressing transcription factors of the E2F 
family (reviewed in Stevaux and Dyson, 2002). There are at least six mammalian E2F 
proteins (E2FI-6), composed of strong (E2FI-3) and weak (E2F4-5) transcription 
activators, and one transcription repressor (E2F6) which is the only E2F member that 
does not bind to the pocket domain of the pRb family. E2F target genes are 
numerous, including genes involved in the G liS transition, S phase and DNA 
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replication such as cyclins, CDKs and DNA synthesis enzymes. Direct evidence for 
E2F central function as ceIl cycle activators cornes from E2FI-3 triple knockout 
fibroblasts, which are incapable of entering S phase and show marked reduction in 
many E2F target genes such as cyclin A and DNA polymerase a (Wu et al., 2001). 
The pRb family represses E2F transcriptional activity by directly binding and 
blocking, the activation domain of E2F proteins, and/or by recruiting histone 
deacetylases (HDACs) and other chromatin remodeling factors to E2F target 
promoters (Figure 1.2). Upon mitogenic stimulation, cyclin D levels are upregulated 
and cdk/cyclin complexes phosphorylate and inactivate pRb family members, which 
allow ceIl cycle re-entry (Classon and Harlow, 2002; Claudio et al., 2002). More than 
ten phosphorylation sites are found in the pocket domain of the pRb-related proteins 
and sequential CDK phosphorylation events are thought to progressively inactivate 
pRb as the cell cycle progresses. The pRb family members are differentially 
expressed through the cell cycle phases, where p 130 is elevated in GO phase and 
decreases with ceIl cycle progression while pl 07 is increased in S phase and pRb level 
remains constant. Moreover, only p107 and p130, which are structuraIly more closely 
related compared to pRb, can directly bind to cdk2-binding cyclins. 
The major role ofpRb during development has been underscored by the severe 
phenotype of Rb pathway knockout mice. Rb null animaIs die around EIS and show 
severe defects in erythroid, muscle, neuronal and lens development (Clarke et al., 
1992; Jacks et al., 1992; Lee et al., 1992; Lipinski and Jacks, 1999). The function of 
the pRb family during neurogenesis has been extensively studied using several 
knockout systems, revealing an important role in proliferation, differentiation and 
apoptosis (reviewed in Slack and Miller, 1996; Ferguson and Slack, 2001). Rb nuIl 
cerebral cortex shows extensive ectopic mitosis outside the proliferating zone, 
apoptosis and reduced early pan-neuronal gene expression (Clarke et al., 1992; Jacks 
et al., 1992; Lee et al., 1992; Slack et al., 1998). Similar phenotypes were also 
observed in Rb null developing PNS, where ectopicaly dividing cells were 
subsequently undergoing apoptosis and showing reduction in early and mature 
neuronal specific proteins (Lee et al., 1994). Interestingly, chimeric mice partially 
composed of Rb-deficient cells revealed that pRb functions both in a cell autonomous 
and non-autonomous manner, as Rb null cells integrate to most of the tissues and 
presente a much milder phenotype than the original Rb knockouts (Williams et al., 
1994). In the developing brains, these Rb deficient ceIls still show ectopic mitosis, 
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while sorne are able to survive and express pan-neuronal markers (Lipinski et al., 
2001). However, a significant rescue of Rb deficient embryos was observed by 
double knockout with E2Fl or E2F3, suggesting that pRb acts primarily by repressing 
these proteins (Tsai et al., 1998; Ziebold et al., 2001). The generation of 
telencephalon-specific Rb knockouts further support a direct function in cortical 
neurogenesis (Ferguson et al., 2002). These knockouts survive until birth and 
recapitulate most of the cortical defects observed in the original knockouts. 
Specifically, marked ectopic mitosis within the subventricular zone and the cortical 
plate is observed, along with increased apoptosis during early (E13.5) but not late 
(E16.5) neurogenesis. In vitro studies also provide strong evidence for pRb as a major 
cortical precursor proliferation regulator, where dominant negative cdk2, cdk4 or cdk6 
overexpression leads to cell cycle exit in wild-type but not in pRB knockout precursor 
cells (Ferguson et al., 2000). However, Rb deficiency does not grossly affect neuronal 
gene expression as measured with the early pan-neuronal marker PIII-tubulin. Similar 
results were obtained using cultured cortical precursor cells from Rb knockout 
embryos, where pRb is shown to be essential for cell cycle exit but not for neuronal 
gene expression and survival (Slack et al., 1998; Callaghan et al., 1999). One 
potential explanation for the variation of the phenotype severity observed between Rb 
knockout types and in vivo versus in vitro studies is compensation by other members 
of the pRb family. In differentiating cortical precursor cells, pRb levels are stable, 
while p107 is enriched only in proliferating precursors and not in neurons, and p130 
levels are kept low during differentiation (Callaghan et al., 1999). Conversely, in Rb 
deficient cortical cells, pl 07 is markedly upregulated during differentiation. 
Moreover, ablation of all pRb family members, by expression of the adenovirus ElA, 
leads to rapid and massive apoptosis of cortical precursor cells (Slack et al., 1998). 
Differentiated cortical neurons are resistant to ablation of all pRb family members 
(Slack et al., 1998), which might at least be explained by the observation that sorne 
components of the cell cycle machinery, such as E2Fs, are downregulated in 
differentiated neurons (Dagnino et al., 1997). White either pl07 or p130 single 
knockouts develop normally and are fertile, double knockouts show neonatallethality 
and a more severe phenotype, such as defective chondrocyte and limb development 
(Cobrinik et al., 1996; Lee et al., 1996). Interestingly, single knockouts for p107 or 
p130 with an enriched Balb/cJ background display a much more profound phenotype, 
such as impaired growth and myeloproliferation, or E Il lethality and impaired 
9 
neuronal and muscle development, respectively (LeCouter et al., 1998b; LeCouter et 
al., 1998a). Compensation between the pRb family members is further supported by 
the phenotype of Rb knockouts deficient in either p107 or p130, where the double 
knockout embryos die two days earlier than the Rb single knockouts with enhanced 
apoptosis within the CNS (Lee et al., 1996). An additional compensatory molecule is 
necdin, a member of the MAGE protein family, which can bind to and inhibit several 
pRb target prote in s, such as the E2F transcription factors. Necdin is highly enriched 
in both CNS and PNS differentiated neurons and is essential for proper maturation and 
survival of dorsal root ganglia neurons (Uetsuki et al., 1996; Takazaki et al., 2002). 
A role for pRb family in differentiation is supported mechanistically by its 
interaction with several transcription factors. Notably, pRb deficiency impairs muscle 
and adipocyte formation, while pRb was shown to directly interact with and potentiate 
the muscle and adipocyte tissue specific transcription factors MyoD and CIEBP, 
respectively (Gu et al., 1993; Chen et al., 1996; Novitch et al., 1999). Recently, the 
pRb family was also shown to directly regulate neuronal differentiation. The Notch 
pathway is a negative regulator of neurogenesis (see below) and p107 inhibits the 
transcription of the Notch receptor 1 via repression at the E2F binding sequence 
(Vanderluit et al., 2004). Both in vivo adult neural stem cells and in vitro expanded 
embryonic stem cells show an increased proliferation capacity in the absence of p 1 07, 
suggesting that members of the pRb family are important regulators of sorne types of 
differentiating cells, such as neural precursor cells. 
B. Regulators ofneuronal gene expression 
1. Positive regulators of neuronal genes: neurogenic bHLH proteins 
The large Helix-Loop-Helix (HLH) transcription factor family comprises more 
than 200 members, present in organisms from yeast to man, and which can be 
subdivided in six classes based on their DNA binding properties and there expression 
patterns (reviewed in Massari and Murre, 2000). These HLH proteins have been 
implicated in the regulation of many cellular processes within several organs, such as 
muscle, heart, blood, pancreas and nervous system. Originally best studied during 
. Drosophila neurogenesis and mammalian myogenesis, the HLH protein family is now 
considered a major regulator ofmammalian neural development (reviewed in Bertrand 
I!J> 
10 
et al., 2002; Schuurmans and Guillemot 2002; Ross et al., 2003; Kageyama et al., 
2005), as described below. 
Class II HLH proteins (also referred as class B), which include neurogenic 
HLHs, show a restricted expression pattern and are positive transcriptional regulators 
of tissue or cell-type specific genes (reviewed in Massari and Murre, 2000). They 
form heterodimers through their helix domains with the widely expressed class 1 HLH 
proteins, E proteins such as El2 and E47 (also referred as class A HLHs). Both these 
HLH classes have a basic domain through which heterodimerbind to E-box 
recognition sites, CANNTG, and activate transcription after recruitment of 
coactivators, such as p300/CBP which have histone acetyl transferase (HAT) activity 
(Figure 1.2). Vertebrate myogenic and neurogenic bHLH proteins can be further 
subdivided in two categories, the determining and differentiating groups, where the 
former ones are expressed within precursor cells and are responsible for early 
establishment of the lineage while the latter are expressed by differentiating and 
maturing cells. Drosophila determining proneural bHLH proteins, achaete-scute and 
atonal families have been weIl characterized (reviewed in Bertrand et al., 2002), 
where 10ss and gain-of-function studies have shown that these proteins are both 
essential and sufficient to induce neural differentiation from early embryonic 
ectodermal ceIls, and that together they account for almost aIl neurogenic activity of 
the nervous system. In comparison, the vertebrate neurogenic bHLH family is 
composed of both Drosophila-related and novel mammalian members leading to a 
functionally more complex regulation of neurogenesis. The mammalian asc-related 
bHLH is Mashl, while the ato-related family is much larger, inc1uding the neurogenin 
(ngn), Math and NeuroD families. While overexpression ofmany ofthese neurogenic 
bHLHs is sufficient to induce neuronal differentiation of non-neural mammalian cells 
as measured by pan-neuronal gene expression and morphology (Farah et al., 2000), 
only a small subset of these proteins shows proneural determining factor potential in 
loss-of-function studies. SpecificaIly, Mashl deficiency leads to severe neuronal 
defects in the ventral telencephalon and the olfactory epithelium (Guillemot et al., 
1993; Casarosa et al., 1999; Cau et al., 2002), while ngnl-2 double knockout animaIs 
lack cranial and spinal sensory ganglia and sorne ventral spinal cord neurons (Fode et 
al., 1998; Ma et al., 1998; Ma et al., 1999; Scardigli et al., 2001). As observed in 
Drosophila, the proneural activity of Mashl and ngns is at least partly mediated by 
their ability to induce both Notch ligand expression, which leads to lateral inhibition 
11 
ofneighboring cells (see below), and the expression of differentiating bHLHs, such as 
NeuroD and Math3 (reviewed in Bertrand et al., 2002). Within the developing 
embryonic telencephalon, Mashl and ngns have a complementary expression pattern, 
where Mashl is highly enriched within the ventral part and ngns are expressed in 
overlapping dorsal regions (ngnl is more restricted to the lateral cortex) (Fode et al., 
2000). Deletion of both ngns leads to an upregulation of Mashl within the dorsal 
telencephalon which acts as a compensatory proneural bHLH and largely rescues 
cortical neurogenesis. However, deletion of both ngn2 and Mashl results in a more 
severe loss of cortical neurons (Fode et al., 2000) .. No such compensatory effect is 
observed in the Mashl null telencephalon, where ventral neurons are lost, specifically 
within the developing medial ganglionic eminence (MGE) (Casarosa et al., 1999). 
While proneural bHLH deficiency leads to a loss in neural precursor cells as observed 
in the Mashl and ngns knockouts, downstream neurogenic bHLH mutation results in 
differentiation defects. Mathl, Math2, Math3, Math5 and NeuroD deficient animaIs 
show abnormalities in restricted subpopulations of neurons, such as cerebellar granule 
cells, hippocampal granule cells, and retinal ganglion cells, consistent with a 
differentiating bHLH function (Ben-Arie et al., 1997; Miyata et al., 1999; Morrow et 
al., 1999a; Tomita et al., 2000; Brown et al., 2001; Gazit et al., 2004). No defect in 
the developing cerebral cortex has been reported for these mutants. However, 
compensation between both determining and differentiating bHLH proteins is likely to 
occur as double knockouts for Mashl/ngn2 or Mashl/Math3 show a marked lost in 
many neuronal populations in comparison with the single mutants (Fode et al., 2000; 
Tomita et al., 2000). 
Besides induction of neurogenic and lateral inhibition genes, two additional 
functions of proneural bHLH proteins have been suggested. First, the complementary 
expression patterns of Mashl and ngns in both the PNS and CNS, where they are 
expressed in autonomic/ventral telencephalon and sensory/dorsal telencephalon 
neurons respectively, suggest a role in neuronal subtype specification and patterning. 
Careful examination of Mashl and ngns knockout telencephalon has indeed revealed a 
role in neuronal subtype specification. Mashl upregulation in the absence of ngns is 
sufficient to maintain neuronal differentiation but produces neurons which ectopically 
express ventral telencephalon specific markers, such as GAD47 and DIx1 (Fode et al., 
2000). A ngn2 to Mashl replacement mutation is sufficient to induce ventral 
phenotype in cortical neurons, providing further support that Mashl acts instructively 
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to induce neuronal subtype specification (Fode et al., 2000). In cultured PNS neural 
precursor cells, overexpression of Mashl or ngn2 induces autonomic or sensory 
neuronal phenotype, respectively (Lo et al., 1998; Lo et al., 2002). However, in 
conditions promoting autonomic lineage, ngn2 overexpression can also promote 
autonomic neuron differentiation (Lo et al., 2002). To further study the differences 
and similarities between proneural bHLHs in vivo, the coding sequences of Mashl and 
ngn2 were swapped. Interestingly, while ectopic ngn2 can rescue most of the Mashl 
null phenotypes, ectopic Mash 1 leads to misspecification of sorne ngn2-expressing 
cortical and spinal cord neurons, and ngn2-expressing dorsal root ganglia are not 
rescued by the Mashl expression (Parras et al., 2002). Together, these studies 
demonstrate that proneural genes are not completely redundant in their generic 
neuronal induction potential and either act instructively, in the case of Mashl, or in a 
context-dependent manner, in the case of ngn2, to induce neuronal subtype 
specification. 
The second known function of neurogenic bHLH proteins is cell cycle 
regulation. Overexpression ofneurogenic bHLH proteins in non-neural P19 celllines 
induces cell cycle arrest (Farah et al., 2000). Similarly, NeuroD inhibits Hela cells 
proliferation whereas NeuroD-null small intestine cells show increased proliferation 
(Mutoh et al., 1998). In the nervous system, overexpression ofngn2 in PNS precursor 
cells markedly decreased their proliferation (Lo et al., 2002), while Mashllngn2 
deficient CNS precursor cells show a three-fold increased in clone size (Nieto et al., 
2001). Given that neuronal differentiation is coupled with cell cycle withdrawal, are 
neurogenic bHLHs directly or indirectly regulating the cell cycle? In the P19 cellline, 
overexpression of neurogenic bHLHs leads to upregulation of the negative cell cycle 
regulator CKI, p27 (Farah et al., 2000). In Hela cells, NeuroD transactivates the 
promoter of another CKI, p21, while NeuroD-null small intestine cells have reduced 
p21 expression (Mutoh et al., 1998). Interestingly, during muscle differentiation, 
where muscle-specific gene expression is also coupled to cell cycle withdrawal, the 
myogenic bHLH, MyoD, has been shown to positively regulate the activity of the 
negative cell cycle regulator pRb through either direct binding or by induction of pRb 
gene expression (Gu et al., 1993; Martelli et al., 1994; Magenta et al., 2003). 
However, it is still unclear how neurogenic bHLHs are involved in the regulation of 
cell cycle during neuronal differentiation. 
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Appropriate regulation of neurogenic bHLH proteins also appears to be crucial 
for proper development of the nervous system beyond the neurogenic period. Indeed, 
as seen in loss-of-function studies, sustained expression of sorne neurogenic bHLH 
proteins has been shown to impair neurogenesis. Specifically, while retroviral 
overexpression of Mashl or ngns within the perinatal cortex initially induces neuron 
formation, most of these neurons degenerate and undergo apoptosis within the 
following 3 weeks (Cai et al., 2000). Similarly, ectopic expression of Math 1 under the 
nestin promoter leads to abnormal morphology of the developing telencephalon and 
midbrain along with enhanced apoptosis as early as El1.5 (Isaka et al., 1999). In non-
neural cell lines, NeuroD overexpression can also le ad to apoptosis (Mutoh et al., 
1998). While several mechanisms to negatively regulate neurogenic bHLH activity 
have been identified (as described below), positive regulation is less well 
characterized. As previously described, neurogenic bHLH proteins, like myogenic 
bHLHs, are thought to function in a cascade where proneural bHLHs induce the 
subsequent expression of differentiating bHLHs. For example, ngns are required for 
the expression of Math3 and NeuroD in sensory neurons, while Mashl induces ngnl 
and NeuroD in olfactory sensory epithelium (Fode et al., 1998; Ma et al., 1998; Cau et 
al., 2002). In the developing cortex, the proneural bHLH proteins ngns are expressed 
in precursor cells within the ventricularlsubventricular zones, while the differentiating 
bHLH prote in NeuroD is subsequently expressed in newly born neurons in the cortical 
plate (Fode et al., 2000; Lee et al., 2000). However, the mechanism responsible for 
proneural bHLH expression is still unc1ear. Shh signaling has been shown to promote 
Mashl expression in cultured neural stem cells (Yung et al., 2002), while patterning 
genes, such as the homeodomain transcription factors Phoxb, Pax6 and Gsh2, regulate 
the expression of ngn2 and Mashl in motoneurons and telencephalic neurons 
(Toresson et al., 2000; Scardigli et al., 2001; Dubreuil et al., 2002; Scardigli et al., 
2003). Specifically, Gsh2 and Pax6 show a complementary expression pattern within 
the ventral and dorsal telencephalon, which c10sely corresponds with the Mashl and 
ngn2 expression domains, respectively. Mutants for these homeodomain proteins 
subsequently have decreased expression of the normally co-expressed proneural 
genes. However, only Pax6 has been shown to directly transactivate the ngn2 
promoter in the cortex and spinal cord (Scardigli et al., 2003). 
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2. Positive regulators of neuronal genes: C/EBP transcription factor family 
An additional family of transcription factors which positive1y regulates cortical 
neurogenesis has been recently identified. The CAAT/enhancer binding prote in 
(C/EBP) family has six members (a, ~, 8, E, 'Yand Ç) which are basic leucine zipper 
DNA binding proteins (reviewed in Lekstrom-Himes and Xanthopoulos, 1998). 
These proteins are widely expressed during development and adulthood, form homo 
or heterodimers to directly activate or repress gene transcription, and have been shown 
to regulate differentiation of several cell types, especially during adipogenesis and 
hematopoiesis. At least three members are expressed in cortical precursor cells 
(a, ~ and 8), while the phosphorylated active form of C/EBP~ is highly enriched in 
newly born cortical neurons (Paquin et al., in press; Ménard et al., 2002). Ablation of 
all C/EBP activity by overexpression of a dominant-negative form of C/EBP~ inhibits 
cortical neurogenesis both in vitro and in vivo, and conversely, potentiates cytokine-
induced astrocyte formation (Paquin et al., in press; Ménard et al., 2002). Moreover, 
an activated form of C/EBP~, which mimics phosphorylation at a Rsk site, is 
sufficient to enhance cortical neurogenesis of cultured cortical precursors and in the 
E13 developing cortex in vivo (Paqùin et al., in press). C/EBPs are likely to induce 
neurogenesis by at least two mechanisms. First, they have been shown to directly 
bind to and activate the transcription of the early pan-neuronal gene promoter, TaI a-
tubulin (Ménard et al., 2002). In other cell systems, C/EBPs have been shown to 
collaborate with other transcription factor families in order to induce differentiation 
(Lekstrom-Himes and Xanthopoulos, 1998) and they utilize the coactivators 
p300/CBP to induce gene expression (Blobel, 2000). Therefore, C/EBP could 
potentially act in concert with neurogenic bHLH, through the common recruitment of 
p300/CBP, to promote cortical neurogenesis (Figure 1.2). A second mechanism 
involves cell cycle regulation. C/EBPs inhibit growth of nonneural cells by either 
direct repression of cdk2 and cdk4 proliferation activity (Wang et al., 2001a), or by 
physical interaction with and potentiation ofpRb (Chen et al., 1996; Puigserver et al., 
1998). As no obvious nervous system defects have been reported in C/EBP knockout 
mice (reviewed in Lekstrom-Himes and Xanthopoulos, 1998), C/EBP proteins are 
Jikely to have redundant function during cortical neurogenesis. 
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3. Negative regulators of neuronal genes: Id proteins 
The class V HLH proteins lack the basic domain and, upon HLH domain-
mediated heterodimerization, inhibit positively acting HLH proteins through passive 
repression. These transcription repressors are called "Id", for inhibition of either 
DNA binding or differentiation, and there are 4 vertebrate members identified to date, 
Idl-4 (reviewed in Massari and Murre, 2000; Norton, 2000). Id proteins preferentially 
bind to and sequester E proteins, the ubiquitous essential transcriptional partners of 
activator HLH proteins such as neurogenic bHLHs, and therefore act as naturally 
occurring dominant negative HLH proteins (Benezra et al., 1990). Ids are widely 
expressed throughout the embryo and aIl the members are present within the 
developing brain, while the expression is very low in the adult (Jen et al., 1996, 1997). 
Overexpression studies have shown a general role for Id proteins as inhibitors of 
differentiation by inhibiting positively acting bHLH activity (reviewed in Norton et 
al., 1998). For example, Id1 or Id2 overexpression in muscle and adipocyte celllines 
inhibits their differentiation (Melnikova et al., 1999; Moldes et al., 1999), while 
knock-in animaIs show impaired B cell differentiation and depletion of mature 
thymocytes, respectively (Sun, 1994; Morrow et al., 1999b). Id2 and Id3 knockouts 
show hematopoietic abnormalities, such as deficiencies in natural killer and B cell 
precursor ceIls, respectively (Pan et al., 1999; Yokota et al., 1999; Ikawa et al., 2001). 
The overlapping expression pattern of Id proteins is likely to result in functional 
redundancy, and analysis of Id1/Id3 double knockout shows a much more severe and 
widespread phenotype than the single mutants, with angiogenesis and neurogenesis 
defects (Lyden et al., 1999). In the developing nervous system, Id1/2/3 are enriched 
in neural precursor cells and Id2 expression is also maintained in sorne differentiating 
neuronal populations, including in the cerebral cortex (Neuman et al., 1993; Jen et al., 
1997). In neural ceIls, Id prote in levels are up-regulated in proliferating Schwann 
ce Ils, and Id2 overexpression inhibits whereas Id2 deficiency increases 
oligodendrocyte differentiation (Stewart et al., 1997; Wang et al., 2001b). 
Ove:rexpression of Id! in cortical precursors in culture or in vivo is sufficient to inhibit 
neurogenesis (Cai et al., 2000; Nakashima et al., 2001). Id1/Id3 double knockout 
embryos have several neurogenesis defects, including reduced precursor proliferation 
and premature neuronal differentiation in the tèlencephalon, and have enhanced 
expression of the neurogenic bHLHs NeuroD and Mathl-3 throughout the brain 
(Lyden et al., 1999). Interestingly, Id proteins have also been shown to bind and 
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inhibit the Pax transcription factor family (Roberts et al., 2001). Although direct 
inhibition of only Pax2/5/8 was demonstrated, which are important regulators of B 
cell and kidney development, it is tempting to propose that Ids can further negatively 
regulate neurogenesis by inhibiting Pax6 activity, which is a positive regulator of the 
proneural gene ngn2 (Scardigli et al., 2001; Scardigli et al., 2003). 
Id proteins also have been implicated in tumorigenesis (Norton, 2000; Iavarone 
and LasoreIla, 2004). For example, Ids are highly expressed in several types of 
tumors, such as neuroblastomas (Lasorella et al., 2000; Wartiovaara et al., 2002), 
whereas tumor growth and metastasis is inhibited in Idl +1- in a Id3-null background 
(Lyden et al., 1999). This oncogenic activity of Id proteins certainly reflects their 
ability to both inhibit differentiation and promote proliferation. For example, 
antisense oligomers against Id1l2/3 are sufficient to prevent or delay cell cycle re-
entry in two serum-stimulated cell lines (Barone et al., 1994; Hara et al., 1994). 
Interestingly, only Id2 has the capacity to directly inhibit the activity of the tumor 
suppressor pRb family (Iavarone et al., 1994). Id2, through its HLH domain, binds to 
the pocket domain of the hypophosphorylated active form of pRb, and overexpressed 
Id2 is sufficient to override the activity of pRb activators, p21 and p 16, and promote 
cell cycle progression (Lasorella et al., 1996). Additional potential mechanisms used 
to promote cell cycle by Ids include negative regulation of the CKI p 16 and p21 
genes. The p21 promoter contains E-boxes that are positively regulated by E bHLH 
proteins and inhibited by Idl in NIH 3T3 ceIlline (Prabhu et al., 1997). Id proteins 
have also been shown to interact with and inhibit the transcriptional activity of the 
ETS-domain proteins, which are downstream targets of the MAPK pathway and are 
involved in regulating immediate-early gene transcription (Yates et al., 1999). The 
p16 promoter contains ETS binding sites and has been shown to be positively 
regulated by ETS proteins, which are inhibited by overexpressed Idl in fibroblasts 
(Ohtani et al., 2001). AIl these studies have been performed in cell lines and these 
mechanisms have not been further confirmed in primary neural cells yet. 
Id protein level and activity are known to be regulated in several ways. 
Promoter analysis of Id2 and Id4 has revealed the presence of E-boxes, which are 
transactivated by positively acting bHLH proteins and inhibited by Ids (Neuman et al., 
1995; Pagliuca et al., 1998). In B cells, the Idl promoter has also been shown to be 
regulated by the CIEBP family (Saisanit and Sun, 1997). Knowing thatboth bHLH 
and CIEBP families are positive regulators of neurogenesis, these findings are 
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somehow surprising and suggest the existence of a complex interplay and balance 
between positive and negative regulators. Id protein activity is further regulated by 
bHLH proteins in two ways. First, Ids are short-life proteins sensitive to ubiquitin-
proteasome degradation that is greatly abrogated upon interaction of Ids with E 
proteins (Bounpheng et al., 1999). Second, Id proteins lack a nuclear localization 
signal (NLS) and E proteins serve as chaperones, where co-expression with E proteins 
allows Id translocation to the nucleus (Deed et al., 1996). Subcellular localization of 
Id proteins as a regulatory mechanism is of particular interest as two reports have 
shown that Id proteins are located in the nucleus of precursors, but in the cytoplasm of 
differentiated oligodendrocytes and Schwann cells (Stewart et al., 1997; Wang et al., 
2001b). FinaIly, Id proteins contain several putative phosphorylation sites, and can be 
phosphorylated in vitro by c-AMP-dependent kinase, cdc2 and protein kinase C 
(Nagata et al., 1995). To date, only phosphorylation by cdk2 has been shown to 
impede on Id binding properties during cell cycle progression in a cell line (Deed et 
al., 1997; Hara et al., 1997). 
4. Negative regulators of neuronal genes: Notch signaling pathway 
Notch was initially discovered and extensively studied in Drosophila but its 
signaling pathway and biological functions have also been described during 
mammalian development (reviewed in Kadesch, 2004; Y oon and Gaiano, 2005). 
Proteins of the Notch family (4 members in vertebrates) are transmembrane receptors 
that are activated by the membrane-bound ligands of the Delta and Jagged/Serrate 
families. Ligand binding renders the Notch receptor accessible to two subsequent 
cleavages by the TACE (TNF-a converting enzyme) and the y-Secretase complex, 
which lead to the formation and release from the plasma membrane of the Notch 
intracellular domain (NICD). NICD translocates to the nucleus where it binds to the 
repressor CSL (CBP, ,S.u(H) , ,Lag-2, also called CBFl or RBP-JK) and directs the 
formation of a multi-protein complex, which is now transcriptionally active. Notch 
primary target genes are the HES and HERP (HES-related repressor proteins) families 
(Figure 1.2). These proteins are of the class VI HLH type of transcriptional 
repressors, which inhibit the activity of positively acting bHLH proteins through at 
least two mechanisms (reviewed in Iso et al., 2003). First, HES and HERP proteins 
can bind to N-boxes present in positively acting bHLH gene promoters and inhibit 
their transcription by recruiting different co-repressors, such as TLE and N-Cor, 
18 
respectively. Second, they also can bind to and sequester the ubiquitous positive 
bHLH partners, E47 and E12 (Figure 1.2). 
The Notch pathway was first identified and studied during fly neurogenesis but 
it now has been shown to be involved in numerous organ developmental processes. 
Only Notch function during mammalian CNS development will be presented here. 
Notch signaling is classically viewed as a way to inhibit differentiation and promote 
precursor celI identity through lateral inhibition. Within a pool of precursor celIs, the 
ones expressing higher levels of the Notch ligand Delta will be able to differentiate, 
while inducing Notch signaling in the neighboring celIs to prevent their differentiation 
and to maintain the precursor pool. Compelling evidences for Notch as a positive 
regulator of precursor identity come from the generation of several Notch signaling 
component knockouts (reviewed in Yoon and Gaiano, 2005). Knockouts for the 
Notch receptor, the processing y-Secretase complex proteases (presenilins PSI and 
PS2) and the Notch target genes Hes aIl present similar phenotypes: a loss in neural 
precursor populations and precocious and increased neuronal differentiation (Y oon 
and Gaiano, 2005). SpecificaIly, knockout embryos for Notchl or CSL show 
enhanced expression of many pro-neuronal bHLH genes, such as Mashl and NeuroD, 
while HesS mRNA is markedly reduced throughout the CNS (de la Pompa et al., 
1997). In vitro, inhibition of Notchl expression by antisense oligonucleotides or 
Presenilinl deficiency promotes neurogenesis of ElO forebrain precursor ceIls, while 
Notch activation by exogenous Delta inhibits neuronal differentiation (Faux et al., 
2001). Knockout embryos for HesS alone or in combination with Hesl and Hes3 
deficiencies have several cortical defects, such as enhanced expression of Mash 1 and 
Math3, premature neuronal differentiation of radial glial ceIls and reduced 
proliferation capacity of precursor ceIls (Ohtsuka et al., 2001; Sakamoto et al., 2003; 
Hatakeyama et al., 2004). Complementary studies to inhibit Hes activity have been 
performed taking advantage of Hes6, which is a naturaIly occurring inhibitor of the 
Hes repressors (Bae et al., 2000). In the developing brain, Hes6 is present in both 
precursors and neurons and its expression follows that of proneuronal bHLHs but 
precedes that of differentiated pan-neuronal genes (Bae et al., 2000; Koyano-
Nakagawa et al., 2000). Overexpression studies have shown that Hes6 promotes pro-
neuronal bHLH activity, leading to precocious and increased neuronal differentiation 
in the retina and in cortical precursor ceIls (Bae et al., 2000; Gratton et al., 2003). 
Interestingly, Hes6 expression was shown to be regulated by ngnl at least partiaIly, 
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and not by Notch (Koyano-Nakagawa et al., 2000). Notch pathway gain-of-function 
studies also support an important role for Notch in regulating the precursor state. 
Activated Notchl leads to increased numbers of radial glial cells in the developing 
forebrain (Gaiano et al., 2000) and in utero overexpression of either Hesl or Hes5 
leads to an increased precursor pool that results in differentiated cell overproduction 
later in development (Sakamoto et al., 2003). An additional mechanism that could be 
utilized by Notch to maintain the precursor state is by direct promotion of 
proliferation. In a cellline system, Notch signaling was shown to directly induce the 
expression of the cyclin D via a CLS binding site, therefore promoting cdk2 activity 
and cell cycle progression (Ronchini and Capobianco, 2001). 
FinaUy, Notch signaling also plays a role in asymmetric division of precursor 
cells. Numb and Numblike transmembrane proteins are negative regulators of Notch 
receptor and are asymmetrically expressed on a sub-population of cortical precursor 
cells. This asymmetric distribution correlates with asymmetric divisions that generate 
one neuron and one precursor daughter cell (Shen et al., 2002). Disruption of both 
Numb and Numblike proteins in the forebrain leads to hyperproliferation of precursor 
cells and impaired neuronal differentiation. Moreover, the double knockout precursor 
cells undergo increased symmetric ceU divisions at the expense of asymmetric cell 
divisions (Li et al., 2003). Together, these data strongly suggest that the Notch 
pathway inhibits neuronal differentiation, and is an important positive regulator of the 
precursor cell state. 
5. Transcription factors that positively regulate the precursor cell state 
While Ids and Notch can prevent the onset of neurogenesis by inhibiting the 
neurogenic bHLH differentiation pathways, four apparently unrelated families of 
transcription factors have recently been identified that appear to inhibit neurogenesis 
because they directly promote and maintain precursor identity. Specifically, the 
winged-helix prote in brain factor-l (BFl) (Dou et al., 1999), the activating 
transcription factor/cAMP response element binding protein (ATF/CREB) ATF5 
(Angelastro et al., 2003; Angelastro et al., 2005; Mason et al., 2005), the homeobox 
prote in Emx2 (Tole et al., 2000; Heins et al., 2001), and the HMG-box transcription 
factor SoxBl family (Bylund et al., 2003; Graham et al., 2003) aU seem to promote 
the precursor state. These transcription factors are highly enriched in precursor cells 
and their expression is reduced or absent in differentiated neural progeny. 
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Overexpression of each of these proteins leads to increased proliferation of the 
precursor pool, while loss-of-function results in reduced proliferation and accelerated 
differentiation. Specifically within cortical precursor cells, BFl, Emx2 and ATF5 
were shown to promote multipotent precursor cell proliferation. The BF 1 deficient 
cortex presents a severe reduction in size and premature neuronal differentiation (Dou 
et al., 1999). Emx2 overexpression leads to enhanced proliferation of precursor cells, 
while Emx2 deficient neural precursors have a reduced proliferation potential (Heins 
et al., 2001). ATF5 overexpression inhibits differentiation ofneurons, astrocytes and 
oligodendrocytes, whereas its ablation potentiates growth factor-induced 
differentiation of neuronal and glial cells from cortical precursor cells (Angelastro et 
al., 2003; Angelastro et al., 2005; Mason et al., 2005). Taken together, these data 
show that these transcription factors act as general positive regulators of the precursor 
state. While the upstream and downstream pathways utilized by these factors are 
currently unknown, it is interesting to note that SoxB 1 proteins are downregulated by 
ngn2 in chick neural precursor cells (Bylund et al., 2003). Therefore, inhibition of 
these transcription factor activities might be a prerequisite for the onset of 
neurogenesis. 
C. Regulators ofsurvival and apoptosis ofprecursor cells 
Apoptosis is a highly regulated form of programmed cell death (PCD) that 
plays a fundamental role in regulating the development of the entire nervous system. 
During cerebral cortex development, two distinct types of PCD occur, one targeting 
neural precursor cells during embryogenesis and the other involving cortical neurons 
primarily within the first postnatal weeks (Ferrer et al., 1992; Voyvodic, 1996). While 
the latter happens during synaptogenesis and can be at least partially explained by the 
"trophic hypothesis" where apoptosis eliminates aberrant neuronal connections and 
matches neuron number to target size (reviewed in Oppenheim, 1991), PCD of 
precursor cells is somehow more surprising. A significartt number of precursor cells 
within cortical VZ/SVZ have been shown to undergo apoptosis from E12 to E18, 
numbers varying from 10-70% of total dividing cells depending on the labeling 
method used (Blaschke et al., 1996; Thomaidou et al., 1997; Blaschke et al., 1998). 
The significance of developmental precursor apoptosis is further highlighted in several 
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mutant mice of the apoptotic caspase pathway. The Bcl2 family of proteins contains 
both pro-survival and pro-apoptotic molecules, such as Bcl-XL and Bax respectively, 
which control cytochrome c release from the mitochondria. Upon apoptotic stimuli, 
released cytochrome c interacts with the apoptosis protease-activating factor (AP AF) 
and caspase 9, forming the apoptosome, which then activates the apoptosis effector, 
caspase 3 (Kuan et al., 2000; Yuan and Yankner, 2000). AnimaIs deficient for 
AP AF 1, caspase 9 or caspase 3 present a similar phenotype, showing exencephaly due 
to absence of neural precursor apoptosis in the developing neural tube (Kuida et al., 
1996; Cecconi et al., 1998; Kuida et al., 1998). Moreover, caspase 3 and caspase 9 
deficient cortices have decreased precursor PCD and are markedly larger and 
malformed (Kuida et al., 1998; Pompeiano et al., 2000). Conversely, neural 
precursor-specific disruption of a member of the inhibitor of apoptosis (IAP) family, 
survivin, results in a marked increase of cortical precursor and neuron apoptosis and 
leads to the absence of cortex at later embryonic stages (Jiang et al., 2005). Absence 
of survival is accompanied by a significant increase in caspase 3 and 9 expression and 
activity throughout the developing cortex. Interestingly, knockouts for BcL-XL and 
Bax have respectively increased or decreased apoptosis ofnewly born cortical neurons 
but not of precursor cells, suggesting compensatory mechanisms by other members of 
the Bcl2 family or additional uPstream apoptotic pathways (reviewed in Kuan et al., 
2000). 
Why is neural precursor cell apoptosis such an important developmental 
process? At least three potential explanations have been suggested for this precursor 
PCD, which are elimination of cells with division or differentiation errors, selection of 
specific precursor cell populations, and limiting amounts of survival signaIs, such as 
growth factors (Voyvodic, 1996). Moreover, certain molecular pathways have been 
proposed to regulate sorne of these effects. Dysregulation of the cell cycle leads to 
apoptosis in multiple neuronal populations, such as cortical and sympathetic neurons 
(reviewed in Liu and Greene, 2001). SpecificaIly, pRb deficient cortices show 
increased precursor apoptosis, which can be rescued either in the absence of its target 
E2Fl or the pro-apoptotic protein p53 (Macleod et al., 1996; Tsai et al., 1998). E2Fl 
is thought to be acting upstream of p53 as E2Fl deficiency prevents p53 pathway 
activation caused by pRb inactivation (Pan et al., 1998). A direct role for E2Fl in 
apoptosis was shown in cultured cortical neurons, where E2F 1 overexpression leads to 
apoptosis of the se cells (Hou et al., 2000). The transcription factor p53 is a weIl 
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characterized tumor suppressor prote in that mediates apoptosis at least partialIy 
through transactivation of components of the mitochondria-caspase death pathway in 
several cell types inc1uding neurons. Recently, two p53 related proteins have been 
identified, p63 and p73, which are expressed either as fulIlength proteins (TAp63 and 
TAp73) or as truncated negative forms missing the transactivation domain (i1Np63 
and i1Np73) (Yang and McKeon, 2000; Jacobs et al., 2004; MolI and Slade, 2004). 
The p53 family members act as homo or heterotetramers and the balance between TA 
and i1N proteins will dictate either cell apoptosis or survival. Knockout studies have 
underscored the importance of these p53 members in the regulation of apoptosis, 
tumorigenesis and development. Specifically in the developing cerebral cortex, a 
significant portion of p53 knockout animaIs show embryonic lethality due to 
overproduction of neural tissue and neural tube malformation (Armstrong et al., 1995; 
Sah et al., 1995). Conversely, cortical neurons, which express the i1Np73 , are 
progressively lost via apoptosis from the second postnatal week until adulthood in p73 
deficient animaIs (Pozniak et al., 2002). Deficiency for p63 leads to neonatallethality 
and dramatic developmental defects, such as limb truncation and absence of epidermis 
(Mills et al., 1999; Yang et al., 1999), whereas cortical development has not yet been 
studied in details in these animaIs. Together, these data suggest an important role for 
p53 and i1Np73 as positive and negative apoptosis regulators of cortical precursors 
and neurons, respectively. Additional studies have linked neural precursor PCD to 
DNA replication or differentiation processes. Deficiency in DNA repair proteins, 
DNA ligase IV or XRCC4, leads to massive neuronal apoptosis, while concurrent 
absence of p53 rescues neural precursor and neuron death, inc1uding within the 
developing cortex (Barnes et al., 1998; Frank et al., 2000; Gao et al., 2000). Deletion 
of the chromatin-remodeling prote in, ATRX, in the developing forebrain results in 
loss of newly born cortical neurons by apoptosis both in vivo and in culture (Berube et 
al., 2005). However, the mechanism underlying this phenotype is unc1ear, but might 
involve transcriptional regulation of essential survival or differentiation genes. 
Finally, a less well studied explanation for neural precursor PCD is limitation of 
growth factors. The trophic hypothesis of developmental PCD of peripheral neuronal 
populations has been weIl characterized (reviewed in Yuan and Yankner, 2000). 
Specifically, in the absence of growth factors, such as neurotrophins (see below), a 
JNK-p53 apoptotic cascade is activated. Interestingly, JNKl/JNK2 double knockouts 
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harbor a similar phenotype to other precur~or PCD factor deficiencies, such as 
exencephaly and impaired neural tube elosure (Kuan et al., 2000), suggesting that 
precursor cell survival is also regulated by trophic factors present within the 
developing brain. One such trophic factor is erythropoietin, a member of the 
haematopoietic cytokine family, which signaIs through the erythropoietin receptor 
(EpoR) to induce intracellular signaling pathways. Analysis of EpoR knockouts has 
revealed increased apoptosis in the embryonic brain, ineluding a marked reduction in 
cortical precursor cells (Yu et al., 2002). Cultured embryonic cortical neurons are 
more sensitive to hypoxia-induced apoptosis in the absence of EpoR, whereas 
erythropoietin treatment protects wild type neurons from apoptosis at least partially by 
increasing the levels of the anti-apoptotic protein Bel-XL (Yu et al., 2002). 
III. Extracellular players in cortical neurogenesis 
The hypothesis of Chapter 3 is that the cortical precursor pool secretes 
autocrine/paracrine-acting factors that regulate their survival and neuronal 
difJerentiation. Here, 1 review our current knowledge of the extracellular factors that 
regulate proliferation and neurogenesis of cortical precursor cells. 
A. Control of proliferation 
1. FGF family 
The fibroblast growth factor (FGF) family comprises more than twenty 
members that act through the transmembrane tyrosine kinase FGF receptors (FGFRs), 
which have four members in mammals. FGF signaling is involved in many 
developmental processes in several tissues, and within the central nervous system has 
been implicated in axon growth, neuroprotection, leaming and memory (reviewed in 
Reuss and von Bohlen und Halbach, 2003). Specifically in the developing brain, 
FGF2 (also called basic FGF) has been shown to be an important mitogenic factor for 
neural precursor cells. FGF2 is expressed in the developing cerebral cortex and in 
cultured precursor cells, along with FGFR-l and FGFR-3 (Hajihosseini and Dickson, 
1999; Vaccarino et al., 1999). An additional source of FGF2 for cortical precursor 
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cens cornes from thalamic afferents. Conditioned media from thalamic explants 
promotes cortical precursor cell proliferation that is abolished in the presence of FGF2 
function blocking antibodies, and precursor proliferation is enhanced in cortical 
explants presetving thalamocortical innervation (Dehay et al., 2001). Both early and 
late cortical precursor cells and embryonic and adult neural stem cells proliferate in 
the presence of FGF2 (for example, see Vescovi et al., 1993; Ghosh and Greenberg, 
1995; Qian et al., 1997). In addition to its potent mitogenic activity, FGF2 was also 
shown to promote survival of cortical precursors in clonaI cultures, as FGF2 increases 
both the number of cells within a clone and the number of clones per se (Hajihosseini 
and Dickson, 1999). Several findings implicate FGF2 as a key regulator of cortical 
neurogenesis in vivo. A single injection of FGF2 in cerebral cortex during early 
neurogenesis (E15 in rat) leads to at least a 50% increase of the cortex volume and the 
total cortical cell number and density after five days (Vaccarino et al., 1999). When 
analyzed as adults,El5 FGF2 injected cortices show an 87% increase in the number 
of neurons and 58% increase in neuronal densitY. Interestingly, when FGF2 is 
administered at the end of embryogenesis (E20 in rat), at the onset of gliogenesis, a 
76% increase in astocytes is observed three weeks later, without significant effect on 
the number of cortical neurons (Vaccarino et al., 1999). Conversely, FGF2 knockout 
cortices present impaired proliferation and neuronal production (Dono et al., 1998; 
Ortega et al., 1998; Vaccarino et al., 1999). As early as Ell, FGF2 knockout cortices 
have reduced proliferating cells and total numbers of cells in the ventricular zone 
(Vaccarino et al., 1999; RabaUo et al., 2000). The FGF2 knockout adult cortices have 
decreased total cell number (Dono et al., 1998; Ortega et al., 1998), as well as a 25-
50% reduction in the numbers of neurons and glial cells (Vaccarino et al., 1999; 
Raballo et al., 2000). Compensation by other FGF family members is possible, as 
additional FGFs are expressed in the developing telencephalic ventricular zone, such 
as FGF11 and FGF13, and can mimic FGF2 effects on cortical precursor cens, such as 
FGF4 (Smallwood et al., 1996; Hartung et al., 1997; Hajihosseini and Dickson, 1999). 
FGFR-l and not FGFR-3 likely mediates FGF2 effects as FGFR-l knockouts die in 
early development with severe abnormalities, including neural tube defects 
(Yamaguchi et al., 1994; Ciruna et al., 1997), whi1e FGFR-3 deficiency does not 
obviously affect neural development (Colvin et al., 1996; Deng et al., 1996). 
Intracellular signaling is initiated by interaction between two FGF-FGFR complexes 
bridgedby heparan sulfate proteoglycan molecules. Receptor trans-phosphorylation 
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leads to recruitment and activation of several downstream signaling molecules, such 
as PLCyand the Ras/MAPK (reviewed in Reuss and von Bohlen und Halbach, 2003). 
In cortical precursor cells, sorne intracellular mechanisms mediating FGF2 mitogenic 
signal have been proposed. FGF2 stimulation leads to activation of the known growth 
factor signaling proteins, MAPK and cAMP response element-binding protein 
(CREB), and induction of c-jun expression (Ghosh and Greenberg, 1995). A direct 
link with the cell cycle machinery has also been shown, where FGF2 induces CDK 
activity by upregulating the expression of both cyclin D and E as well as by 
decreasing the expression of the CKI, p27 (Lukaszewicz et al., 2002; Li and DiCicco-
Bloom, 2004). FGF2 mitogenic activity has also been correlated with telomerase 
activity in cortical precursor cells. Telomerase activity is high in proliferating cells, 
preserving the telomere length, while decrease or loss of telomerase activity leads to 
senescence and loss of proliferation potential in various cell types. In cortical 
precursor cells, telomerase activity is potentiated by FGF2, while treatment with a 
telomerase inhibitor prevents FGF2-induced precursor proliferation (Haik et al., 
2000). 
2. EGF family 
The epidermal growth factor (EGF) family is another known neural precursor 
mitogen. EGF and the related transforming growth factor-a (TGFa), through 
activation of the common tyrosine kinase receptor EGFR, have been shown to 
promote proliferation of several neural precursor and stem cell populations, such as 
forebrain embryonic and adult stem cells (Threadgill et al., 1995; Komblum et al., 
1998; Sibilia et al., 1998; Wong and Guillaud, 2004). However, EGF family 
mitogenic potential seems more restricted than that of FGF2 during cortical 
development. Several EGFR knockout mice have been generated and show a 
background-dependent variation in phenotypes, where EGFR deficiency is either 
lethal at mid-embryogenesis, at birth, or after a few weeks postnatally (reviewed in 
Wong, 2003). In surviving postnatal EGFR knockouts, the major cortical phenotype 
is degeneration and apoptosis, which are also observed in several other parts of the 
brain (Komblum et al., 1998). EGFR is highly expressed in the ventral telencephalon, 
whereas it is only expressed in a subpopulation of cortical SVZ cells and only during 
late embryogenesis (Komblum et al., 1997). Similarly, the EGFR ligand, TGFa, is 
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selectively expressed in the ventral telencephalon and TOFa knockouts have a 
specifie lost of striatal neurons, which are decreased by 50% (Blum, 1998). The 
inverse phenotype occurs in the FOF2 knockout telencephalon, which shows specifie 
defects in cortical precursors and neurons with a normal basal ganglia (Raballo et al., 
2000), suggesting that FOF and EOF families promote proliferation of distinct and 
complementary precursor populations. Interestingly, in telencephalon-derived stem 
cells, E10 precursors are readily responsive to FOF2 mitogenic activity, whereas they 
acquired EOF responsiveness only at later embryonic times (E14) (Tropepe et al., 
1999). Moreover, while EOFR deficient stem cells proliferate in xesponse to FOF2, 
EOF is unable to expand FOFRI deficient stem cells (Tropepe et al., 1999). Together, 
these studies strongly suggest that cortical precursor proliferation is mainly promoted 
by FOF signaling, while EOF signaling is involved in ventral telencephalon precursors 
and in later or maturing cortical precursor cells (as discussed below). 
3. Other secreted mitogenic signaIs 
Insulin-like growth factor 1 (lOF1), signaling through the IOFl tyrosine kinase 
receptor, has been shown to regulate brain development (reviewed in Bondy and 
Cheng, 2004). Brain development impairment and growth retardation is observed in 
both IOFl and lOF receptor knockout animaIs (reviewed in D'Ercole et al., 2002). 
Analysis of transgenic animaIs overexpressing IOFl in nestin positive precursor cells 
has revealed a more specifie role for lOF 1 during cortical development (Popken et al., 
2004): cortical neurons, as well as other neuronal populations, were increased as a 
consequence of enhanced proliferation and reduced apoptosis. Similar results were 
obtained by overexpressing IOFl in astrocytes, where increased numbers of neurons, 
astrocytes and oligodendrocytes led to brain overgrowth (Ye et al., 2004), suggesting 
that IOFl is a general proliferation and/or survival factor during brain development. 
Additionally, the secreted factor Wnt and its downstream ~-catenin pathway have 
been shown to positively regulate both cortical precursor state and cortical neuronal 
differentiation in a deve1opmenta1 stage specifie manner. Transgenic embryos that 
overexpressed a stabilized active form of ~-catenin in precursor cells displayed a 
striking enlargement of the forebrain and horizontal overgrowth of the cortex that was 
at least partially attributable to increased numbers of precursor cells re-entering the 
cell cycle (Chenn and Walsh, 2002). Conversely, activation of the Wnt/~-catenin 
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signaling pathway in E13.5 cortical precursor cells in culture or using in utero 
e1ectroporation increased neuronal differentiation in part by direct positive regulation 
of the neurogeninl promoter (Hirabayashi et al., 2004). 
4. Neurotransmitters 
Several neurotransmitters are expressed during development of the central 
nervous system and many neural precursor populations express the appropriate 
receptors and show specific responses to these factors, such as proliferation, migration 
and survival (reviewed in Nguyen et al., 2001). Cortical precursor cells are responsive 
to GABA, glutamate and acetylcholine, and neurotransmitter stimulation generates a 
calcium influx in these cells (LoTurco et al., 1995; Ma et al., 2000). In a first set of 
studies, GABA and glutamate and their respective receptors, GABA-A and 
AMP A/kainate receptors, were found to be expressed in cortical precursor cells, and 
activation of these neurotransmitter receptors led to inhibition of proliferation of 
precursor cells in cortical explants (LoTurco et al., 1995; Antonopoulos et al., 1997). 
Conversely, antagonists of either GABA-A or AMPA receptor are sufficient to 
increase DNA synthesis of precursor cells, suggesting an endogenous anti-
proliferative function for these neurotransmitters (LoTurco et al., 1995). Using a 
similar culture model, another group found that GABA and glutamate have opposing 
roles for different precursor cell populations, where these neurotransmitters induce 
proliferation of early cortical ventricular precursors while they inhibit proliferation of 
later born subventricular precursors, respectively (Haydar et al., 2000). A second set 
of studies has shown that acetylcholine muscarinic receptors (mAChR) are expressed 
by cortical precursor cells and their activation promotes cell proliferation in vitro (Ma 
et al., 2000; Li et al., 2001). Stimulation of these mAChRs leads to activation of at 
least two downstream signaling cascades, the PB-kinase and MEK-ERK pathways (as 
discussed below), which are both mediators of the precursor proliferation effect (Li et 
al., 2001). Therefore, cortical precursor cells are responsive to neurotransmitter 
production by newly generated neurons in their developing environment, which can 
differentially affect their proliferation behavior. 
5. PACAP 
While cortical precursor proliferating factors have been extensively studied, an 
anti-mitogenic signal has also been recently discovered. Pituitary adenylate cyclase 
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activating polypeptide (PACAP) and its preferred receptor PACI are expressed at the 
ons et of cortical neurogenesis and have been shown to actively promote cell cycle 
withdrawal of precursor cells (Dicicco-Bloom et al., 1998; Suh et al.., 2001). 
Specifically, PACAP stimùlation of cultured cortical precursor cells increases 
intracellular cAMP levels and phosphorylation of CREB within minutes, while 
decreasing DNA synthesis and proliferation within hours, even in the presence of 
mitogenic factors, such as FGF2 and EGF (Lu and DiCicco-Bloom, 1997). The 
P ACAP inhibition of DNA synthesis is mimicked by a cAMP analog or activator. 
Conversely, PACAP inhibition increases precursor proliferation. Most of these 
findings have been confirmed in vivo, where E15.5 intraventricular injection of 
PACAP leads to activation of CREB and about 35% decrease of cortical proliferating 
cells after 3 to 5 days (Suh et al., 2001). Inhibition of endogenous PACAP signaling, 
using either PACI or cAMP antagonist, leads to a 20-30% increase in precursor cell 
proliferation, suggesting an important role for endogenous PACAP/PACI. However, 
no cortical defects have been reported in mice lacking PAC1, which are viable and 
show only altered glucose response and social behavior (Jamen et al., 2000; Nicot et 
al., 2004). This probably reflects the presence of additional or compensatory anti-
mitogenic mechanisms. Interestingly, while acting as an anti-mitogenic factor on 
cortical precursor ceIls, PACAP has been shown to promote proliferation of a PNS 
neuronal precursor population, sympathetic ganglia precursors (Lu et al., 1998) This 
dual action of PACAP is thought to be mediated by the differential expression of 
P AC 1 isoforms by cortical and sympathetic precursors. P ACAP was also shown to 
elicit cAMP accumulation and expression of astrocyte specific markers in older 
cortical precursor cultures (Vallejo and Vallejo, 2002). However, this gliogenic action 
is potentially indirect and results in the promotion of cell cycle withdrawal, which was 
not addressed in this study. Indeed, P ACAP was shown to directly impact on the cell 
cycle machinery by inhibiting cdk2 activity through the upregulation of the CKI, p57 
(Carey et al., 2002). 
B. Control of neuronal differentiation 
The precursor-to-neuron transition of cortical precursor cells clearly involves 
cell-intrinsic components, such as neuronal transcription factors, as mentioned 
previously. However, several lines of evidence indicate that extrinsic factors present 
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within the developing cortex also influence precursor neuronal differentiation, as non-
cortical neural precursor cells derived form embryonic stem cells or human fetal brain 
cells can differentiate into neurons that integrate into the developing cortex upon 
transplantation into the rodent embryonic brain (Brustle et al., 1997; Brustle et al., 
1998). Two families of growth factors have been identified as potent cortical 
neurogenic signaIs, which will be presented here. 
1. PDGF family 
The platelet-derived growth factor family is composed of five members, the 
biologically active PDGF-AA, BB and AB proteins, and the two recently discovered 
PDGF-CC and DD which are secreted as inactive pro-forms (reviwed in Tallquist and 
Kazlauskas, 2004). These proteins preferentially induce homo or heterodimerization 
of the tyrosine kinase PDGF receptor subunits (PDGFR-a or ~), which then activate 
intracellular signaling cascades, such as the PB-kinase and Ras-MAPK pathways. 
Both the PDGFR-a and ~ subunits are expressed by cortical precursor cells and 
stimulation with either PDGF-AA or BB increases the number of neuronal clones at 
the expense of precursor clones in cultured cortical precursor cells (Williams et al., 
1997). PDGF neurogenic activity was found to be transcription dependent, to require 
only a few hours of exposure, and to be dominant over gliogenic factors, such as 
CNTF (see below) (Williams et al., 1997; Park et al., 1999). Because cortical 
precursor cells do not produce PDGF proteins themselves, but can spontaneously 
generate neurons in culture in the absence of PDGF, it was proposed that the 
neurogenic potential of precursor cells is at least partially due to PDGF exposure in 
vivo prior to isolation and culture (Williams et al., 1997; Park et al., 1999). Indeed, 
PDGF ligands and receptors have been shown to be expressed in the embryonic 
forebrain (Reddy and Pleasure, 1992; Sasahara et al., 1992). Coexpression of PDGF 
pathway ligands and receptors in the developing cortex could also explain the lack of 
neuronal defects in PDGF signaling component knockouts (reviewed in Tallquist and 
Kazlauskas, 2004), where functional redundancy is likely to occur. Recently, a 
neurogenic cascade initiated by PDGF as been proposed. PDGF stimulation activates 
the MAPK pathway in cortical precursor cells, which results in the activation of the 
neurogenic C/EBP transcription factors by phosphorylation at the Rsk site, as 
mentioned above (Park et al., 1999; Ménard et al., 2002). Therefore, PDGF signaling 
30 
induces neuronal differentiation through a MAPK-C/EBP pathway III cortical 
precursor cells, at least in culture. 
2. Neurotrophin family 
The neurotrophin family includes four mammalian members, nerve growth 
factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and 
neurotrophin-4 (NT -4). These proteins induce signal transduction through two types 
of receptors, the receptor tyrosine kinase Trk family (TrkA, TrkB, and TrkC) and the 
p75 neurotrophin receptor (P75NTR). Neurotrophin signaling has been implicated in 
regulating several aspects of the developing and adult nervous system, such as 
survival, differentiation, growth, maturation and apoptosis of both neuronal and glial 
cells (reviewed in Kaplan and Miller, 2000; Huang and Reichardt, 2001). 
Neurotrophins are expressed as precursor proteins which can aIl bind to p75NTR, 
while the protease-cleaved mature forms bind to the Trk receptors with more 
specificity: NGF binds to TrkA, BDNF and NT -4 bind to TrkB and NT -3 binds 
preferentially to TrkC and can also bind to TrkA and TrkB. Neurotrophin dimers 
induce activation of Trk receptors by trans-phosphorylation and subsequent 
recruitment and activation of several downstream signaling pathways, mainly the 
MEKIMAPK and the PI3-KlAkt pathways (reviewed in Kaplan and Miller, 2000; 
Segal, 2003) (Figure 1.3). Neurotrophin signaling through p75NTR is highly context 
dependent and is dictated by the expression of specifie neurotrophin members, co-
receptors and Trk receptors, as it can either potentiate or antagonize Trk signaling. 
All the neurotrophins and the Trk receptor knockout animaIs present severe PNS 
defects which have revealed an essential role in survival of specifie neuronal 
populations, where NGF/TrkA is essential for sympathetic neurons and a subset of 
sensory' neurons responsive to pain and temperature, BDNF/TrkB for tactile stimulus-
responsive sensory neurons and NT -3/TrkC for sensory neurons responsible for limb 
movement and position (reviewed in Klein, 1994; Huang and Reichardt, 2001). While 
neurotropliins and the Trk receptors are also highly expressed in the developing brain 
and cortex (Maisonpierre et al., 1990; Knusel et al., 1994; Fukumitsu et al., 1998), the 
knockout CNS phenotypes are much milder and necessitate a more careful analysis to 
be uncovered, potentially because of the overlapping expression of several 
neurotrophins/Trks leading to redundancy or compensatory mechanisms in the CNS. 
As the amount and diversity of studies on neurotrophins is substantial, only the major 
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findings ûn neurûtrûphin functiûns in the develûping cûrtex and neural precursûr cells 
will be presented here. 
A role in neuronal differentiatiûn has been demûnstrated fûr BDNF and NT-3 
in different neural precursûr cell pûpulatiûns. In the embryûnic cûrtex, bûth BDNF 
and NT -3 and their preferred Trk receptûrs, TrkB and TrkC, are expressed within the 
VZ/SVZ precursûr cells and in newly bûm neurûns (Maisûnpierre et al., 1990; 
Fukumitsu et al., 1998). Stimulatiûn ûfE13fûrebrain tissue by BDNF, NT-3 ûr NT-4, 
but nût NGF, leads to. a marked phûsphûrylatiûn and activatiûn ûf Trk receptûrs 
(Knusel et al., 1994). Cultured cûrtical precursûr cells are respûnsive tû BDNF and 
NT-3 and neurûtrûphin stimulatiûn leads tû phûsphûrylatiûn ûf MAPK and CREB 
(Ghûsh and Greenberg, 1995). NT-3 treatment was shûwn tû increase neuronal 
differentiatiûn ûf cûrtical precursûr ceIls, while blûcking ûf endûgenûusly prûduced 
NT-3 decreases the fûrmatiûn ûf neurûns by cûrtical precursûr cells (Ghûsh and 
Greenberg, 1995). NT-3 alsû regulates cûrtical precursûr prûliferatiûn in an ûppûsite 
fashiûn tû FGF2, where NT -3 decreases cdk and cyclin expressiûn and increases the 
levels ûfthe CKI p27, inducing cell cycle withdrawal (Lukaszewicz et al., 2002). In 
the adult brain, increasing BDNF levels by injectiûn ûr adenûvirus-mediated 
expressiûn within the lateral ventricles led tû recruitment ûf neural precursûr cells that 
migrated intû the ûlfactûry bulb and the neûstriatum where they generated ectûpic 
newly bûm neurûns (Zigûva et al., 1998; Benraiss et al., 2001). Anûther site ûf adult 
neurûgenesis is the hippûcampus, where precursûr differentiatiûn, proliferatiûn and 
survival were fûund tû be decreased in the absence ûf ûne BDNF allele (Lee et al., 
2002). Neurotrûphin treatment alsû affects neurûnal differentiatiûn and survival ûf 
embryûnic neural stem cells grûwn in culture as neurûspheres (Ahmed et al., 1995; 
Lachyankar et al., 1997). Finally, NT -3 promûtes the differentiatiûn ûf glial precursor 
cells: exûgenûus NT-3 induces ûligûdendrûcyte differentiatiûn while NT-3 ûr TrkC 
knûckûuts animaIs have CNS glial cell deficiencies (Heinrich et al., 1999; Kahn et al., 
1999). 
Neurûtrûphins have alsû been implicated in the control of embryonic CNS 
neuron maturatiûn and migratiûn. Bûth BDNF and NT-3 treatments· increase the 
number ûf calbindin pûsitive hippûcampal and cûrtical neurûns (Cûllazû et al., 1992; 
Fiumelli et al., 2000), whereas BDNF deficiency leads tû impaired calbindin 
expressiûn (Jûnes et al., 1994). Cûnversely, BDNF negatively regulates the 
expressiûn ûf calretinin and reelin, which are expressed by Cajal-Retzius cells within 
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the developing cortex, as BDNF deficiency increased reelin expression and ectopic 
BDNF decreases calretinin and reelin expression (Jones et al., 1994; Ringstedt et al., 
1998; Fiumelli et al., 2000; Alcantara et al., 2005). BDNF was also shown to regulate 
migration of cortical Cajal-Retzius and ventral telencephalon derived intemeurons. 
BDNF overexpression in nestin-expressing precursor cells disturbs intemeuron 
migration within the cortical plate and leads to accumulation of ectopie calbindin 
expressing intemeurons and Cajal-Retzius cells in the marginal zone (Angelastro et 
al., 2003; Alcantara et al., 2005). The TrkB deficient cortex shows reduced tangential 
migration of intemeurons from the ventral telencephalon (Polleux et al., 2002) . 
. Moreover, BDNF/TrkB signaling is important for cortical neuron dendritic growth, as 
BDNF or TrkB knockout pyramidal neurons show reduced dendrite growth both in 
vitro and in vivo (Gates et al., 2000; Itami et al., 2000; Xu et al., 2000). TrkB and 
TrkC were also shown to be important for the proper axonal growth and 
synaptogenesis ofhippocampal neurons (Martinez et al., 1998). 
Finally, neurotrophin signaling also supports neuronal survival of cortical 
neurons. In embryonic cortical neuron cultures, inhibition of endogenous BDNF 
suppresses activity-dependent neuronal survival, while BDNF treatment protects 
neurons from serum-deprivation or DNA damage-induced apoptosis (Ghosh et al., 
1994; Hetman et al., 1999). Cultured TtkB knockout cortical neurons show a marked 
reduction in survival (Gates et al., 2000). Moreover, in vivo studies have shown that 
TrkB deficiency results in ectopic pyknotic nuc1ei within several cortical layers and 
CaMKII conditional TrkB knockouts show a loss of a defined cortical neuron 
population (Alcantara et al., 1997; Xu et al., 2000). Finally, cortex-derived BDNF is 
an important regulator of innervating neurons, as apoptosis is doubled in the dorsal 
thalamus in the absence of TrkB during the embryonic period of naturally occurring 
cell death (Lotto et al., 2001). Together, these data support an essential role for 
neurotrophin signaling during embryonic brain development. 
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IV. Downstream signaling pathways regulating cortical precursor 
neurogenesis 
A second hypothesis of Chapter 3 is that extracellular signais utilize distinct, 
experimentally separable downstream cascades to mediate their effects on cortical 
precursor cells. This section summarizes the known functions of two of the main 
signaling pathways in neural cells, the PI3-K/Akt and MEK/ERK pathways. 
Several RTKs elicit similar or identical downstream signaling cascades in a 
variety of cell types. For example, stimulation by FGF2, EGF, PDGF or 
neurotrophins activates the MEKIERK and PI3-KlAkt pathways, which results from 
the common signaling mechanisms utilized by these RTKs (reviewed in Schlessinger, 
2000). Ligand-induced activation of RTKs leads to tyrosine residue phosphorylation 
within the RTK catalytic domain, which further activates the receptors, and within the 
RTK noncatalytic domain, which creates binding sites for Src homology 2 (SH2) or 
phosphotyrosine binding (PTB) domain-containing proteins. Activation of the 
downstream signaling proteins is either directly mediated by interaction with RTKs or 
via adaptor proteins, such as Grb2, Shc or Gabl (reviewed Kaplan and Miller, 2000; 
Schlessinger, 2000). Therefore, RTK signaling and biological response specificity is 
highly dependent on the cellular context and on the integration of multiple signaling 
events. Here, the potential functions in cortical precursors and neurons of two major 
RTK pathways, the MEKIERK and PI3-KlAkt pathways, will be presented. 
A. MEKIERK pathway 
Upon ligand stimulation, R TK bound adaptor proteins Shc and Grb2 recruit 
the guanine nucleotide exchange factor Sos to the plasma membrane, where it 
activates the Ras GTPase. Activated Ras then triggers the sequential activation of the 
MAP kinase cascade (Raf, MEK and ERK) which results in Ser/Thr phosphorylation 
of ERK targets or activation of the transcription factor CREB via the activation of the 
Rsk kinase family (reviewed in Kaplan and Miller, 2000; Segal, 2003) (Figure 1.3). 
The MEKIERK signaling pathway has been mostly implicated in proliferation, 
growth, differentiation and survival of neurons. This pathway is activated in cortical 
precursor cells upon stimulation with growth factors such as FGF2, neurotrophins, 
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PDGF, and ACh agonists (Ghosh and Greenberg, 1995; Ma et al., 2000; Ménard et al., 
2002). Specifically, ERK activation was shown to at least partially mediate ACh-
induced proliferation in cultured cortical precursor cells (Ma et al., 2000; Li et al., 
2001). Moreover, PDGF-induced ERK activation has been proposed to trigger 
neuronal differentiation of cortical precursors via the phosphorylation of C/EBP by 
Rsk (Ménard et al., 2002). A role for the MEKIERK pathway in neuronal 
differentiation has also been demonstrated in neural precursor cells derived from the 
embryonic ventral telencephalon, where Ephrin tyrosine kinase-mediated ERK 
activation leads to increased neuron production (Aoki et al., 2004). In embryonic 
cortical neuron cultures, BDNF treatment protects against DNA damage induced 
apoptosis through the activation of the MEKIERK pathway (Hetman et al., 1999). 
Potential targets of MEKIERK mediated survival include activation of CREB and 
inhibition of glycogen synthetase kinase-3~ (GSK3~) activity, as inhibition of CREB 
induces death while overexpression of MEK prevents GSK3 ~ induced apoptosis 
(Bonni et al., 1999; Hetman et al., 2002). 
B. PI3-kinase/Akt pathway 
Recruitment of the phosphatidylinositol3'-kinase (PI3-K) to activated RTKs is 
mediated through either the adaptor proteins Shc, Gab-l, Grb2 or Ras, which 
stimulates its lipid kinase activity and produces phosphorylated PI4,5 lipids. These 
phospholipids bind to and activate the protein kinases PDK and Akt (reviewed in 
Kaplan and Miller, 2000; Segal, 2003) (Figure 1.3). A major pro-survival role for the 
PI3-KlAkt pathway has been shown in many neuronal populations. Likewise, the 
survival of embryonic cortical neurons is highly dependent on this pathway under 
basal culture conditions and in response to BDNF (Hetman et al., 1999; Pozniak et al., 
2002). In cortical precursor cells, overexpression of Akt enhances survival and 
proliferation of cultured precursors and increases the number of precursor cells in vivo 
(Sinor and Lillien, 2004). A survival and proliferation role for Akt was further 
supported by the analysis of neural precursor cells lacking the negative Akt regulator, 
PTEN. Nestin-specific PTEN knockouts, which exhibit elevated levels of activated 
Akt, show markedly enlarged brains due to reduced apoptosis and increased 
proliferation of neural precursor cells, including within the embryonic cortex (Groszer 
et al., 2001). Several Akt downstream targets have been identified (Figure 1.3). The 
Akt pro-sui"vival effect is thought to be primarily mediated by phosphorylation and 
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inhibition of pro-apoptotic proteins, such as GSK3~ and the Forkhead transcription 
regulator family, and through expression of pro-survival proteins, such as Bel-XL, via 
the activation of the transcription factors CREB and NF-KB (reviewed in Brunet et al., 
2001). 
v. Regulation of cortical precursor gliogenesis: astrocyte 
formation 
The hypothesis tested in Chapter 4 is that key signaIs instructing cortical 
precursors to switch from neurogenesis to gliogenesis are provided by the first wave 
of cortical precursor progeny, newly born neurons. Here, 1 review the current state of 
knowledge regarding gliogenesis-inducing factors and their downstream signaling 
pathways. 
Cortical precursor cells differentiate sequentially into neurons and glial cells. 
In vivo, a few cortical astrocytes start to appear at the end of embryogenesis, 
concordant with the end of the neurogenic period, white the vast majority of them are 
born within the first postnatal weeks. This precisely timed differentiation pattern is 
recapitulated in vitro where E13 cortical precursor cells generate neurons first and, 
only 5-6 days later, start forming astrocytes. This suggests that cortical precursors are 
biased initially to generate neurons, and that an undefined timing mechanism then 
instructs them to generate astrocytes at later timepoints. In the la st decade, efforts 
have been made to identify both intrinsic and extrinsic molecular mechanisms that 
regulate the cortical precursor cell fate switch from making neurons to astrocytes. 
A. Intrinsic factors 
One potential molecular explanation for this timing mechanism is a cell-
intrinsic one where, over time, precursor cells themselves change so they are less 
biased to make neurons and more likely to make glial cells. Such a change could 
occur, for example, as a consequence of dilution of a neurogenic factor such as a 
transcription factor, by expression of specific regulatory proteins, or by chromatin 
modification as will be described here. 
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1. Dilution of neurogenic factors 
While cell type-specifie transcription factors are involved in both neuron and 
oligodendrocyte differentiation, such as the neurogenic bHLHs, C/EBP family and the 
·Olig genes (as presented above and below), no such astrocyte specifie transcription 
factor has yet been identified. Inactivation of neurogenic transcription factors might 
be a prerequisite for astrocyte differentiation. Indeed, ngn2/Mashl double knockouts 
show enhanced astrocyte precursor formation in the embryonic cortex, and the 
cultured knockout precursor cells have an increased potential to differentiate along the 
astrocytic lineage (Nieto et al., 2001). A similar neuronal-to-glial fate switch is 
observed in the tectum, the hindbrain and the retina of Math3/Mash1 double knockout 
embryonic brain, where specific neuronal populations are lost and replaced by 
excessive gliogenesis (Tomita et al., 2000). Moreover, in either Mashl or NeuroD-
deficient retinal cens, the number of retinal neurons is decreased whereas the glial 
cens are increased (Tomita et al., 1996; Morrow et al., 1999a). One molecular 
mechanism underlying this gliogenesis repression by neurogenic factors is through 
sequestration of the transcription coactivators p300/CBP (Figure 1.4). Several 
transcription factors require p300/CBP to activate transcription and these transcription 
factors are likely competing for limiting levels of these coactivators (reviewed in 
Goodman and Smolik, 2000). Both ngn1 and C/EBP utilize p300 as a coactivator to 
activate gene transcription (Blobel, 2000; Sun et al., 2001) and neurogenin1 has been 
shown to directly inhibit astrocyte gene expression by sequestering this co-factor and 
preventing the SMAD/STAT-dependent gliogenic gene expression (Sun et al., 2001). 
Therefore, dilution or inhibition by naturally occurring dominant negative forms of 
these neurogenic factors, such aS the Ids, will make p300/CBP and other transcription 
coactivators available for astrocyte specific gene expression. Indeed, astroglial 
differentiation of a neural cell line is accompanied by a transient upregulation of 
endogenous Id proteins (Andres-Barquin et al., 1997), while retroviral expression of 
Id! in the late embryonic or perinatal cortex completely inhibits neurogenesis and 
promotes exc1usively glial cell formation (Cai et al., 2000). Furthermore, 
overexpression of a dominant negative form of C/EBP in cultured cortical precursor 
cens results in enhanced astrocyte production in response to CNTF (Paquin et al., in 
press; Ménard et al., 2002). 
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2. Expression of specific signaling proteins 
The developing cortical VZ is predominant during neurogenesis while the SVZ 
develops and thickens at later embryonic stages. Thus, neurons are thought to derive 
mostly from the VZ while astrocytes come from SVZ precursor ceUs (Bayer et al., 
1991b). One molecular change that parallels this VZ to SVZ transition is the 
expression ofEGFR, which is enriched in SVZ precursor cells (Eagleson et al., 1996; 
Caric et al., 2001). Using both in vivo and in vitro approaches, it was shown that 
retroviral overexpression of EGFR in E15 rat cortical precursor cells is sufficient to 
increase astrocyte formation (Burrows et al., 1997). Ectopic EGFR expression leads 
to SVZ-derived cell migration and increases sphere formation by cortical neural stem 
cells (Burrows et al., 1997). At low ligand concentration, EGFR expression can also 
mediate chemotactic migration of neurons, astrocytes and cortical stem cells in E12-
E16 rat cortical explants (Caric et al., 2001). FinalIy, a subpopulation of cortical 
precursor cells shows an asymmetric distribution of EGFR that was proposed to 
regulate the astrocyte-oligodendrocyte fate choice at the end of embryogenesis (Sun et 
al., 2005). However, the underlying signaling cascade is not c1early understood. 
Several EGFR knockouts have been generated and while sorne are embryonically 
lethal (Threadgill et al., 1995; Sibilia et al., 1998), CDl background EGFR knockouts 
survive and the neonates do not show gliogenesis defect (Komblum et al., 1998). 
Actually, cortical gliogenesis in EGFR null peri-natal cortex is up-regulated followed 
by a focal neuronal degeneration by apoptosis (Komblum et al., 1998). Together, 
these data indicate that EGF signaling is involved to sorne extent in cortical precursor 
maturation, proliferation and migration, and that EGFR might act predominantly as a 
permissive, rather than instructive, signal for cortical gliogenesis. 
Another example of upregulation of astrocyte specification genes has been 
proposed by He et al., where they show that the gpI30-JAK-STAT pathway was 
induced both at the expression and activation levels as cortical precursor cells mature 
(i.e. around the time ofgliogenesis) (He et al., 2005). However, they also suggest that 
there is a positive autoregulatory loop that feeds back into this pathway once it is first 
activated. Thus, the upregulation of these gliogenic pathway components might be a 
consequence and not the cause of the onset of gliogenesis. 
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3. DNA methylation and chromatin modification 
Late cortical precursor cells have been shown to be more responsive than early 
precursors to astrocyte-inducing signaIs, such as CNTF (MoIne et al., 2000; Takizawa 
et al., 2001b). Because both these precursor populations express, to sorne extent, the 
signaling machinery utilized by such gliogenic factors (as discussed below, Takizawa 
et al., 2001 b), a change in their epigenetic status has been proposed to regulate this 
transition from neuron-to-astrocyte specific gene transcription (Figure 1.4). Indeed, 
methylation of genomic DNA at CpG dinucleotides represents a regulatory 
mechanism of mammalian cell and tissue-specific gene expression, by either 
preventing transcription factor binding to target gene promoters, or by recruiting 
transcription inhibitory proteins (Bird and Wolffe, 1999). In a first study, Taga's 
group shows that a CpG dinucleotide within the STAT3 binding element of the GF AP 
promoter is highly methylated in early El1.5 precursor cells, which prevents STAT3 
binding and transactivation. The methylation level decreases over time in culture or in 
older precursor cells, allowing responsiveness to astrocyte-inducing factors (Takizawa 
et al., 2001b). In a complementary study, this group analyzed the methylation level of 
the astrocyte precursor/early astrocyte marker, SlOOp. As observed for the GFAP 
promoter, CpG dinucleotide methylation levels decrease with time and developmental 
age of the precursor cells. However, as the CpG site is outside the gliogenic 
transcription factor element, the transcription silencing is achieved through the 
recruitment of the methyl DNA binding protein, MeCP2 (Namihira et al., 2004). 
Recently, analysis of a nestin-driven conditional mutant for maintenance DNA 
methyltransferase 1 (Dnmtl) has underscored the importance of DNA methylation 
during astrogliogenesis. The mutants display enhanced and premature CNS astrocyte 
differentiation, including in the developing cortex, which is accompanied by increased 
activity of the gp130/JAK/STAT pathway (Fan et al., 2005). This study suggests that 
in addition to astrocyte markers, such as GF AP and SlOOp, genes essential for 
activation of the JAK/STAT pathway are developmentally regulated by methylation 
(Fan et al., 2005). Finally, chromatin modification has been shown to impinge on the 
level of GF AP expression. While the mitogenic factor FGF2 does not induce GF AP-
expressing astrocytes on its own, it can potentiate CNTF-induced astrocyte formation 
(Song and Ghosh, 2004). Late precursor cells exposed to FGF2 for 3-6 days show 
increased STAT3/CBP association with the GF AP promoter along with changes in 
associated Histone 3 methylation levels. Blockage of methyl transferases or over-
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expression of the methyl transferase SET 7/9 is sufficient to inhibit or mimic FGF2 
effect, respectively (Song and Ghosh, 2004). Together, these studies provide strong 
evidence for a DNA methylation and chromatin modification-based mechanism 
during cortical gliogenesis, which can be at least partially controlled by exogenous 
factor(s). 
B. Extracellular pathways 
The sequential generation of neurons and glial cells by cortical precursor cells 
observed in vivo can be reproduced both in bulk and clonaI cultures, suggesting that a 
cell intrinsic mechanism regulates precursor differentiation (Davis and Temple, 1994; 
Qian et al., 2000). However, since the majority of such precursor clones contain both 
neurons and glial ceIls, a second and complementary hypothesis for the sequential 
regulation of neuron and glial cell differentiation is the presence of cell-extrinsic 
gliogenic factors. Consistent with this hypothesis, early precursor cells cultured over 
early cortical slices will mostly generate neurons, while early precursors cultured over 
late or post-natal cortical slices will preferentially form astrocytes (Morrow et al., 
2001). These observations strongly suggest that extracellular factors present within 
the developing cortex influence the neuron-to-glia transition of precursor cells. 
Indeed, several potential gliogenic factors have been identified as described below 
(Sauvageot and Stiles, 2002) (Figure 1.4). 
1. Cytokine signaling 
The cytokines are a large group of molecules which mostly signal through the 
class l cytokine receptor family, such as common 13, y and gp 130 molecules. While 
cytokines have been largely implicated in the regulation of the immune and 
hematopoietic systems, the IL-6 cytokine family is pleiotropic and is an important 
regulator of the nervous system. These IL-6 related cytokines signal through the 
ubiquitously expressed gp130, although in slightly different ways (reviewed in Taga 
and Kishimoto, 1997; Tumley and Bartlett, 2000; Kamimura et al., 2003). IL-6 and 
IL-Il bind to a soluble or membrane-associated ligand receptor, IL-6R or IL-1IR, and 
trigger the homodimerization and activation of gp130. CNTF, LIF, CT-l, OsM, CLC 
and NP bind to the gp130-related LIFR, which heterodimerizes with gp130 to activate 
downstream signaling events. CNTF, CLC and NP (Plun-Favreau et al., 2001; 
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Derouet et al., 2004) first bind to an IL-6R-related ligand receptor, CNTFR, prior to 
recruiting the LIFR-gp130 complex. While gp130 is ubiquitously expressed, IL-6 
related cytokines have a temporal and tissue-specific expression pattern and most of 
them have been shown to be expressed in the late embryonic and early postnatal brain. 
Stimulation of cultured precursor cells with LIF (Nakashima et al., 1999b), CNTF 
(Johe et al., 1996; Bonni et al., 1997; Rajan and McKay, 1998; Park et al., 1999), CT-
1 (Ochiai et al., 2001), OsM (Yanagisawa etaI., 1999), IL-6 (Bonni et al., 1997; 
Takizawa et al., 2001a), IL-Il (Yanagisawa et al., 2000) or CLC (Uemura et al., 
2002) induces premature astrocyte formation in vitro. Despite their in vitro gliogenic 
potential, no defect in astrocyte formation has been reported for developing animaIs 
lacking individual cytokines such as CNTF, LIF and CT-l (Masu et al., 1993; Bugga 
et al., 1998; Oppenheim et al., 2001), with the exception of the LIF knockout adult 
hippocampus, which shows reduced levels of GF AP expression (Bugga et al., 1998; 
Koblar et al., 1998). However, mice lacking their common receptors gp130 or LIFR 
have significantly reduced numbers of CNS astrocytes. Specifically, E18 gp130 -/-
brains show a marked de crea se in both GF AP protein and rnRNA levels, and cultured 
cortical precursor cells from these animaIs do not respond to gliogenic cytokines, 
failing to differentiate into astrocytes even after an extended culturing period 
(Nakashima et al., 1999c; Nakashima et al., 1999a). Similar in vivo and in vitro 
gliogenic phenotypes are observed with the LIFR knockout (Ware et al., 1995; Koblar 
et al., 1998). Interestingly, IL-6 stimulation along with addition of the soluble IL-6 
receptor, which directly activates gp130, can induce LIFR -/- precursor cells to 
generate astrocytes (Bonni et al., 1997). CNTFR knockouts have been generated and 
these die perinatally, displaying severe motor neurons defects (DeChiara et al., 1995). 
However, no gliogenesis defect has been reported and the forebrain of these CNTFR 
null animaIs has not been analyzed in detail yet. Together, these data suggest an 
essential role for gp130/LIFR signaling in astrogliogenesis, which can be activated by 
several functionally redundant cytokines. 
The common IL-6 cytokine family receptor gp 130 is devoid of an intrinsic 
tyrosine kinase domain. Signal transduction occurs via activation of Janus kinase 
proteins (JAKI and JAK2), which are associated with the intracellular domain of 
gp130 and are activated upon gp130 homo or heterodimerization (reviewed in Taga 
and Kishimoto, 1997). Activated JAKs phosphorylate gp 130 tyrosine residues, which 
creates docking sites for the SH2 domains of signal transducers and activators of 
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transcription (STAT) proteins. Following JAK phosphorylation, STATs 
homodimerize, translocate to the nucleus and transactivate specifie genes, such as 
GFAP. There are 7 major STAT proteins (STATl-4, 5a, 5b, 6), but IL-6 related 
cytokines have been shown to specifically induce the phosphorylation of STAT3 and 
to a lesser extent STAT1 in cortical precursor cells (Rajan and McKay, 1998). 
STAT3 activation by cytokine stimulation is completely prevented in gp130-/- cortical 
precursor cells (Nakashima et al., 1999c), and a dominant-negative form of STAT3 
inhibits the cytokine gliogenic effect on cortical precursor cells (Bonni et al., 1997; 
Rajan and McKay, 1998; Yanagisawa et al., 1999; Yanagisawa et al., 2000; Ochiai et 
al., 2001). Moreover, mutations within the STAT3 binding site of the GFAP promoter 
inhibit cytokine-induced GFAP transcription (Yanagisawa et al., 1999; Yanagisawa et 
al., 2000; Ochiai et al., 2001; Uemura et al., 2002). Finally, knockin animaIs with a 
gp 130 deficient for STAT3 signaling exhibit perinatal lethality as observed for the 
gp130 knockouts (Ohtani et al., 2000), demonstrating that STAT3 is a major 
cytokine/gp130 downstream signaling component. JAK1, JAK2, STATl and STAT3-
deficient animaIs have all been generated, but none of them have been analyzed 
specifically for nervous system defects (reviewed in Imada and Leonard, 2000; 
Takeda and Akira, 2000). JAK1 animaIs show perinatal lethality with no gross 
developmental abnormality (Rodig et al., 1998), while JAK2 deficient embryos die at 
mid-gestation due to erythropoiesis defects (Neubauer et al., 1998; Parganas et al., 
1998). Recently, a conditional JAK2 knockout has been generated which could allow 
neural specific deletion of this protein, bypassing the embryonic lethality of the 
original knockout (Krempler et al., 2004). STATI knockout animaIs show no obvious 
developmental abnormality and have a severe defect in interferon-dependent immune 
response (Durbin et al., 1996; Meraz et al., 1996). Finally, STAT3 deficiency results 
in a rapid degeneration of the embryo by E6-7 (Takeda et al., 1997). A neural 
conditional knockout has also been generated by deleting ST A T3 in nestin expressing 
precursor cells; while sorne knockout animaIs die perinatally, others survive into 
adulthood and are hyperphagic, obese, diabetic and infertile (Gao et al., 2004). No 
detailed analysis of these knockout brains have been performed to date. 
IL-6 related cytokine signaling through gp 130 also leads to the activation of 
the Ras/MAPK signaling cascade (Boulton et al., 1994; Taga and Kishimoto, 1997). 
It has been proposed that JAK, Ras and Raf activation are essential for cytokine-
induced ERKIMAPK activation, where ligand-induced JAK activation leads to 
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phosphorylation of receptor tyrosine residues, thereby creating docking sites for the 
SH2 domain-containing proteins such as SHP-2, Grb2 and Shc, which in tum activate 
a Ras/Raf/MAPK signaling pathway (Winston and Hunter, 1995; Kamimura et al., 
2003). Comparing mutated SHP-2 and STAT3 binding-site gp130 knockin animaIs, it 
was shown that these two signaling cascades support distinct functions, as ST AT3 
signaling-deficient animaIs die perinatally while SHP-2/MAPK signaling-deficient 
mice are grossly healthy and fertile (Ohtani et al., 2000). While the SHP-
2/Ras/MAPK pathway can directly lead to transactivation of specific genes, it has 
been suggested that it could also impinge on STAT activation (Taga and Kishimoto, 
1997). In addition to tyrosine phosphorylation essential for dimerization and nuclear 
translocation, STAT3 can be phosphorylated on a specific serine residue (Ser-727) 
which is a consensus phosphorylation site for MAPK and Cdk family members. Both 
these kinase families can phosphorylate STAT3 (Chung et al., 1997; Fu et al., 2004) 
but the function of this phosphorylated Ser-727 is still unclear and controversial. 
While sorne studies have shown a positive effect ofphosphorylated Ser-STAT3, such 
as increased transcriptional activation potential (Wen and Damell, 1997; Lim and 
Cao, 2001; Schuringa et al., 2001; Fu et al., 2004), others have presented data 
supporting a negative regulatory role for Ser phosphorylation as it inhibits Tyr 
phosphorylation of STAT3 (Chung et al., 1997; Jain et al., 1998). The large variation 
in cell types and cytokines used in the se studies might account for at least sorne of 
these discrepancies. Two studies have addressed the role of cytokine-induced MAPK 
activation in cortical precursor cells (Bonni et al., 1997; Rajan and McKay, 1998). 
While both of them show that CNTF stimulation leads to a rapid phosphorylation of 
ERKIMAPK, they come to opposite conclusions as to the role of this pathway during 
cytokine-induced astrocyte formation. Using a dominant negative MAPK kinase 
(MKK), Greenberg's group showed that the inhibition of MAPK signaling increases 
CNTF induction of the GFAP promoter (Bonni et al., 1997). In contrast, using a 
MAPK pharmacological inhibitor and overexpression of an activated MKK, McKay's 
group showed that MAPK signaling is a positive regulator during the early phase of 
cytokine-induced astrocyte formation (Rajan and McKay, 1998). A more distantly 
related in vivo study suggests that only JAK-induced tyrosine phosphorylation of 
STAT3, and not MAPK-induced serine phosphorylation, precedes and leads to 
transactivation of GF AP in a CNS neural injury model (Sriram et al., 2004). Taken 
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together, the role of the cytokine-induced Ras-MAPK-STAT3 pathway is still poorly 
understood, especially in the context of cerebral cortex development. 
Upon cytokine stimulation, the JAKISTAT and ERKIMAPK signaling proteins 
are rapidly phosphorylated and this activation level is gradually attenuated (Rajan and 
McKay, 1998; Kamimura et al., 2003). There are three groups ofnegative regulators 
of cytokine signaling that have been weIl characterized so far (reviewed in Greenhalgh 
and Hilton, 2001; Kamimura et al., 2003). First are the phosphatases, SHP-l, SHP-2 
and the membrane-bound CD45, which have been shown to dephoshorylate either 
cytokine receptors or their substrates, such as JAKs. Second exists the protein 
inhibitor of activated STAT (PIAS) family, which associates with ligand-induced 
phosphorylated STAT proteins and inhibits STAT DNA-binding activity. While 
phosphatases and PIAS are thought to be constitutively expressed in many cell types, 
the last class of cytokine negative regulators, the suppressor of cytokine signaling 
(SOCS) family, is induced by cytokine signaling and acts as a negative feedback loop. 
SOCS proteins inhibit cytokine signaling through different mechanisms, such as direct 
binding and inactivation of the JAK kinase domain or binding and masking 
phosphorylated residues on the gp 130 receptor. Several SOCS knockouts have been 
generated, exhibiting a wide range of phenotypes (reviewed by Greenhalgh and 
Hilton, 2001). The only reported knockout with a nervous system phenotype is 
SOCS7, which is highly expressed in the brain. Half of SOCS7 knockout animaIs die 
of hydrocephalus showing cranial distortion, ventricle enlargement and thinner 
cerebral cortex (Krebs et al., 2004). 
2. BMP signaling 
The bone morphogenetic protein (BMP) family, with more than 20 members, 
is a subclass of the transforming growth factor-~ (TGF-~) superfamily of ligands 
(reviewed in Mehler et al., 1997; Chen et al., 2004). BMP signaling is achieved by 
activation of serine-threonine kinase receptor subunits after heterotetramerization of 
type l and type II BMP receptors, leading to the activation of latent transcription 
factors, SMADS. Phosphorylated SMAD 1, 5 and 8 then form a complex with the 
common partner SMAD4, which translocates to the nucleus and transactivates specific 
genes. BMPs have a wide range of functions in numerous embryonic and adult 
tissues, such as heart, cartilage and bone (Chen et al., 2004). Pleiotropic BMP roles 
are also observed within the nervous system, where BMPs have been shown to be 
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important embryonic development regulators during neurulation, dorsoventral 
patteming of the CNS and neural crest neuronal lineage formation (Mehler et al., 
1997). Specifically, BMP2 and BMP4 along with their receptors are expressed 
throughout the developing cerebral cortex (Li et al., 1998; Mabie et al., 1999; 
Nakashima et al., 2001; Gajavelli et al., 2004) and have been shown to regulate 
several aspects of cortical precursor cells. In early cortical precursor cells (from E13-
16), BMP stimulation promotes cell cycle exit and neuronal differentiation (Li et al., 
1998; Mabie et al., 1999). Using asimilar cell culture system, two reports have 
shown that BMPs could also lead to apoptosis of precursor cells (Mabie et al., 1999; 
Rajan et al., 2003). Moreover, BMP stimulation induces astrocyte formation from 
cortical precursor cells either after a long exposure time or within 2 days when applied 
in combination with a member of the IL-6 family of cytokines (Mabie et al., 1999; 
Nakashima et al., 2001; Ochiai et al., 2001; Uemura et al., 2002; Rajan et al., 2003). 
How does BMP stimulation trigger such a variety of responses in cortical 
precursor cells? The cellular effectors of BMP signaling, SMADs, bind to the 
coactivators p300/CBP on a site distinct from the neurogenic bHLH neurogeninl (Sun 
et al., 2001) and the IL-6 cytokine-induced STAT proteins (Nakashima et al., 1999b). 
In early neurogenic precursor cells, SMADs could potentiate bHLH transcriptional 
activity, while in late precursor cells or in precursors in a gliogenic environment, 
SMADs will act synergistically with STATs to transactivate astrocyte specific genes, 
such as GFAP. An additional mechanism by which BMPs potentiate cytokine-
induced gliogenesis independently of SMAD has been proposed by McKay's group, 
where BMP stimulation leads to activation of the serine-threonine kinase mTOR, 
which can directly phosphorylate and facilitate the activation of STATs (Rajan et al., 
2003). Interestingly, while LIFR knockout precursor cells do not generate astrocytes 
in vivo, these cells remain responsive to BMP-induced astrocyte formation after a 
prolonged exposure time in vitro (Koblar et al., 1998), which argues that BMPs can 
promote astrocyte formation in the absence of cytokine/LIFR signaling. BMP-
induced gliogenesis might also be explained by the inhibition of neurogenic bHLH 
activity. BMP treatment was shown to directly induce the expression of the dominant-
negative HLH proteins, Idl and Id3, as weIl as the Notch pathway target gene Hes5 
(Nakashima et al., 2001). Moreover, BMP-activated SMADI can form a complex 
with the Notch receptor intracellular domain (NICD) and the coactivator p300, which 
results in a synergistic transactivation of the Hes5 promoter (Takizawa et al., 2003). 
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Together, these numerous studies suggest that BMP signaling in cortical precursor 
cells is largely context and transcription partner dependent. Unfortunately, in vivo 
functions of BMP signaling during cortical precursor differentiation has not been 
assessed to date, as the vast majority of BMP, BMP receptor and SMAD knockout 
animaIs are embryonic lethal (reviewed in Chen et al., 2004). 
3. Notch signaling 
In addition to Notch function as'a positive regulator of precursor cells, recent 
studies have suggested that Notch signaling can actively promote astrocyte formation 
in different developing brain regions, such as the retina, the forebrain and the 
hippocampus (Gaiano and Fishell, 2002). Overexpression ofNICD in the developing 
forebrain first leads to an increase in radial glial cells of which many differentiate into 
astrocytes perinatally (Gaiano et al., 2000). Similar results wete found using cultured 
cortical precursor cells, where NICD increased the number of astrocytes at the 
expense of neurons (Chambers et al., 2001). In utero expression of either Hesi or 
Hes5 in late embryonic cortex leads to increased astrocyte formation (Sakamoto et al., 
2003). Moreover, neural stem cells derived from embryos deficient for the Notch 
ligand, Delta-l, show increased neurogenesis and decreased gliogenesis, while 
stimulation with another Notch ligand, Jagged, renders these cells able to generate 
astrocytes at the expense of neurons (Grandbarbe et al., 2003). Together these studies 
demonstrate that Notch is permissive for gliogenesis. 
An instructive role for the Notch pathway in gliogenesis has been further 
proposed. Overexpressed NICD binds to CSL to form an active transcription complex 
on the GF AP promoter in cortical precursor cells. While astrocyte differentiation is 
only delayed in CSL-deficient neural stem cells, it was found that Notch-induced 
GFAP expression is inhibited by co-expression of dominant negative STAT3 (Ge et 
al., 2002). Crosstalk between the Notch and the JAK-STAT pathways is further 
supported by the findings that Notch-induced Hesi activates STAT3 transcriptional 
activity by recruiting and facilitating activated JAK2 phosphorylation of STAT3 
(Kamakura et al., 2004). Indeed, Notch-induced astrocyte formation is more likely to 
proceed via the JAK-STAT pathway than CLS-mediated transcription as neural stem 
cells deficient for N-CoR, a co-repressor for many other transcription factors, such as 
CSL, exhibit a loss of proliferation and spontaneous astrocyte formation (Hermanson 
et al., 2002). Transient overexpression of activated Notch in cortical precursor cells 
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during the El3 to ElS neurogenesis period maintains the cell in a precursor state 
which can subsequently undergo neuronal differentiation upon suppression of Notch 
overexpression (Mizutani and Saito, 2005). Thus, Notch signaling might regulate 
astrogliogenesis b~ inhibiting pro-neuronal bHLH activity via Hes proteins, and by 
promoting astrocyte specific gene expression via potentiation of the JAK-STAT 
pathway in collaboration with additional gliogenic signaIs. 
VI. Regulation of cortical precursor gliogenesis: oligodendrocyte 
formation 
Although the majority of oligodendrocytes found in the postnatal cerebral 
cortex are derived from the ventral telencephalon, cortical precursor cells can generate 
oligodendrocytes in culture (Qian et al., 2000). Even if most of the knowledge on 
oligodendrocyte development cornes from studies using rat optic nerve-derived 
oligodendrocyte precursor cells (OPC) as a model, these findings probably can be 
generalized to most differentiating CNS oligodendrocyte populations. Many 
molecular mechanisms regulating oligodendrocyte precursor cell differentiation have 
been characterized and will be quickly surnrnarized here, as the present thesis has not 
studied this subject (reviewed in Miller, 2002). 
A. Intrinsic factors 
In a manner very similar to neurons, oligodendrocyte differentiation relies on 
both cell cycle regulators and cell type specific transcription factors (reviewed in 
Sauvageot and Stiles, 2002). SpecificaIly, the CKI p27 and the bHLH proteins Oligl-
2 have been shown to be involved in the regulation of OPC proliferation and 
differentiation, respectively (Casaccia-Bonnefil et al., 1997; Durand et al., 1998; Lu et 
al., 2000b; Zhou et al., 2000). The Olig proteins, as the pro-neuronal bHLHs, are 
expressed prior to early oligodendrocyte genes and are both sufficient and necessary 
for oligodendrocyte formation. Indeed, overexpression of Oligl induces 
oligodendrocytes at the expense of neurons from cortical precursor cells both in vivo 
and in culture (Lu et al., 2000b; Lu et al., 2001). During oligodendrocyte 
differentiation, three negative regulator of bHLH activity, Id2, Id4 and HesS, are 
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downregulated and Id2 deficient precursors more readily differentiate into 
oligodendrocytes (Kondo and Raff, 2000a, b; Wang et al., 2001b). Conversely, 
overexpression of either Id or Hes proteins inhibits oligodendrocyte differentiation. 
Generation of Oligl, Olig2 and Oligl/2 knockouts further shows the importance of 
these bHLH proteins, as both single knockouts have reduced oligodendrocyte 
precursors, which are virtually absent in the double knockout CNS (Lu et al., 2002; 
Zhou and Anderson, 2002). Interestingly, analysis of these knockouts also revealed a 
role in motor neuron formation (reviewed in Rowitch et al., 2002). The spinal cord 
common precursors of motor neurons and oligodendrocytes express both ngn2 and 
Olig proteins, with the former being downregulated during oligodendrocyte formation. 
Strikingly, both motor neuron and oligodendrocyte markers are absent in the Oligl/2 
knockout spinal cord, while astrocyte formation still occurs (Lu et al., 2002; Zhou and 
Anderson, 2002). Overexpression of Olig bHLH along with ngn2, but not Oligs by 
themselves, induces ectopic motor neuron formation (Mizuguchi et al., 2001), 
suggesting collaboration between neuronal and oligodendroglial bHLHs during 
development. 
B. Extracellular pathways 
Several growth factors have been shown to regulate oligodendrocyte precursor 
proliferation and differentiation (Miller, 2002). Specifically, PDGF and FGF2 
promote OPC proliferation and upon withdrawal of these mitogenic factors, 
oligodendrocyte differentiation occurs spontaneously (Raff et al., 1988; Bogler et al., 
1990). However, exogenous factors can further induce OPC differentiation, such as 
Sonic hedgehog (Shh), retinoic acid and thyroid hormone, an effect antagonized by 
BMP (Barres et al., 1994a; Johe et al., 1996; Ahlgren et al., 1997; Zhu et al., 1999; 
Grinspan et al., 2000). Specifically in the developing telencephalon, Shh deficiency 
leads to a marked reduction in oligodendrocyte precursor cells. Shh treatment induces 
oligodendrogenesis, while Shh inhibition decreases oligodendrocyte formation from 
cortical precursor cells in culture (Alberta et al., 2001; Tekki-Kessaris et al., 2001). 
These observations suggest that oligodendrocyte formation from cortical precursor 
cells is at least partially promoted by endogenously produced Shh. The differentiating 
effect of Shh involves the induction of Olig gene expression, as Shh knockout brains 
show a lack of Olig bHLHs whereas Shh overexpressing transgenic animaIs show 
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increased Oligl expression and ectopie oligodendrocyte production in the spinal cord 
(Lu et al., 2000b; Alberta et al., 2001). The neurotrophin family member NT-3 has 
also been shown to promote differentiation and survival of oligodendrocyte precursors 
derived from different sources, such as postnatal cortex, embryonic striatum- derived 
neurospheres and OPCs (Barres et al., 1994a; Barres et al., 1994b; Lachyankar et al., 
1997; Heinrich et al., 1999). Both NT-3 and TrkC knockouts have reduced 
oligodendrocyte precursor cells (Kahn et al., 1999), which strongly supports a survival 
role for NT -3/TrkC signaling. 
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VII. Figures and figure legends 
Figure 1.1 A) Schematic representation of cerebral cortex development during 
embryogenesis, where ventricular zone precursor cells sequentially form the neurons 
of the six layers of the mature cortex (adapted from Pamavelas 2000; Pozniak 2002). 
VZ, ventricular zone; IZ, intermediate zone; PP, preplate; SP, subplate; CP, cortical 
plate; MZ, marginal zone. B) Cortical precursor cells also sequentially differentiate 
into neurons and glial cells and the timing observed in vivo is maintained in culture. 
Micrographs are from E13 precursor cells cultured for the indicated time. 
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Figure 1.2 A summary of the major intracellular players regulating cortical 
precursor neuronal gene expression and cell cycle withdrawal. 
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Figure 1.3 Detailed signaling pathways induced by RTKs. (adapted from Kaplan 
and Miller 2000). 
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Figure 1.4 Schematic representation of the major pathways regulating astrocyte 
differentiation of precursor cells. 
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CHAPTER2 
I. Preface 
Upon neuronal differentiation, cortical precursors undergo two temporally 
coupled events: tenninal mitosis and expression of neuronal genes (Gloster et al., 
1999). Two distinct prote in families are known to be involved in the se events. First, 
the pRb family is essential for proper cell cycle exit, as lack of pRb results in ectopie 
mitosis of cortical cells in vivo and in culture (Jacks et al., 1992; Slack et al., 1998; 
Fergusson et al., 2002). Second, the proneural bHLH proteins are sufficient and 
essential for neuronal gene expression in both non-neuronal and neural precursor cells 
(Lee 1997; Casarosa et al., 1999; Farah et al., 2000). A potential common regulator of 
these protein families is Id2, which has been shown to inhibit both pRb and positively 
acting bHLHs (Iavarone et al., 1994; Lasorella et al., 1996; Norton 1998). Based on 
these findings, the hypothesis of the present study is that pRb and bHLHs collaborate 
via Id2 to induce the precursor-to-neuron transition. Overexpression experiments 
, 
using Id2 and a constitutively activated fonn of pRb in cortical precursor cells were 
perfonned to test this hypothesis. 
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II. Abstract 
The retinoblastoma tumor suppressor protein (pRb) family is essential for cortical 
progenitors to exit the cell cycle and survive. In this report, we test the hypothesis that 
pRb collaborates with basic helix-Ioop-helix (bHLH) transcription factors to regulate 
cortical neurogenesis, taking advantage of the naturally occurring dominant-inhibitory 
HLH prote in Id2. Overexpression of Id2 in cortical progenitors completely inhibited 
the induction of neuron-:specific genes and led to apoptosis, presumably as a 
consequence of conflicting differentiation signaIs. Both of these phenotypes were 
rescued by coexpression of a constitutively activated pRb mutant. In contrast, Id2 
overexpression in postmitotic cortical neurons affected neither neuronal gene 
expression nor survival. Thus, pRb cOllaborates with HLHs to ensure the coordinate 
induction of terminal mitosis and neuronal gene expression as cortical progenitors 
become neurons. 
Key words: neurogenesis; Id2; pRb; bHLH transcription factors; cortical 
development; neuronal gene expression; a-tubulin; neural progenitor cells; 
neurofilaments; apoptosis 
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III. Introduction 
During embryogenesis, cycling neural progenitor cells in the ventricular zones of the 
CNS commit to a neuronal fate, and as a consequence of that decision, coordinately 
undergo terminal mitosis and induce early, neuron-specific genes. One group of 
proteins known to be essential for this transition is the retinoblastoma tumor 
suppressor prote in (PRb) family. In particular, inactivation of the Rb gene by 
homologous recombination led to ectopic mitoses and massive cell death in the 
developing nervous system (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992, 
1994), problems attributed to the essential role that this protein plays in cell cycle 
regulation (for review, see Slack and Miller, 1996). More recent studies defined a 
critical temporal requirement for the pRb family during cortical neurogenesis (Slack et 
al., 1998); these cell cycle regulators were essential for terminal mitosis and survival 
of progenitors but were dispensable for the induction of early neuronal genes. These 
findings thus implicated the pRb family as key regulators of terminal mitosis but left 
in question the intracellular mechanisms responsible for coordinately inducing 
neuronal gene expression. 
One class of proteins known to play a key role in the induction of cell type-
specific gene expression is the basic helix-Ioop-helix (bHLH) transcription factor 
family (for review, see Weintraub, 1993; Lee, 1997), whose role has been perhaps 
best defined during myogenesis and in Drosophila neurogenesis (Campos-Ortega, 
1993; Jan and Jan, 1993). Interestingly, one of the key myogenic bHLHs, MyoD 
(Weintraub, 1993), is thought to interact with pRb to regulate muscle development 
(Gu et al., 1993). Although it is not known whether similar interactions between 
transcription factors and cell cycle proteins regulate neurogenesis, a significant body 
of work has defined a role for the positive bHLHs during mammalian neural 
development (Kageyama and Nakanishi, 1997; Lee, 1997). In particular, in the PNS, 
bHLHs such as Mash-l (Johnson et al., 1990) and the neurogenins (Ma et al., 1996; 
Sommer et al., 1996) regulate the genesis of defined neuronal populations (Guillemot 
et al., 1993; Fode et al., 1998; Ma et al., 1998). Many positively acting bHLHs are 
also expressed in the developing CNS (for review, see Lee, 1997), and insights into 
their potential developmental roles are now starting to emerge. For example, in the 
absence of NeuroDl, NeuroD2, Mathl, and/or Math2 (Ben-Arie et al., 1997; Miyata 
et al., 1999; Schwab et al., 2000), cerebellar and/or hippocampal granule cells fail to 
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form appropriately, whereas progenitor cells are depleted in a defined region of the 
telencephalon in Mashl-j- mice (Casarosa et al., 1999; Torii et al., 1999). The rather 
limited nature of the CNS phenotypes in these mutant animaIs is likely attributable to 
compensation by other bHLH transcription factors, a phenomena that is weIl 
documented for myogenic bHLHs (Weintraub, 1993). 
ln this paper, we have chosen an alternative strategy to define the role of 
positively acting bHLH transcription factors during cortical neurogenesis. 
Specifically, we have chosen to inhibit aIl bHLH transcriptional activity by 
overexpressing 1d2 (Christy et al., 1991; Sun et al., 1991; Biggs et al., 1992), a 
member of a family of naturally occurring dominant-inhibitory HLH proteins that lack 
a DNA-binding domain (Benezra et al., 1990). This family, which has four members 
(Idl-ld4) (for review, see Norton et al., 1998), binds to and inhibits the ubiquitously 
expressed E2A bHLHs (Jeu et al., 1992), which are obligate partners for tissue-
specific bHLHs such as MyoD and Mash-l (Lassar et al., 1991; Norton et al., 1998). 
AIl four of the Id family members are expressed in the developing cortex in which 
sorne are expressed primarily in precursor ceIls and sorne (such as 1d2) in both 
precursors and subpopulations of postmitotic neurons (Neuman et al., 1993; 
Riechmann and Sablitzky, 1995; Jen et al., 1997). Interestingly, unlike the other Id 
proteins, 1d2 interacts with and regulates the activity of the pRb family (Iavarone et 
al., 1994; Lasorella et al., 1996), making endogenous 1d2 a molecule that could 
regulate both ceIl cycle progression and neuronal gene expression in cortical 
progenitor ceIls. 
Here, we report that overexpression of Id2 in cortical progenitor cells completely 
inhibited induction of neuron-specific genes and ultimately led to apoptosis. Both of 
these 1d2-induced phenotypes could be rescued by coexpression of constitutively 
activated pRb. In contra st to progenitors, overexpression of Id2 in postmitotic cortical 
neurons affected neither survival nor neuronal gene expression. These findings 
support the hypothesis that positively acting bHLH transcription factors, in 
collaboration with the pRb family, are essential for cortical progenitors to become 
neurons and support the idea that interactions between endogenous pRb, Id2, and 
bHLH transcription factors play a key role in regulating the progenitor-to-neuron 
transition. 
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IV. Results 
Expression of endogenous and exogenous Id2 in cortical progenitor cells 
To address the role of HLH proteins in the progenitor-to-neuron transition, we used a 
culture system that we have characterized previously (Slack et al., 1998; Gloster et al., 
1999). 
Cultures of progenitor cells were derived from E12-E13 mouse cortex and 
were plated in the presence of bFGF. Vpon plating, virtually all of the cells were 
dividing, nestin-positive progenitors (data not shown; Slack et al., 1998; Gloster et al., 
1999). Over the ensuing 5 d, many of these cells exited the cell cycle to become 
postmitotic neurons that expressed the panneuronal markers ~IIItubulin, neuron-
specific enolase, MAP-2, and neurofilament M (NFM), as well as a neuron-specific 
TaI :nlacZ transgene composed of the TaI a-tubulin promoter linked to a nuclear ~­
galactosidase reporter gene (Gloster et al., 1994; Slack et al., 1996, 1998). 
To determine whether positively acting bHLH transcription factors were 
essential for induction of the neuronal phenotype in cortical progenitors, we chose to 
inhibit their activity by overexpressing the dominant-inhibitory HLH, Id2. As a 
prelude to these studies, we characterized expression of endogenous Id2 in these 
cultures. Reverse transcription (R T)-PCR analysis demonstrated that Id2 mRNA was 
expressed in the E13 brain, the postnatal day 0 (PO) neocortex, and, at reduced levels, 
in the adult brain (Fig. 2.1A). Id2 mRNA was also expressed in cultured cortical 
progenitors (Fig. 2.1A), as predicted by previous in situ hybridization studies 
localizing Id2 mRNA to the ventricular zone of the embryonic neocortex (Neuman et 
al., 1993). Western blot analysis confirmed this pattern of expression (Fig. 2.1A); Id2 
was present at higher levels in the embryonic versus adult brain and was expressed by 
cortical progenitors. 
To increase the level of expression of Id2 in cortical progenitors, we generated 
a recombinant adenovirus expressing myc-tagged Id2. We have previously used such 
an adenovirus approach to genetically manipulate cortical progenitor cells (Slack et 
al., 1998) and postmitotic neurons (Slack et al., 1996; Aloyz et al., 1998; Mazzoni et 
al., 1999; Vaillant et al., 1999). Western blot analysis of HEK293 cells infected with 
the Id2 adenovirus revealed that the recombinant Id2 prote in was appropriately sized 
at 14-16 kDa (Fig. 2.1B). Progenitors infected with Id2, but not ~-galactosidase, 
adenovirus also expressed a myc-positive protein of the appropriate size (Fig. 2.1B). 
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To confirm this result, we performed immunocytochemistry on progenitors infected 
with 50 MOI of Id2 adenovirus. Double-label analysis revealed that myc-tagged Id2 
was expressed in nestin-positive progenitor cells (Fig. 2.1 C). A similar analysis with 
antibodies to the myc-tag and to the endogenous Id2 prote in demonstrated that 
endogenous Id2 was distributed in both the cytoplasm and nucleus as reported 
previously(Deed et al., 1996; Tzeng and de Vellis, 1998) and that the adenovirally 
driven Id2 was primarily targeted to the nucleus (Fig. 2.1 C). 
Id2 inhibits induction of neuronal gene expression in cortical progenitors but not 
in postmitotic cortical neurons 
To determine whether positively acting bHLH transcription factors are essential for 
induction of neuron-specific gene expression, we infected progenitor cells with 50 
MOI of the Id2 adenovirus upon plating and, 2.5 d later, monitored expression oftwo 
neuronspecific markers, the TaI :nlacZ transgene and NFM. As controls, sister 
cultures were infected with 50 MOI of an adenovirus expressing GFP. Double-label 
immunocytochemistry revealed that Id2, but not GFP, completely inhibited induction 
of the TaI :nlacZ transgene in cortical progenitors (Fig. 2.2A). Quantitation 
demonstrated that TaI :nlacZ was virtually never expressed in Id2-expressing cells, 
although it was expressed in the majority of control, GFP-expressing cells (Fig. 
2.2A,B). Id2 overexpressÎon also inhibited NFM expression (Fig. 2.2B); Id2-
expressing cells were virtually never NFM-positive, whereas control cells were (Fig. 
2.2B). Similar results were obtained at MOIs of the Id2 virus ranging from 25 to 100 
MOI (data not shown). 
To determine whether the Id2-mediated inhibition of neuronal gene expression 
was specific to progenitors, we also examined postmitotic cortical neurons. Double-
label immunocytochemical analysis revealed that cortical neurons expressing myc-
tagged Id2 also expressed robust levels of NFM (Fig. 2.2A). Thus, Id2 inhibits the 
induction of neuronal gene expression in cortical progenitors cells, presumably by 
binding to and inhibiting positively acting bHLH transcription factors. 
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Id2 expression leads to apoptosis of cortical progenitors but not postmitotic 
neurons 
We have demonstrated previously that inhibition of the pRb family in cortical 
progenitors led to apoptosis, although it had no effect on induction of neuronal gene 
expression (Slack et al., 1998). Because Id2 also interacts with members of the pRb 
family (Iavarone et al., 1994; LasoreIla et al., 1996), we monitored survival of the Id2-
infected progenitor ceIls. SpecificaIly, cortical progenitor ceIls were infected with 10-
100 MOI ofId2 or ~-galactosidase adenovirus, and 4 d later, survival was determined 
using MTT assays, which measure mitochondrial function. This analysis revealed that 
expression of Id2 led to a dose-dependent decrease in cortical progenitor ceIl number, 
whereas similar MOIs of the control virus had no effect (Fig. 2.3A). To confirm that 
this decrease in MTT reflected a decre~se in survival, we performed TUNEL on 
cortical progenitor ceIls infected with 50 MOI of Id2 or ~-galactosidase adenovirus. 
Double-label analysis revealed that, 4 d after infection, the majority of Id2-expressing 
progenitor ceIls were TUNEL-positive (Fig. 2.3C), whereas the vast majority of ~­
galactosidase-expressing ceIls were not (Fig. 2.3C). 
Because inhibition of the pRb family led to apoptosis of cortical progenitors 
but not postmitotic neurons (Slack et al., 1998), we examined the effect of Id2 on 
survival of cortical neurons. Cortical neurons were plated at E 16 and, 5 d later, were 
infected with various MOIs of adenovirus expressing either Id2 or ~-galactosidase. 
MTT assays revealed that neither Id2 nor ~-galactosidase had any effect on neuronal 
survival (Fig. 2.3B). TUNEL analysis confirmed this conclusion; quantitative double-
label analysis revealed that the vast majority of neurons expressing either Id2 or ~­
galactosidase were not TUNEL-positive 4 d after infection (Fig. 2.3C). Thus, 
overexpression of Id2 ultimately caused apoptosis of progenitors but not postmitotic 
neurons, an effect similar to that observed after inhibition of the pRb family (Slack et 
al., 1998). 
Constitutively activated pRb rescues both the loss of neuronal gene expression 
and the progenitor cell apoptosis induced by Id2 
Together, these data indicated that increased expression of Id2 in cortical progenitors 
(1) completely suppressed induction of neuronal gene expression, presumably by 
binding to and inhibiting positively acting bHLH transcription factors, and (2) led to 
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progenitor cell apoptosis, potentially by interacting with pRb family members and 
disrupting terminal mitosis. To test this latter possibility, we asked whether pRb could 
rescue these Id2-induced phenotypes. To perform these experiments, we used a 
recombinant adenovirus expressing an HA-tagged, phosphorylation-deficient, 
constitutively activated form ofpRb (Chang et al., 1995). InitiaIly, we confirmed that 
this mutant form of pRb interacted with Id2, as does wild-type pRb (Iavarone et al., 
1994; Lasorella et al., 1996). Lysates of HEK293 cens infected with Id2 or pRb 
adenoviruses were incubated together, and the mutant pRb was immunoprecipitated 
with anti-HA. These immunoprecipitates were then probed for the presence of myc-
tagged Id2 using Western blots. This analysis revealed that the pRb adenovirus 
expressed an HA-tagged protein of ~90-100 kb (the appropriate size) (Fig. 2.4B) and 
that the mutant pRb and myc-tagged Id2 coimmunoprecipitated (Fig. 2AA), 
confirming an interaction between these two proteins. Confirmation that this 
interaction also occurred in neurons was obtained by performing similar coinfection 
experiments in sympathetic neurons. As seen in HEK293 ce Ils, the mutant pRb and 
myc-tagged Id2 coimmunoprecipitated in this neuronal context (data not shown). 
We next determined whether this mutant pRb had any effect on the progenitor-
to-neuron transition. Progenitor cens were infected with 50 MOI of pRb adenovirus 
and analyzed for neuronal gene expression and ceIl survival. Western blot analysis 
demonstrated that pRb-infected cortical progenitors expressed an HA-tagged protein 
of the appropriate size (Fig. 2.4B), and immunocytochemistry demonstrated that 
progenitors infected with the mutant pRb adenovirus expressed detectable HA-
immunoreactivity (Fig. 2AC), whereas those infected with a control ~-galactosidase 
adenovirus did not (data not shown). To analyze neuronal gene expression in these 
cultures, we performed double-label immunocytochemistry 2.5 d after infection. Most 
of the HA-positive, pRb-expressing progenitors also expressed NFM or the Tal:nlacZ 
transgene (Fig. 2.4C, D), and there was no difference in neuronal marker gene 
expression between cens infected with the pRb versus control, GFP adenovirus (Fig. 
2.4D). Similarly, expression of mutant pRb had no effect on neuronal survival, as 
monitored by either MTT assays (Fig. 2.5B) or quantitative TUNEL (Fig. 2.5C). 
Having ascertained that activated pRb had no effect on either neuronal gene 
induction or survival, we determined whether it could rescue the Id2-induced 
progenitor cell phenotype. Initially, we confirmed that coinfection of progenitor ceIls 
with the pRb virus did not alter expression of myc-tagged Id2 (Fig. 2.lB). We then 
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used double-label immunocytochemistry to show that many of the progenitor cells 
expressed both myc-tagged 1d2 and HA-tagged pRb (Fig. 2.SA). Having performed 
these controls, we examined Id2-induced apoptosis. Cortical progenitor cells were 
coinfected with varying MOIs of adenoviruses expressing Id2 and mutant pRb, or Id2 
and ~-galactosidase, and survival was measured using MTT assays 4 d later. This 
analysis demonstrated that constitutively active pRb, but not ~-galactosidase, partially 
rescued the decrease in neuronal survival induced by 1d2 (Fig. 2.5B). This conclusion 
was confirmed by quantitative TUNEL; sister cultures were coinfected with 50 MOI 
each of Id2 and pRb or ~-galactosidase adenoviruses, and the cultures were analyzed 
by double-Iabeling (Fig. 2.SC). When Id2- expressing cells were coinfected with the 
~-galactosidase virus, 68 ± 6.2% of the myc-tagged cells were TUNEL-positive, a 
result similar to that seen with the Id2 virus alone (Fig. 2.3C). In contrast, in cortical 
progenitors coinfected with the pRb virus, only 32 ± 4.9% of the myc-tagged cells 
were TUNEL-positive, a rescue of approximately half of the 1d2-expressing 
progenitor cells. This rescue was statistically significant (p < 0.01) and was similar in 
magnitude to the rescue observed in the MTT assays (Fig. 2.5B). Thus, constitutively 
activated pRb substantially rescued the 1d2-induced apoptosis, supporting the idea that 
1d2 interacts with endogenous pRb (and or pRb family members) to regulate terminal 
mitosis and ultimately, survival of cortical progenitors as they become postmitotic 
neurons. 
We then determined whether activated pRb rescued the inhibition of neuronal 
gene expression seen with Id2. Progenitor cells were coinfected with 50 MOI each of 
adenoviruses expressing 1d2· and pRb, or Id2 and GFP, and were analyzed for 
expression of the TaI :nlacZ transgene or NFM. Double-Iabeling revealed that 
coinfection with activated pRb rescued the expression of the neuron-specific 
TaI :nlacZ transgene in Id2-expressing progenitor cells (Fig. 2.5D,E). Similarly, 
coinfection with activated pRb rescued the expression of NFM in Id2-expressing cells 
(Fig. 2.5D,E). In contrast, coinfection with a GFP- or ~-galactosidase-expressing 
adenovirus was unable to rescue neurofilament gene expression in Id2-positive cells 
(Fig. 2.5E), indicating that activated pRb rescued not only Id2-induced apoptosis but 
also the Id2-induced inhibition of neuronal gene expression. Thus, inhibition of the 
pRb family does not on its own inhibit induction of neuronal genes in cortical 
67 
progenitors, but activation of pRb IS sufficient to rescue the 1d2-induced loss of 
neuronal gene expression. 
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v. Discussion 
In this paper, we have tested the hypothesis that HLH proteins collaborate with pRb to 
regulate the progenitor-to-neuron transition. Data presented here support four major 
conclusions. First, these studies support the hypothesis that transcription by positively 
acting bHLHs is essential for induction of neuronal gene expression in cortical 
progenitor cells; when bHLH transcriptional activity is inhibited by overexpression of 
Id2, progenitor cells do not express neuronal genes. Second, these studies 
demonstrate that perturbation of the progenitor-to-neuron transition by overexpression 
of Id2 leads to apoptosis. We propose that this phenotype is attributable to inhibitory 
interactions between Id2 and endogenous pRb, because (1) this apoptotic phenotype is 
similar to that observed when the pRb family is ablated in these same progenitor cells 
(Slack et al., 1998), and (2) constitutively activated pRb can rescue the Id2-driven 
apoptosis. Third, our data indicate that once a progenitor cell has become a 
postmitotic cortical neuron, then Id2 overexpression does not inhibit neuronal gene 
expression or cause neuronal apoptosis, suggesting that the bHLH transcription factors 
and pRb are required for induction of the neuronal phenotype, but not necessarily for 
its maintenance. Fourth, our data demonstrate that constitutively activated pRb can 
rescue both the Id2-driven apoptosis and the inhibition of neuronal genes, suggesting 
that interactions between pRb and HLHs are likely to regulate both terminal mitosis 
and the induction of neuronal gene expression. Together, these studies indicate that 
collaborative interactions between the pRb family and HLHs play a key role in 
regulating cortical neurogenesis and suggest that endogenous Id2 may weIl be critical 
in enacting the progenitor-to-neuron decision. 
The idea that interactions between the pRb family and HLH proteins may 
regulate cellular differentiation is a particularly attractive one when considering 
neurogenesis in the CNS. With a few exceptions, such as the precursors that migrate 
in the rostral migratory stream from the lateral ventricles to the olfactory bulb 
(Menezes et al., 1995), when CNS progenitor cells become postmitotic neurons, they 
coordinately undergo terminal mitosis and induce neuronal gene expression (Gloster 
et al., 1999). Moreover, when one aspect of this process is perturbed, such as occurs 
after functional ablation of the pRb family, the end result is cellular apoptosis (Slack 
et al., 1998). This integral relationship between terminal mitosis and neuronal gene 
expression suggests that the same molecules may well regulate both events. Data 
69 
presented here suggest that Id2, which can interact with and inhibit pRb-driven 
tenninal mitosis and bHLH-driven induction of neuronal gene expression, might be 
one such molecule. 
It is likely that Id2 overexpression inhibits the induction of neuronal gene 
expression by directly binding to the ubiquitous E2A bHLH transcription factors (for 
review, see Norton et al., 1998), thereby titrating out the requisite binding partners for 
neurogenic bHLHs, such as Mash-1 (Johnson et al., 1990), neurogenins (Ma et al., 
1996; Sommer et al., 1996), or NeuroD (Lee et al., 1995), although Id2 may also 
directly bind the neurogenic bHLHs themselves (Langlands et al., 1997). A similar 
mechanism is thought to underlie the ability of Id1 and Id3 to inhibit myogenesis (Jen 
et al., 1992; Atherton et al., 1996) and adipogenesis (Moldes et al., 1997) in celllines 
and of Id1 (Sun, 1994) and Id2 (Morrow et al., 1999b) to inhibit B cell and T cell 
development in vivo. Genetic evidence that endogenous Id proteins play a similar 
inhibitory role in thenervous system derives from Drosophila (Ellis et al., 1990) (for 
review, see Campos-Ortega, 1993; Jan and Jan, 1993) in which the extramachrochaete 
gene product (the Drosophila equivalent of Id) antagonizes both Daughterless 
(Drosophila E2A) and achaete-scute (Drosophila Mash) bHLH prote in s, which are 
involved in sex detennination and neurogenesis. Similarly, Id2 was also suggested to 
be involved in cell fate decisions in the chick neural crest (Martinsen and Bronner-
Fraser, 1998). More recently, the targeted deletion of the Id1 and Id3 genes was 
shown to cause altered nervous system development accompanied by perturbed 
angiogenesis in the embryonic brain (Lyden et al., 1999). Deletion of either gene on 
its own produced no detectable phenotype, presumably because of compensation by 
different family members. An essential role for Id2 .during development is also 
indicated by the recent report of Id2-/- mice, which display arrested development and 
lack lymph nodes and Peyer's patches (Yokota et al., 1999). Although no infonnation 
is yet available regarding the nervous system of these .animals and the underlying 
cellular deficit is unclear, these data do indicate that Id2 is essential for nonnal 
mammalian development. 
Studies presented here also strongly support the idea that endogenous Id2 
interacts with the pRb family to regulate neurogenesis and cell survival. As confinned 
here, previous studies demonstrated that Id2 binds to the hypophosphorylated fonn of 
pRb and inhibits its ability to mediate growth arrest (Iavarone et al., 1994; Lasorella et 
al., 1996). Because pRb is required for cortical progenitors to exit the cell cycle and 
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survive (Slack et al., 1998), then this finding predicts that increased Id2 would mimic 
the phenotype observed when the pRb family is ablated. In fact, this is what we 
observe; cortical progenitor ceUs, but not postmitotic neurons, undergo apoptosis 
when Id2 is overexpressed. Moreover, coexpression of a mutant pRb that is 
constitutively hypophosphorylated rescues this apoptotic phenotype, presumably by 
sequestering Id2 and allowing progenitor ceUs to undergo terminal mitosis. Thus, 
although our studies do not directly demonstrate that endogenous Id2 regulates the 
ability of pRb to mediate terminal mitosis in progenitor ceUs, they suggest that such 
may be the case. 
Why does constitutively activated pRb rescue the deficit in neuronal gene 
expression induced by Id2 when (1) the hypophosphorylated pRb mutant does not, on 
its own, induce neuronal gene expression (shown here), and (2) functional ablation of 
the pRb family has no effect on induction of the same neuron-specific genes (Slack et 
al., 1998)? We propose that hypophosphorylated pRb, by binding to Id2, inhibits its 
ability to bind to and inhibit positively acting bHLH transcription factors. In this 
model, a cycling progenitor ceU would have relatively high levels of Id2, and pRb 
would be primarily present as a hyperphosphorylated protein. At this point in time, 
Id2 levels would be sufficient to bind and inhibit any positively acting bHLH 
transcription factors and to bind and inhibit any hypophosphorylated pRb. In response 
to an as-yet undefined cue to become a postmitotic neuron, Id2 levels would decrease 
and/or Id2 activity would be altered by phosphorylation (Nagata et al., 1995; Hara et 
al., 1997), and the ratio of hypophosphorylated to hyperphosphorylated pRb would 
increase. Id2 would then no longer be able to sequester aU of the hypophosphorylated 
pRb, thereby allowing pRb to "stop" the cell cycle. Moreover, the decrease in Id2 
levels-activity, coupled with the increase in hypophosphorylated pRb, would ensure 
that little or no Id2 was available to bind and sequester E2A bHLHs, which could then 
form productive transcription complexes with neurogenic bHLHs. Thus, pRb, Id2, 
and neurogenic bHLHs would aU collaborate to enact the neuronal commitment 
decision, once such a decision had been made. Such a mechanism would ensure (1) 
the coordinate induction of neuronal gene expression and terminal mitosis, and (2) the 
apoptosis of any progenitor cell that failed to properly enact this transition. 
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VI. Experimental procedures 
Primary cultures of cortical progenitors and neurons. The preparation of cortical 
progenitors from embryonic day 12 (EI2) to E13 mouse embryos has been described 
in detail previously (Slack et al., 1998; Gloster et al., 1999). Briefly, cortical tissue, 
obtained from E12-E13 mice, was dissected in ice-cold HBSS (Life Technologies, 
Burlington, CA) and then transferred into 37°C Neurobasal media (Life Technologies) 
containing 500 mM glutamine, 1 % N2 supplement, 2% B27 supplement, and 1 % 
penicillin-streptomycin (Life Technologies); this media was supplemented with 40 
ng/ml basic fibroblast growth factor (bFGF) (Collaborative Research, Bedford, MA). 
The tissue was triturated with a fire-polished glass Pasteur pipette into small c1usters 
of cells that were plated in multiwell tissue culture dishes (Nunc, Naperville, IL) or 
chamber slides precoated with laminin and poly-D-lysine (Collaborative Research). 
Cell density was 100,000 cells per well. Cultures were maintained at 37°C in a 5% 
CO2 incubator. Mature postmitotic neurons were prepared from E16 embryos, from 
which cortices were collected, triturated in culture media (Neurobasal with 0.5 mM 
glutamine, 1 % penicillin-streptomycin, 1 % N2, 2% B27 supplements, and 20 ng/ml 
bFGF), and plated at a density of 50-75,000 cells per weIl. For analysis of TaI :nlacZ 
expression, cultures were prepared from the K6 tine of transgenic mice, which has 
been characterized in detail previously (Gloster et al., 1994; Bamji and Miller, 1996; 
Gloster et al., 1999). These animaIs are homozygous for the transgene, eliminating 
the need for genotyping. 
Recombinant adenovirus vectors. The adenovirus vectors carrying the Escherichia 
coli lacZ expression cassette (Ad5CAI7lacZ; gift of Dr. Frank Graham, McMaster 
University, Hamilton, Ontario, Canada) (Slack et al., 1998) and constitutively 
activated pRb (Chang et al., 1995) have been described previously. The adenoviruses 
expressing green fluorescent prote in (GFP) and myc-tagged human Id2 were both 
constructed in the Ad5 backbone (Bett et al., 1994), which drives expression from the 
cytomegalovirus promoter. The GFP-expressing virus was obtained commercially 
from Quantum Biotechnologies (Montreal, Canada), and that expressing myc-tagged 
human Id2 was constructed using standard protocols, as we have described previously 
(Mazzoni et al., 1999). AlI recombinant adenoviruses were purified on CsCl 
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gradients, as we have described previously (Aloyz et al., 1998; Mazzoni et al., 1999), 
and extensively purified. Infectious titer was determined by plaque assay on HEK293 
cens (Graham and Prevec, 1991). Cortical progenitor cens were infected at the time 
of plating, and 24 hr after infection, half of the media was change d, and cens were fed 
every 2 d. The multiplicity of infection (MOI) indicates the number of plaqueforming 
units added per cen. 
Immunocytochemistry of cultured cells. For immunocytochemical detection of 
nestin (1: 1000; gift from Dr Ron McKay, National Institute ofNeurological Disorders 
and Stroke, Bethesda, MD), neurofilament M (1 :400; Chemicon, Temecula, CA), ~­
galactosidase (1: 1000; ICN Biomedicals, Cleveland, OH), the myc-tag (1 :200; 
PharMingen, San Diego, CA), and the hemagglutinin (HA)-tag [1:500; monoclonal 
from Boehringer Mannheim (Indianapolis, IN) and polyclonal from Babco 
(Richmond, CA)], cens were fixed for 20 min with 4% paraformaldehyde. Cultures 
were then washed with HEPES-buffered saline (HBS), pH 7.4, permeabilized for 5 
min in 0.2% NP-40 in HBS, and then blocked for 45 min with buffer containing 6% 
goat serum and 0.5% bovine serum albumin. cens were then incubated at 4°C 
overnight with primary antibodies in HBS containing 3% goat serum. After three 
washes with HBS, cens were incubated at room temperature for 60 min with 
indocarbocyanine (Cy3)-conjugated goat anti-mouse (1 :400; Jackson 
ImmunoResearch, West Grove, PA), Cy3-conjugated anti-rabbit (1:400; Jackson 
ImmunoResearch), FITC-conjugated anti-mouse (1:100; Jackson ImmunoResearch), 
or FITC-conjugated anti-rabbit (1:100; Jackson ImmunoResearch) secondary 
antibodies (as necessary) prepared in HBS containing 3% goat serum. Samples were 
washed three times with HBS and then were counterstained for 2 min with Hoechst 
33258 (Sigma, St. Louis, MO) before examination by fluorescence microscopy. For 
quantitation, three to six random images of each treatrnent (per experiment) were 
captured and processed. Digital image acquisition and analysis was performed with 
the Northem Eclipse software (Empix Ine.) using a Sony (Tokyo, Japan) XC-75CE 
CCD video camera. 
Cell survival assays and terminal deoxynucleotidyl transferase-mediated 
biotinylated UTP nick end labeling. MTT survival assays were performed as 
described previously (Slack et al., 1998; Vaillant et al., 1999). In brief, 20 III ofMTT 
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reagent was added to the medium in each well of a 96-well plate containing the 
cultured progenitors or neurons. After a 2.5 hr incubation at 37°C, the medium-MTT 
mixture was removed, and the cells were lysed with 100 ml of isopropanol containing 
2 f.ll/ml concentrated HCL The absorbance of the lysate at 570 and 630 nm was 
determined using a Bio-Tek Instruments (Burlingame, CA) model Elx-800 UV plate 
reader (Mandel Scientific Inc.). All MTT assays were performed in triplicate. For the 
terminal deoxynuc1eotidyl transferase-mediated biotinylated UTP nick end labeling 
(TUNEL) experiments, cells were briefly rinsed in HBS, pH 7.4, and fixed for 20 min 
in 4% paraformaldehyde (Sigma) in HBS. Cells were then permeabilized with 0.4% 
NP-40 in HBS for 5 min and washed three times with HBS. TUNEL reaction was 
performed for 1 hr at 37°C. Each 100 f.ll ofTUNEL reaction mixture contained 20 f.ll 
of 5X terminal deoxynuc1eotidyl transferase (TdT) buffer, 1.5 f.ll of TdT enzyme (both 
from Promega, Madison, WI), and 1 f.ll of biotin-16-dUTP (Boehringer Mannheim). 
After the TUNEL reaction, cells were rinsed three times in HBS and incubated for 45 
mm at room temperature with Cy3-conjugated streptavidin (Jackson 
ImmunoResearch) diluted 1 :2000 in HBS. In those experiments in which cells were 
double-Iabeled, cells were then incubated ovemight in the primary antibody, as above, 
and immunocytochemical analysis was performed as described. 
Western blot analysis and coimmunoprecipitations. For biochemistry, cortical 
progenitors or neurons were plated in 60 mm dishes and were lysed in TBS lysis 
buffer (Knusel et al., 1994) containing 137 mM NaCI, 20 mM Tris, pH 8.0, 1% (v/v) 
NP-40, 10% (v/v) glycerol, 1 mM PMSF, 10 f.lg/ml aprotinin, 0.2 f.lg/mlleupeptin, 1.5 
mM sodium vanadate, and 0.1 % SDS. Cells were collected in cold PBS by gentle 
scraping to detach them, were washed three times with the same buffer, and then were 
resuspended in 50-100 f.ll of lysis buffer, followed by rocking for 10 min at 4°C. 
After a 5 min centrifugation, the lysates were normalized for protein concentration 
using a BCA Protein Assay Reagent (Pierce, Rockford, IL). Equal amounts ofprotein 
(50-100 f.lg) were then boiled in sample buffer for 5 min and separated by 7.5-15% 
SDS-PAGE gradient gels. Altematively, for Id2, samples were separated on tricine-
SDS-PAGE gels, which are optimized for small proteins (Schagger and von Jagow, 
1987). After electrophoresis, proteins were transferred to 0.2 f.lm nitrocellulose for 3 
hr at 0.75 A, and the membrane was washed three times with TBS. For all antibodies, 
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the membranes were blocked in 5% nonfat milk in TBS plus 0.2% Tween (TB ST) 
(blotto) for 2 hr at room temperature. The membranes were then incubated ovemight 
at 4°C with the primary antibodies in blotto: anti-myc (1:500), anti-HA (1:1000), anti-
Id2 (1 :200; Santa Cruz Biotechnology, Santa Cruz, CA) or anti-extracellular signal-
regulated kinase (ERK) (1 :500; Santa Cruz Biotechnology). After incubation with the 
primary antibodies, membranes were washed four times with TBST over 40 min and 
incubated with the secondary antibody for 1.5 hr at room temperature. The secondary 
antibodies (goat anti-mouse or goat anti-rabbit HRP from Boehringer Mannheim) 
were used at 1:10,000 dilution. After three washes with TBST, detection was 
performed using the ECL chemiluminescence reagent from Amersham Pharmacia 
Biotech (Arlington Heights, IL) and XAR x-ray film from Eastman Kodak (Rochester, 
NY). For coimmunoprecipitations, HEK293 cells or sympathetic neurons of the 
superior cervical ganglion, cultured as described previously (Aloyz et al., 1998), were 
infected with recombinant adenoviruses expressing HApRb, myc-Id2, or ~­
galactosidase, cells were lysed in lysis buffer, and 200 J-Lg ofprotein from the relevant 
lysates were mixed and incubated ovemight at 4°C in the presence of anti-HA. 
Protein G-Sepharose (Amersham Pharmacia Biotech) was added to the lysates and 
incubated for 2 hr at 4°C, and the lysates were then centrifuged to collect the 
immunoprecipitated prote in. Immunoprecipitates were washed twice with lysis 
buffer, boiled 5 min in 23 sample buffer, and loaded on 7.5-15% SDS-PAGE gradient 
gels for electrophoresis. 
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VII. Figures and figures legends 
Figure 2.1. Expression of endogenous Id2 and a myc-tagged Id2 adenovirus in 
cortical progenitor cells. A, Top panels, RT-PCR analysis of Id2 and GAPDH 
mRNAs in cDNA isolated from adult cortex (Ad), E13 brain (El3), PO brain (PO), or 
cortical progenitor cells 1 d after plating (CP). As controls, analysis was performed 
on embryonic brain samples in which the reverse transcriptase was eliminated from 
the cDNA reaction (Ell/RT-) and on samples thatcontained no cDNA (-). Bottom 
panels, Western blot analysis for endogenous Id2 in cortical progenitors (C-CP), and 
E16 (El6B), E18 (EJ8B) , P2 (P2B) , and adult brain (AdB). The arrow indicates 
endogenous Id2. The same blot was reprobed with an antibody directed against ERKs 
1 and 2 (a-Erks) to control for protein loading. B, Western blot analysis for myc-
tagged Id2 in HEK293 cells and cortical progenitor cells (CP). Cells were infected 
with the Id2 adenovirus (Ad-Id2) and/or a virus expressing constitutively activated 
pRb (Ad-Rb), proteins were separated on tricine gels and transferred to nitrocellulose, 
and filters were probed with an anti-myc antibody. Control lysates of cells infected 
with a ~-galactosidase adenovirus (Ad-LacZ) were analyzed on the same blot. A 
myctagged protein of ~ 15 kDa was detected in both HEK293 cells and cortical 
progenitor cells infected with the Id2 adenovirus. C, Double-label 
immunocytochemical analysis of cortical progenitor cells infected with 50 MOI of an 
adenovirus expressing myc-tagged Id2 and analyzed for myc and for nestin (top 
panels) or for myc and Id2 (bottom panels). The right panels are photomicrographs of 
the Hoechst staining for the same fields. Arrows indicate double-Iabeled cells. 
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Figure 2.2. Id2 inhibits expression of neuron-specific genes in cortical progenitor 
cells as they become neurons but does not perturb neuronal gene expression in 
postmitotic cortical neurons. A, Double-label immunocytochemical analysis of 
cortical progenitor cells (CP) or postmitotic cortical neurons (PM) infected with 
adenoviruses expressing Id2 (a-mye) or GFP (left panels) and then analyzed for 
expression of the neuron-specific Tal:nlacZ transgene (middle panels) or NFM 2.5 d 
later. The right panels are photomicrographs of the Hoechst staining for the same 
fields. Note that none of the myc-stained cortical progenitor cens express TaI :nlacZ 
(arrows, top panels), whereas GFP and Tal:nlacZ are colocalized in many cens 
(arrows, middle panels). In contra st to progenitors, expression of myc-tagged Id2 in 
cortical neurons does not inhibit neurofilamentM expression (arrows, bottom panels). 
B, Quantitation of double-label immunocytochemical analysis similar to that in A, 
showing results for TaI :nlacZ and NFM. For each treatment in each individual 
experiment, three to six random fields were analyzed. cens expressing myc-tagged 
Id2 virtually never expressed either of these two neuronal marker genes. In contrast, 
many of the GFP-expressing cens coexpressed Tal:nlacZ or NFM [range, 53 ± 3.3 
(Expt 3) to 82 ± 10.5 (Expt 4)]. Results indicate the mean ± SE. *p < 0.05, **p < 
0.005. 
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Figure 2.3. Overexpression of Id2 leads to apoptosis of cortical progenitors but not 
postmitotic cortical neurons. A, MTT as say to measure survival of cortical progenitor 
cens 4 d after infection with adenoviruses expressing Id2 (Ad-Id2) or ~-galactosidase 
(Ad-Bgal ) at MOIs ranging from 10 to 100 MOI. An points were performed in 
triplicate, and results represent the mean ± SE, with 100% survival being defined as 
the MTT value obtained for uninfected cens in the same experiment. **p < 0.005. B, 
MTT assay to measure survival of postmitotic cortical neurons after infection with 
adenoviruses expressing Id2 (Ad-Id2) or ~-galactosidase (Ad-Bgal ) at MOIs ranging 
from 10 to 100. An points were performed in triplicate, and results are as in A. C, 
Quantitation of the percentage of TUNEL-positive cortical progenitors (CP) and 
postmitotic cortical neurons (PM) infected with adenoviruses expressing myc-tagged 
Id2 (Ad-Id2) and/or ~-galactosidase (Ad-Bgal) for 4 d. Results are the mean ± SE of 
data obtained from three to six randomly chosen fields. *p = 0.015 compared with 
cens infected with Ad-Id2. Note that the majority of Id2-expressing cortical 
progenitor cens are TUNEL-positive, whereas ~-galactosidase-expressing progenitors 
are not. 
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Figure 2.4. A, B, Constitutively activated pRb interacts with [d2. A, Lysates of 
HEK293 cens infected with adenoviruses expressing myc-tagged Id2 (293 cells/Id2), 
13-galactosidase (293 cells/Bgal ), and/or HA-tagged activated pRb were mixed, the 
HA-tagged pRb was immunoprecipitated with anti-HA (a-HA IP), and then the 
immunoprecipitated proteins were probed with anti-HA to detect the 
immunoprecipitated pRb and anti-myc to detect coimmunoprecipitated Id2. B, 
Cortical progenitors (CP) or HEK293 cens were infected with adenoviruses 
expressing Id2 (Ad-Id2) or activated pRb (Ad-Rb), and lysates were analyzed with 
anti-HA on Western blots to detect expression of the pRb protein. The arrow 
indicates a band of the appropriate size that is seen only in cens infected with Ad-Rb. 
C, D, Expression of constitutively activated pRb does not affect the induction of 
neuronal gene expression in cortical progenitor cel/s. C, Double-label 
immunocytochemical analysis of cortical progenitor cens infected with adenoviruses 
expressing HA-tagged constitutively activated pRb (a-HA; left panels) and then 
analyzed for expression of TaI:nlacZ (middle panel, top) or NFM(middle panel, 
bottom). The right panels are photomicrographs of Hoechst staining for the same 
fields. Note that many of the HA-stained cens express either TaI :nlacZ or 
neurofilament (arrows). D, Quantitation of double-label immunocytochemical 
analysis similar to that in C. For each treatment in each individual experiment, three 
to six random fields were analyzed. Many of the HA-tagged pRb-expressing cens 
coexpressed Tal:nlacZ or NFM [range, 59 ± 4.9 (Expt 5) to 96 ± 3.7 (Expt 4)], a 
result similar to that obtained for cens expressing GFP [range, 53 ± 3.3 (Expt 2) to 82 
± 10.5 (Expt 3)]. Results indicate the mean ± SE. In an experiments, the percentage 
ofpRb-positive cens coexpressing one ofthese twoneuronal markers was statisticany 
similar to the percentage of GFP-positive cens expressing the same marker ( p > 
0.05). 
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Figure 2.5. A, Coinfection of cortical progenitors with adenoviruses ex pressing HA-
tagged pRb and myc-tagged [d2. Double-label immunocytochemical analysis for the 
HA-tag (a-HA, top panel) on pRb and the myc-tag (a-mye, bottom panel) on Id2 
revealed that most of the cortical progenitors were infected with both adenoviruses 
and expressed both proteins. B, C, Constitutively activated pRb rescues the apoptosis 
induced by overexpression of [d2 in cortical progenitor cells. B, MTT assay to 
measure survival of cortical progenitor cens 4 d after infection with adenoviruses. 
expressing Id2 and/or constitutively activated pRb or B-galactosidase (Bgal) at MOIs 
ranging from 10 to 100. An points were performed in triplicate, and results represent 
the mean ± SE, with 100% survival being defined as the MTT value obtained for 
uninfected progenitor cens in the same experiment. C, Quantitation of the percentage 
of TUNEL-positive cortical progenitors 4 d after infection with 50 MOI of 
adenoviruses expressing Id2 (Ad-Id2) and/or constitutively activated pRb (Ad-Rb) or 
B-galactosidase (Ad-Bgal). In the rescue experiments involving transduction with 
two adenovirany driven proteins, cens were double-Iabeled for TUNEL and anti-myc 
to detect those cens expressing myc-tagged Id2. Results indicate the mean ± SE. *p < 
0.05, **p < 0.01 relative to cens infected with Ad-Id2 plus Ad-Bgal. D, E, 
Constitutively activated pRb rescues the inhibition of neuronal gene expression 
induced by overexpression of [d2 in cortical progenitor cells. D, Double-label 
immunocytochemical analysis of cortical progenitor cens infected with 50 MOI of 
adenoviruses expressing Id2 and constitutively activated pRb and then analyzed for 
expression of the myctagged Id2 protein (a-mye, left panel) and NFM or Tal:nlacZ 
(middle panels). The right panels are photomicrographs of the Hoechst staining for 
the same field. Note that, when coinfected with constitutively activated pRb, many of 
the Id2-expressing cortical progenitors also express these two neuronal genes 
(arrows). E, Quantitation of double-label immunocytochemical analysis similar to 
that in D. For each treatment i~ each individual experiment, three to six random fields 
were analyzed. Cortical progenitor ceIls expressing myc-tagged Id2 virtuaIly never 
coexpressed TaI :nlacZ or NFM. In contrast, when coinfected with Ad-Rb, many of 
the Id2-positive cens were alsÇ> positive for neuronal marker genes. Results indicate 
the mean ± SE. *p < 0.05, **p < 0.005. 
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CHAPTER3 
1. Preface 
Cortical development relies on both intrinsic factors and extracellular signaIs. 
Data presented in the previous chapter demonstrated the importance of intracellular 
players during neuronal differentiation of cortical precursors. The present chapter 
aims at defining the role of one c1ass of growth factors, the neurotrophins which are 
expressed within the developing cortex (Maisonpierre et al., 1990; Fukumitsu et al., 
1998). While exogenous neurotrophin stimulation has been shown to promote 
neuronal differentiation and cell cycle exit of cortical precursors (Ghosh and 
Greenberg, 1995; Lukaszewicz et al., 2002), the role of endogenously produced 
neurotrophins and their downstream signaling cascades during cortical precursor 
development was not c1ear. Here, l characterized distinct functions of endogenous 
neurotrophin signaling pathways, PI3-KlAkt and MEKIERK, in cortical precursors by 
using a combination of function blocking antibodies and specifie pharmacologie 
inhibitors. 
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II. Abstract 
Cultured embryonic cortical progenitor cells will mimic the temporal differentiation 
pattern observed in vivo, producing neurons first and then glia. Here,we investigated 
the role of two endogenously produced growth factors, the neurotrophins brain-
derived neurotrophic factor and neurotrophin-3 (NT -3), in the early progenitor-to-
neuron transition. Cultured cortical progenitors express BDNF and NT-3, as weIl as 
their receptors TrkB (tyrosine kinase receptor B) and TrkC. Inhibition of these 
endogenously expressed neurotrophins using function-blocking antibodies resulted in 
a marked decrease in the survival of cortical progenitors, accompanied by decreased 
proliferation and inhibition of neurogenesis. Inhibition of neurotrophin function also 
suppressed the downstream Trk receptor signaling pathways, PB-kinase (phosphatidyl 
inositol-3-kinase) and MEK-ERK (MAP kinase kinase--extracellular signal-regulated 
kinase), indicating the presence of autocrine-paracrine neurotrophin: Trk receptor 
signaling in these cells. Moreover, specific inhibition of these two Trk signaling 
pathways led to distinct biological effects; inhibition of PB-kinase decreased 
progenitor cell survival, whereas inhibition ofMEK selectively blocked the generation 
of neurons, with no effects on survival or proliferation. Thus, neurotrophins made by 
cortical progenitor cells themselves signal through the TrkB and TrkC receptors to 
mediate cortical progenitor cell survival and neurogenesis via two distinct downstream 
signaling pathways. 
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III. Introduction 
The generation of differentiated neurons and glial cells from proliferating mammalian 
neural stem or progenitor cells is a complex process involving an interplay between 
intrinsic cellular programs and extrinsic cues such as growth factors. This complex 
process has perhaps been best studied in the developing cortex. In rodents, stem and 
progenitor cells proliferate within the cortical ventricular zone and then differentiate 
into neurons during midgestation and into glial cells during late gestation and early 
postnatal life. Remarkably, cortical progenitor cells isolated at the onset of 
neurogenesis and plated in serum-free conditions will reproduce this temporal in vivo 
differentiation pattern, generating neurons first and glia second (Qian et al., 2000). 
Study of this system has led to identification of a number of key intracellular 
proteins that are essential for proliferation and differentiation of cortical progenitor 
cells, inc1uding the pRb family (Slack et al., 1998; Toma et al., 2000; Ferguson et al., 
2002), neurogenic and gliogenic basic helix-Ioop-helices (HLHs) (Lu et al., 2000, 
2001; Nieto et al., 2001; Sun et al., 2001), the inhibitory HLH Id2 (Lasorella et al., 
2000; Toma et al., 2000), and the CIEBP (CAAT enhancer-binding protein) familyof 
transcription factors (Ménard et al., 2002). In addition, sorne of the signaling 
pathways that allow extrinsic cues to regulate these intracellular proteins have been 
identified. For example, ciliary neurotrophic factor (CNTF) and leukemia inhibitory 
factor signal via the JAK-STAT (Janus-activated kinase-signal transducer and 
activator of transcription) pathway to promote the differentiation of glial cells 
(Sauvageot and Stiles, 2002), whereas exogenous platelet derived growth factor 
(PDGF) (Park et al., 1999) promotes the differentiation ofneurons via activation of an 
MEK-RSK-CIEBP (MAP kinase kinase-ribosomal S6 kinase-CAAT enhancer-
binding protein) pathway (Ménard et al., 2002). Moreover, although the intracellular 
signaling pathways have not yet been elucidated, fibroblast growth factor 2 (FGF2) is 
known to be an essential survival and proliferation factor for cortical progenitors both 
in vivo (Vaccarino et al., 1999; Raballo et al., 2000) and in vitro (Ghosh and 
Greenberg, 1995; Lukaszewicz et al., 2002). 
One c1ass of growth factors that might play a role in regulating cortical 
progenitor cell biology are the neurotrophins. At least two members of the 
neurotrophin family, BDNF and neurotrophin-3 (NT -3), along with their preferred 
tyrosine kinase receptors (TrkB and TrkC) , are expressed in the cortical 
89 
ventricularlsubventricular zones at the onset of cortical neurogenesis (Maisonpierre et 
a1., 1990; Fukumitsu et a1., 1998). Moreover, culture work has suggested that NT-3 
rnight selectively regulate cell cycle exit and neuronal differentiation in cortical 
progenitors (Ghosh and Greenberg, 1995; Lukaszewicz et a1., 2002). However, 
although animaIs lacking either single neurotrophins or their Trk receptors do display 
sorne CNS phenotypes, including cortical abnormalities (Minichiello and Klein, 1996; 
Alcantara et a1., 1997; Martinez et a1., 1998; Ringstedt et a1., 1998; Kahn et a1., 1999; 
Xu et a1., 2000; Lotto et a1., 2001), the precise role of neurotrophins produced by 
cortical precursors is still unclear, as are the receptor-signaling mechanisms that 
underlie these biological effects. 
Here we investigated these questions using cortical progenitor cells isolated at 
the onset ofneurogenesis in vivo. We demonstrated previously that these cells are aIl 
dividing, nestin-positive precursors at the tirne of isolation and that a significant 
number of thern differentiate into postmitotic neurons over the first week in vitro. Our. 
studies here indicate that, as se en in vivo, cultured cortical precursors express the 
neurotrophins BDNF and NT-3, as weIl as their preferred TrkB and TrkC receptors, 
and that this autocrine-paracrine neurotrophin loop is essential for progenitor cell 
surviva1. Moreover, these endogenously produced neurotrophins signal via Trk 
receptors to activate the PB-kinase-Akt and MEK-BRK pathways, and the se 
pathways subserve distinct functions, with PB-kinase being essential for progenitor 
survival and MEK for the differentiation of neurons but not glial cells. Thus, cortical 
progenitors rely on endogenously produced neurotrophins and distinct Trk-rnediated 
signaling pathways for multiple aspects of their biology, including survival and 
neurogenesis. 
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IV. Results 
Cortical progenitor cells express and are responsive to neurotrophins 
To address the potential role of neurotrophins in cortical neurogenesis, we examined 
cortical progenitors that were isolated from EI2.5-E13.5 mouse cortex and plated in 
the presence ofFGF2. We showed previously (Slack et al., 1998; Gloster et al., 1999; 
Toma et al., 2000; Ménard et al., 2002) that, on plating, virtually all of these cells are 
dividing, nestin-positive progenitors and that, over the ensuing 5 d, many of them exit 
the cell cycle to become postmitotic neurons. To ask whether endogenously produced 
growth factors such as the neurotrophins might be involved in these events, we 
. 
initially measured the effect of cell density on cortical progenitor cell survival. SeriaI 
dilutions of progenitor cells plated in 40 ng/ml FGF2 led to a proportional increase in 
apoptosis (Fig. 3.1a), suggesting the presence of endogenously produced survival 
factors. 
The neurotrophins BDNF and NT -3 and their preferred TrkB and TrkC 
receptors are expressed within the ventricular zone of embryonic rats (Maisonpierre et 
al., 1990; Fukumitsu et al., 1998), suggesting that they could participate as autocrine-
paracrine survival factors in cortical progenitors. To verify that these neurotrophins 
were expressed by cultured murine cortical progenitors, we first performed reverse 
transcription (RT)-PCR analysis on total RNA isolated from cells cultured for either 1 
or 2 d (Fig. 3.1b,c). This analysis indicated that cortical progenitors selectively 
express the neurotrophins BDNF and NT-3, but not NGF (Fig. 3.1b), as well as the 
TrkB and TrkC receptors (Fig. 3.1c), in agreement with previous in vivo studies. To 
determine the percentage of cells expressing the TrkB receptor, we then performed 
double-label immunocytochemical analysis for TrkB and for nestin, a marker for 
progenitor cells (data not shown), for Ki67, a prote in expressed in dividing cells (Fig. 
3.1d) (Scholzen and Gerdes, 2000; Kee et al., 2002), or for MAP2, a marker for 
postmitotic neurons (Fig. 3.1d). This analysis demonstrated that the majority of both 
progenitors and newly born neurons were positive for TrkB. Coincubation of the 
TrkB antibody with an excess of the control peptides abolished immunoreactivity 
(data not shown). Western blot analysis confirmed expression of full-length forms of 
both TrkB and TrkC by cortical progenitors as soon as 4 hr after plating (Fig. 3.1e). 
To verify that the Trk receptors expressed by cortical progenitors were 
functional, we washed and then stimulated cortical progenitors for 10 min with each 
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of the four members of the neurotrophin family and looked for Trk receptor activation. 
As a positive control, we used postmitotic cortical neuron cultures. 
Immunoprecipitation of total Trk proteins followed by Western blot analysis for 
phosphotyrosine demonstrated that BDNF, NT-3, and NT-4, the ligands for TrkB and 
TrkC, led to Trk receptor activation in both cortical progenitors and neurons. In 
contrast, NGF, which binds to TrkA, had no effect (Fig. 3.2a, left). Trk receptor 
activation was also observed in both cortical progenitors (2 DIV) and postmitotic 
cortical neurons maintained in media, without washing and without the addition of 
exogenous neurotrophins (Fig. 3.2a, right), consistent with the endogenous expression 
of BDNF and NT-3. To confirm this result, we examined activation of Akt and the 
ERKs, signaling proteins known to be activated downstream of tyrosine kinase 
receptors such as the Trks. Cortical progenitors were cultured in the absence of 
exogenous FGF2 and then were stimulated for 15 min with NGF, BDNF, NT-3, or 
FGF2 4 hr after plating. Western blot analysis demonstrated that BDNF, NT-3, and 
FGF2, but not NGF, caused a small, but consistent increase in the activated, 
phosphorylated form of Akt, along with a robust increase in phosphorylation of the 
ERKs (Fig. 3.2b). Immunocytochemical analysis demonstrated that > 95% of the 
cells in these cultures were nestin positive at the time of stimulation (data not shown), 
confirming that cortical progenitors respond to BDNF, NT-3, and NT-4 via the TrkB 
and TrkC receptors. 
Endogenous neurotrophins are essential for cortical progenitor cell survival, 
proliferation, and neuronal differentiation 
To examine the potential role of the se endogenously produced neurotrophins, we used 
function-blocking antibodies for BDNF and NT-3 (Kohn et al., 1999). Using the se 
antibodies, we first asked wh ether endogenous BDNF and/or NT-3 made any 
contribution to activation of downstream signaling pathways when progenitors were 
cultured in our normal culture conditions, in the presence of exogenous FGF2. 
Progenitors were cultured and treated for 18 hr with 20 Ilg/ml anti-BDNF or anti-NT-
3 or, as a control, 40 !-lg/ml control chicken IgY. Western blot analysis of these 
treated cells for phospho-Akt and phospho-ERK revealed that, even when progenitors 
were cultured in exogenous FGF2, blocking BDNF or NT-3 led to a significant 
decrease in activation of both of these signaling proteins (Fig. 3.2c). Thus, 
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endogenous BDNF and NT -3 contribute significantly to the activation of these two 
pathways in cortical progenitors. 
We next asked .about the effects of blocking endogenous neurotrophins on 
cortical progenitor cell biology. To perform the se experiments, progenitors were 
immediately cultured in FGF2 with or without anti-BDNF and/or anti-NT-3. Initially, 
we examined cell survival by TUNEL. This analysis revealed that cortical progenitors 
cultured in the presence of anti-BDNF or NT -3 showed a marked increase in apoptosis 
(Fig. 3.3a,c), with ~40-50% of cells being TUNEL positive. When both anti-BDNF 
and anti-NT-3 were added together, a larger increase in TUNEL-positive cells was 
observed (Fig. 3.3c) (p < 0.05), although this increase was not additive, suggesting 
that BDNF and NT -3 act to support the survival of overlapping populations of 
progenitors. A statistically similar decrease in cell survival of ~40% was obtained 
when Trk receptor signaling was blocked using 200 nM of the pharmacological 
inhibitor K252a (two separate experiments; data not shown). 
To confirm that this increase in apoptosis was attributable to the death of 
cortical progenitors and not just newly bom neurons, we performed similar 
experiments and quantitated the percentage of cells with apoptotic nuclear 
morphology (determined by staining with Hoechst) that expressed or did not express 
the early neuron-specific marker ~III-tubulin (neurons and progenitor cells, 
respectively) (Fig. 3.3b). This analysis revealed that, in cultures treated with the 
control IgY antibody, ~ Il and 3% of progenitors and neurons, respectively, had 
apoptotic nuclei. In contrast, in cultures treated with anti-BDNF, ~45% ofprogenitors 
and 25% of neurons were apoptotic, whereas in those treated with anti-NT -3, ~55% 
and 19% of progenitors and neurons were apoptotic, respectively. Thus, the majority 
of cells dying after treatment with anti- BDNF or anti-NT-3 were progenitors, 
although neuronal apoptosis was also increased, consistent with previous observations 
(Ghosh et al., 1994). 
This dramatic effect on progenitor cell biology was confirmed when we 
examined ceIl proliferation and neuronal differentiation. To assess proliferation, we 
immunostained progenitors for Ki67, an antigen that is highly expressed by 
mitotically active cells throughout the cell cycle (Scholzen and Gerdes, 2000; Kee et 
al., 2002). These experiments demonstrated that the number of Ki67-immunoreactive 
cells was greatly reduced in the presence of anti-BDNF and/or anti-NT -3 (Fig. 3.3b,d). 
Similar results were obtained for neuronal differentiation, as assayed by 
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immunostaining for ~III -tubulin, an early neuronal gene, and MAP2, a late neuronal 
marker (Fig. 3.3a,b,e,j); the addition of anti-BDNF and/or anti-NT-3 significantly 
reduced the number of neurons present in these cultures. Thus, endogenous 
neurotrophin signaling is essential for progenitor cell survival, and FGF2 alone cannot 
substitute for these endogenous neurotrophins with regard to survival. Whether 
endogenously produced neurotrophins play an equally important role in promoting 
progenitor cell proliferation or differentiation cannot be determined because the 
observed decreases in these two parameters may be because of decreased survival. 
PI3-kinase and MEK signaling pathways subserve distinct functions in cortical 
progenitor cells 
To ask how neurotrophins might signal through the TrkB and TrkC receptors to 
mediate progenitor cell survival, we initially focused on the PB-kinase and MEK-
ERK pathways, both of which are activated by endogenous neurotrophins, as shown in 
Figure 3.2b,c, and both ofwhich have been implicated in survival of other neural cells 
(Kaplan and Miller, 1997, 2000). To inhibit these pathways, we used two weIl 
characterized pharmacological inhibitors, LY294002 (to inhibit PB-kinase) and 
PD98059 (to inhibit MEK). We first verified the ability of these two compounds to 
selectively inhibit the appropriate pathways in progenitors; cells were treated with 
different concentrations of one of these two compounds for 4 hr and were then 
assessed for phosphorylation of Akt and the ERKs, which are downstream substrates 
of PB-kinase and MEK, respectively. Western blot analysis revealed that 50 or 100 
llM L Y294002 specifically inhibited Akt but not ERK phosphorylation, whereas 50 
llM PD98059 decreased ERK but not Akt phosphorylation, as predicted (Fig. 3.4a). 
We then used these inhibitors to ask whether either of these two pathways was 
important for survival, proliferation, or differentiation of cortical progenitors; cells 
were cultured for 2 d in the presence of FGF2 with or without L Y294002 or PD98059. 
Phase microscopy of living cultures, along with analysis of these cells for TUNEL, 
revealed that inhibition of PB-kinase with 50 or 100 llM L Y294002 had a profound 
effect on progenitor cell survival (Fig. 3.4b-e); 50-70% of cells in these cultures were 
TUNEL positive. Similar results were obtained with a second pharmacological 
inhibitor of PB-kinase, wortmannin (data not shown). In contrast, inhibition ofMEK 
had no effect on cell survival (Fig. 3.4b-e). To confirm that inhibition of PB-kinase, 
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but not MEK, selectively increased apoptosis of progenitors, we also examined 
caspase 3 activation. Western blot analysis revealed that 1 d of treatment with 
L Y294002 caused an increase in levels of the cleaved, active form of caspase-3, 
whereas PD98059 had no significant effect (Fig. 3.4[). Thus, PB-kinase, but not 
MEK, is essential for survival of cortical progenitors. 
We next examined the potential role of these two pathways in proliferation of 
cortical progenitors by measuring BrdU incorporation and by immunostaining for 
Ki67. For the BrdU studies, progenitors were cultured in FGF2 with or without 
L Y294002 or PD98059 and were then pulsed with BrdU overnight before analysis by 
immunostaining. These experiments demonstrated that inhibition of MEK had no 
effect on either BrdU incorporation (Fig. 3.5a) or on the percentage of cells 
expressing Ki67 (Fig. 3.5b,c) but that inhibition of PB-kinase greatly reduced both of 
these parameters (Fig. 3.5a- c). Additional support for the conclusion that PB-kinase, 
but not MEK, was important for survival and proliferation in these cultures derived 
from the finding that total cell number was unaffected by MEK inhibition, whereas 
PB-kinase inhibition reduced total cell number by 40-50% (Fig. 3.5e). 
To confirm these findings biochemically, we also performed Western blot 
analysis for two known S-phase markers, cycE and cdk2 (for review, see (Ekholm and 
Reed, 2000). This analysis revealed that, as predicted, both cycE and cdk2 were 
highly expressed in cortical progenitors cultured for 2 d, whereas they were virtually 
absent in cultures of postmitotic cortical neurons (Fig. 3.5d). Treatment with 
PD98059 did not significantly alter levels of either of these proteins; however, 
LY294002 led to a great decrease in both (Fig. 3.5d), confirming the 
immunocytochemical results. Thus, MEK is not important for either survival or 
proliferation of cortical progenitors. Whether PB-kinase is important for proliferation 
cannot be determined from these experiments because of its important role in 
progenitor cell survival. 
Finally, we asked whether either of these two pathways wàs important for 
differentiation of neurons from cortical progenitors. Progenitors were cultured for 2 d 
in the presence of FGF2 with or without PD98059 or L Y294002 and then were 
immunostained for three different panneuronal proteins, ~III -tubulin and HuD 
(Clayton et al., 1998), two early neuronal markers, and MAP2, a late neuronal protein. 
This analysis revealed that treatment with PD98059 significantly decreased the 
percentage of cells expressing all three of these neuronal proteins (Fig. 3.6a-d), a 
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result similar to what we observed previously when MEK was inhibited in cortical 
progenitors using a dominant-negative MEK construct (Ménard et al., 2002). 
Confirmation of this result was obtained by Western blot analysis of similar cultures 
for two additional neuron-specific proteins, neuron-specific enolase and the medium 
neurofilament protein (Fig. 3.6e). Both immunocytochemistry (Fig. 3.6a-d) and 
Western blot analysis (Fig. 3.6e) indicated that a similar inhibition was observed for 
treatment with LY294002. However, this latter effect may be attributable to the 
decrease in cell survival observed when PB-kinase is inhibited. 
Cortical progenitor cells normally only generate astrocytes when they are 
stimulated with the gliogenic factor CNTF (Park et al., 1999; Ménard et al., 2002) or 
after long periods of time in culture (Qian et al., 2000). To ask whether the inhibition 
of MEK, which blocks progenitors from becoming neurons, also alters the generation 
of astrocytes, we examined the se cultures for expression of GF AP. 
Immunocytochemical analysis demonstrated that progenitors cultured in either the 
presence or absence of 50 !lM PD98059 for 3 d did not generate GF AP-positive glial 
cells (two separate experiments; data not shown), a finding confirmed biochemically 
by Western blot analysis (Fig. 3.6f). Moreover, even when progenitors were 
stimulated with CNTF, which induces astrocyte formation, inhibition of MEK had 
little or no effect on GFAP expression (Fig. 3.6f). Because inhibition of the MEK 
pathway blocks the generation of neurons but not astrocytes from cortical progenitors 
and because it has no effect on progenitor cell survival or proliferation, these results 
suggest that MEK activation functions specifically to bias cortical progenitors to 
become neurons in the present culture conditions. 
Inhibition of neurotrophin, PI3-kinase, or MEK signaling has the same effect on 
cortical progenitors in the absence of exogenous FGF2 
Studies presented here indicate that inhibition of endogenous neurotrophins have a 
profound effect on basal activation of the PB-kinase-Akt and MEK-ERK pathways 
even when progenitors were cultured in the presence of FGF2 (Fig. 3.2e). 
Nonetheless, the effects of MEK and PB-kinase inhibition observed here could 
formally be attributable to inhibition ofFGF2 signaling alone. To directly address this 
possibility, we performed a series of experiments in the absence of exogenous FGF2. 
InitiaIly, as a baseline, cortical progenitors were cultured for 2 d with and without 
FGF2, and the cells were assayed for survival, proliferation, and neuronal 
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differentiation. Results of these experiments confirmed, as described previously 
(Ghosh and Greenberg, 1995; Lukaszewicz et al., 2002), that exogenous FGF2 was 
essential to promote maximal survival and proliferation of cultured cortical 
progenitors (Fig. 3.7a). In the absence of FGF2, the percentage of TUNEL-positive 
cells was somewhat increased, and the percentage of Ki67-positive cells was 
decreased by >50%. Somewhat surprisingly, the percentage of ~III-tubulin but not 
MAP2-positive neurons increased (Fig. 3.7a), reflecting either an inhibitory effect of 
FGF2 on early neurogenesis or a preferential loss of proliferating progenitor cells in 
the absence ofFGF2. 
We then assayed these same parameters in cortical progenitors maintained 
without FGF2 but in the presence of function blocking neurotrophin antibodies. 
These studies revealed that the survival of progenitors in the absence of FGF2 was 
primarily attributable to the autocrine-paracrine production of BDNF and NT-3; 
~80% of progenitors were TUNEL positive when either of these two neurotrophins 
were inhibited using function-blocking antibodies (Fig. 3.7 b). Coincidentally with 
this dramatic increase in apoptosis, both the basal rate of proliferation and the 
proportion of neurons were reduced to <10% (Fig. 3.7b), effects likely attributable .10 
the massive apoptosis. 
Finally, we asked what effect inhibition of either PB-kinase or MEK had on 
progenitors in the absence of FGF2. As seen with the inhibition of endogenous 
neurotrophins, the inhibition of PB-kinase increased the percentage of TUNEL-
positive cells to nearly 80% (Fig. 3.7c) while at the same time decreasing both the 
number of proliferating, Ki67-positive cells and the number of newly born neurons 
(Fig.3.7c). In contrast, as would have been predicted, inhibition ofMEK with 50 /lM 
PD98059 had no effect on either survival or proliferation but significantly decreased 
the percentage of ~III-tubulin and MAP2-positive neurons that were generated (Fig. 
3.7c). Although these studies do not definitively show that the neurotrophins are the 
only autocrine-paracrine factors that activate MEK and PB-kinase in cortical 
progenitors, they strongly support the idea that endogenously produced neurotrophins 
mediate their effects via two distinct signaling proteins, PB-kinase for survival and 
MEK for neurogenesis. 
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v. Discussion 
The results presented here support three major conclusions. First, our data 
demonstrate the existence of a neurotrophin/Trk receptor autocrine-paracrine loop in 
cortical progenitor cells, in which the neurotrophins BDNF and NT -3 signal via the 
TrkB and/or TrkC receptors to activate their downstream intracellular effectors PB-
kinase and MEK. Second, using neurotrophin function-blocking antibodies, we show 
that endogenous BDNF and NT -3 are essential for cortical progenitor cell survival, 
even in the presence of exogenous FGF2. Third, our results with specifie 
pharmacological inhibitors demonstrate that the Trk-mediated signaling pathways, 
PB-kinase-Akt and MEK-ERK, subserve distinct biological functions in cortical 
progenitors. PB-kinase is essential for survival, whereas MEK activation is essential 
for neurogenesis but not gliogenesis. Thus, cortical progenitors rely on endogenously 
produced neurotrophins and distinct Trk mediated signaling pathways for multiple 
aspects of their biology, including survival and neurogenesis. 
During embryogenesis, the proliferating precursor cells in the developing 
cortical neuroepithelium are exposed to a variety of different cues, which are 
integrated by these cells so that an appropriate number of cortical neurons are 
ultimately generated. These cues include growth factors, such as the neurotrophins 
FGF2 and epidermal growth factor (Ghosh and Greenberg, 1995; BUITOWS et al., 
1997; Vaccarino et al., 1999; Raballo et al., 2000; Lukaszewicz et al., 2002), 
neurotransmitters, such as GABA, glutamate, acetylcholine, and P ACAP (pituitary 
adenylate cyclaseactivating polypeptide) (LoTurco et al., 1995; Antonopoulos et al., 
1997; Haydar et al., 2000; Ma et al., 2000; Li et al., 2001; Suh et al., 2001), and a 
variety of cell contact mediated signaIs, such as those involving Notch (Chambers et 
al., 2001; Shen et al., 2002). Together, these cues interact with the intrinsic cellular 
machinery to determine precursor cell survival, proliferation, and differentiation into 
neurons versus glia. Data presented here, together with previous work on FGF2 and 
PDGF, support the idea that growth factors that signal via receptor tyrosine kinases 
play a key role in regulating aIl three of the se processes. FGF2 is clearly essential for 
precursor cell proliferation (Ghosh and Greenberg, 1995; Vaccarino et al., 1999; 
Raballo et al., 2000; Lukaszewicz et al., 2002), whereas the CUITent work indicates 
that autocrine and/or paracrine NT -3 and BDNF function within the cortical 
neuroepithelium to promote survival. Moreover, previous work indicates that receptor 
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tyrosine kinase signaling is essential for the genesls of neurons from cortical 
progenitor cells (Park et al., 1999;Ménard et al., 2002). The finding that the same 
class of signaling receptors promotes survival, proliferation, and differentiation raises 
the issue ofbiological specificity. In this regard, one of the surprising results reported 
here is that at least two distinct responses are subserved by different downstream 
signaling pathways, with PI3-kinase promoting survival and MEK promoting 
neurogenesis. Such segregation provides a mechanism whereby the integrated signal 
resulting from coactivation of a number of receptor tyrosine kinases could regulate 
precursor cell biology differentially. 
In addition to the autocrine-paracrine effects reported here for cortical 
progenitor cells, neurotrophins continue to play an essential role for postmitotic 
cortical neurons, regulating survival, growth, phenotype, and ultimately, connectivity 
(Kaplan and Miller, 1997, 2000). In contra st to the peripheral nervous system, in 
which single neurotrophins play essential roles in regulating the biology of specific 
neuronal populations, such as NGF with sympathetic neurons (for review, see Klein, 
1994; Snider, 1994), multiple neurotrophins appear to playredundant and overlapping 
roles for central neurons. Data presented here suggest that this is also true for cortical 
progenitors because these cells express both TrkB and TrkC in culture and in vivo 
(Maisonpierre et al., 1990; Ghosh and Greenberg, 1995; Fukumitsu et al., 1998), and 
BDNF and NT-3 apparently play similar roles in regulating cell survival (data 
presented here). It is likely that this functional overlap between neurotrophins, and 
potentially between other receptor tyrosine kinase ligands, such as FGF2, explains the 
relatively mode st phenotypes observed in the developing cortex of single neurotrophin 
knock-out animaIs (Jones et al., 1994; Ringstedt et al., 1998; Kahn et al., 1999). 
Support for this idea derives from animaIs lacking TrkB and/or TrkC, in which 
numerous CNS abnorrnalities have been described previously (Minichiello and Klein, 
1996; Alcantara et al., 1997; Martinez et al., 1998; Ringstedt et al., 1998; Kahn et al., 
1999; Xu et al., 2000; Lotto et al., 2001). It will be interesting to further examine 
animais deficient in both receptors for deficits in cortical precursor cell survival and 
proliferation. 
Our data indicate that the PI3-kinase pathway is a major survival pathway for 
cortical progenitor cells, a finding reminiscent of previous findings with neurotrophin-
induced survival of postmitotic neurons (Kaplan and Miller, 1997, 2000). 
Specifically, PI3-kinase is the major survival pathway for cortical neurons under 
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normal culture conditions (Hetman et al., 1999; Pozniak et al., 2002), suggesting that 
the PI3-kinase-Akt pathway is a conserved survival pathway throughout nervous 
system development. Additional support for this conclusion derives from a study 
using a nestin-driven conditional knock-out of the Pten tumor suppressor gene, whose 
product normally antagonizes the function of PI3-kinase; these animaIs displayed 
hyperactivation of Akt accompanied by increased proliferation and decreased 
apoptosis of telencephalic ventricular zone progenitors, with a resultant twofold 
increase in brain size and cell number by birth (Groszer et al., 2001). As has been 
reported for other CNS neurons, the PI3-kinase-Akt pathway could promote survival 
of cortical progenitors through the inhibition of F orkhead family members, BAD (Bcl-
2-associated death protein), or glycogen synthase kinase-3~ (Datta et al., 1997; 
Brunet et al., 1999; Hetman et al., 2000; Hetman et al., 2002). 
In contrast to the PI3-kinase pathway, the MEK pathway plays no role in 
cortical progenitor survival or proliferation but, instead, specifically regulates 
neurogenesis. These data are in agreement with our recent findings using a dominant-
negative MEK adenovirus, in which we demonstrated that MEK was necessary for 
neurogenesis when cortical progenitors were stimulated with PDGF (Ménard et al., 
2002), strongly supporting the idea that multiple receptor tyrosine kinases use the 
MEK pathway as a positive neurogenic signal. Moreover, data presented here showing 
that MEK inhibition had little or no effect on CNTF-induced astrocyte formation 
argues that MEK activation is not a generic differentiation pathway but is specific for 
neurogenesis. What are the downstream proneurogenic targets of MEK? One major 
target is the CIEBP family of transcription factors, which are essential for cortical 
progenitor cells to become neurons (Ménard et al., 2002). The lack of survival effect 
by the inhibition of the MEK pathway is reminiscent of studies using postmitotic 
cortical neurons. In these neurons, the MEK pathway was neuroprotective only 
during stress-induced apoptosis and not under the basal culture conditions (Hetman et 
al., 1999). Additional studies will be required to determine whether MEK signaling 
contributes to cortical progenitor survival under pathological conditions. 
A number of studies have investigated previously the role of neurotrophins in 
cortical progenitor cell biology. One study reported that exogenous NT-3 promoted 
generation of MAP2-positive neurons and that a function-blocking NT -3 antibody 
inhibited neurogenesis (Ghosh and Greenberg, 1995), whereas another reported that 
exogenous NT-3 promoted cell cycle exit (Lukaszewicz et al., 2002). Although we 
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have not examined the effects of exogenously added neurotrophins here, except to 
show that they cause an induction of the MEK-ERK and PI3-kinase-Akt pathways, 
such data are consistent with our finding that neurotrophin signaling via MEK is 
essential for neurogenesis. It was impossible, however, in the studies reported here to 
ask whether function-blocking antibodies to BDNF or NT -3 inhibited neurogenesis 
because these growth factors were essential for progenitor cell survival. 
In summary, results presented here strongly support the idea that endogenously 
produced BDNF and NT-3 signal via TrkB and TrkC on cortical progenitor cells to 
promote survival and neurogenesis. They do so via two distinct and separable 
signaling pathways, the PB-kinase and MEK pathways, which are common 
downstream substrates of many receptor tyrosine kinases. On the basis of these 
findings, we propose that neurotrophins play an important autocrine-paracrine role in 
determining progenitor cell biology in vivo in the embryonic telencephalon. 
Moreover, we propose that the PB-kinase and MEK pathways provide points of 
convergence for multiple ligands that use tyrosine kinase receptors, such as FGF2, 
PDGF, and the neurotrophins, and, in so doing, provide one way that the complex 
extracellular environment of the neuroepithelium can be integrated to dynamically 
regulate survival, proliferation, and ultimately, the generation of neurons during 
development. 
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VI. Experimental procedures 
Primary cultures of cortical progenitors and neurons. The preparation of cortical 
progenitors from mouse embryos has been described in detail previously (Slack et al., 
1998; Gloster et al., 1999; Toma et al., 2000; Ménard et al., 2002). Briefly, cortical 
tissue, obtained from embryonic day 12.5 (EI2.5) to E13.5 CDl mice, was dissected 
in ice-cold HBSS (Invitrogen, Gaithersburg, MD) and then transferred into 37°C 
Neurobasal medium (Invitrogen) containing 500 j..lM glutamine, 2% B27 supplement, 
and 1 %penicillin-streptomycin (Invitrogen); this medium was supplemented with 40 
ng/ml FGF2 (Collaborative Research, Bedford, MA), except when mentioned. The 
tissue was mechanically triturated with a plastic pipette into small c1usters of cells that 
were plated in sixwell tissue culture dishes (Nunc, Naperville, IL) or chamber slides 
precoated with laminin and poly-D-Iysine (Collaborative Research). Cell density was 
1,500,000 and 100,000 cells per well, respectively. Two to 3 hr after plating, 
progenitor cells were treated as follows: with either PD98059 or L Y294002 (both 
from Biomol, Plymouth Meeting, PA) in 1% DMSO (final concentration); acutely 
stimulated with 150 ng/ml NGF (Cedarlane Laboratories, Homby, Ontario, Canada), 
BDNF, NT-3, NT-4 (all from Peprotech, Rocky Hill, NJ), or FGF2 for 15 min; 
cultured in the presence of 50 ng/ml CNTF (Peprotech); or treated with 20 j..lglml 
neurotrophin function-blocking antibodies (Promega, Madison, WI) or 40 j..lg/ml 
control chicken IgY (Promega). The same amount of antibody or control IgY were 
readded 24 hr later. Cultures were maintained at 37°C in a 5% C02 incubator. 
Mature postmitotic cortical neurons were obtained as described previously (Pozniak et 
al., 2002; Wartiovaara et al., 2002). Briefly, E16-E17 mouse cortices were 
mechanically dissociated into a single-cell suspension in the same medium as for the 
progenitor cells without FGF2. The cells were plated for 3 d in the same conditions as 
for cortical progenitors, and then one-half of the medium was removed and replaced 
with fresh medium supplemented with a final concentration of 7 j..lM cytosine 
arabinoside (Sigma, St. Louis, MO). Two days later, the cells were treated and/or 
harvested. 
Immunocytochemistry, transferase-mediated biotinylated UTP nick end labeling, 
and quantitation. Immunocytochemistry and 5-bromo-2- deoxyuridine (BrdU) 
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incorporation protocols have been described previously (Toma et al., 2000; 
Wartiovaara et al., 2002). Primary antibodies were mouse anti-nestin (1 :400; 
Chemicon, Temecula, CA), mouse anti-Ki67 (1:200; PharMingen, San Diego), mouse 
anti-MAP2 (microtubule associated protein 2) (1:400; Sigma), rabbit anti-~III-tubulin 
(1: 1000; Research Diagnostics, Flanders, NJ), mouse anti-HuD (1 :300; Molecular 
Probes, Eugene, OR), and rabbit anti-TrkB (1:500; Santa Cruz Biotechnology, Santa 
Cruz, CA). cens [2 d in vitro (DIV), or less when mentioned] were washed with 
HEPES-buffered saline (HBS), pH 7.4, fixed for 20 min with 4% paraformaldehyde 
(Sigma), permeabilized for 5 min in 0.2% NP-40 (Roche Products, Hertforshire, UK) 
in HBS, and then blocked for 1-2 hr at room temperature with buffer containing 6% 
normal goat serum (NGS) and 0.5% bovine serum albumin (BSA) (Jackson 
ImmunoResearch, West Grove, PA). cens were then incubated at 4°C ovemight with 
primary antibodies in HBS containing 3% NGS and 0.25% BSA. After washing with 
HBS, cens were incubated at room temperature for 1 hr with either indocarbocyanine 
(Cy3)-conjugated goat anti-mouse or anti-rabbit IgG (1 :600), or FITC-conjugated 
anti-mouse or anti-rabbit IgG (1 :200; Jackson ImmunoResearch) secondary antibodies 
(as necessary) prepared in HBS containing 3% goat serum and 0.25% BSA. Samples 
were then washed with HBS, counterstained for 2 min with Hoechst 33258 (1 :2000; 
Sigma), and mounted with GelTol (Fisher Scientific, Houston, TX). For the terminal 
deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) 
experiments, cens were washed, fixed, and permeabilized as mentioned above. 
TUNEL reaction was performed for 1 hr at 37°C. Each 100 /-lI of TUNEL reaction 
mixture contained 20 /-lI of 5X terminal deoxynucleotidyl transferase (TdT) buffer, 0.9 
/-lI of TdT enzyme (both from Promega), and 1 /-lI of biotin-16-deoxyuracil 
triphosphate (Boehringer Mannheim, Mannheim, Germany). After the TUNEL 
reaction, preparations were washed with HBS and incubated for 1 hr at room 
temperature with dichlorotriazinyl aminofluorescein or Cy3-conjugated streptavidin 
(Jackson ImmunoResearch) diluted 1 :2000 in HBS. In those experiments in which 
cens were double labeled, cens were then blocked with 3% NGS and 0.5% BSA for 1 
hr, and immunocytochemical analysis was performed as above. For BrdU 
incorporation analysis, 10 /-lM BrdU (Boehringer Mannheim) was added ovemight 
directly to the media of cultured progenitor cens. After washing with HBS, the cells 
were fixed for 30 min with 70% ethanol, air dried for 1 min, treated for 10 min with 
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2N HCI, and then treated for 10 min with 0.1 M borate buffer (Na2B407-H20, pH 
8.5). Preparations were washed three times with 0.5% Tween 20 and 1% BSA in 
HBS, before incubation ovemight at 4°C with mouse anti-BrdU (1:150; Chemicon) in 
HBS containing 3% NGS and 0.5% BSA. After washing, the slides were incubated 
for 1 hr at room temperature with Cy3-conjugated anti-mouse IgG, counterstained 
with Hoechst, and mounted. For quantitation, four to six random fields of each 
treatment (per experiment) were captured and processed. Digital image acquisition 
and analysis was performed with the Northem Eclipse software (Empix, Mississauga, 
Ontario, Canada) using a Sony (Tokyo, Japan) XC-75CE CCD video camera. In all 
graphs, error bars indicate the SD, and the statistics were performed using one-way 
ANOV A with the Student-Newman-Keuls method. 
Western blot analysis and immunoprecipitations. For biochemical analysis, cortical 
progenitors (4 hr to 2 DIV) and neurons (6 DIV) were washed with ice-cold HBSS 
and lyzed directly in the dish with either TBS lysis buffer (137 mM NaCI, 20 mM 
Tris, pH 8, and 1 % NP-40, and 10% glycerol) or radioimmunoprecipitation assay 
buffer (50mM Tris, pH 7.2, 150 mM NaCI, 2 mM EDTA, 1% NP-40, 1% Na 
deoxycholate, and 0.1% v/v SDS) supplemented with protease inhibitor mixture 
(Boehringer Mannheim) and 1.5 mM sodium vanadate. Lysates were scraped into 
Eppendorf Scientific (Westbury, NY) tubes, rocked for 10 min at 4°C, and cleared by 
centrifugation. Prote in concentration was determined using the bicinchoninic acid 
assay (Pierce, Rockford, IL) and BSA as a standard. Equal amounts ofprotein (25-50 
~g) were boiled in sample buffer, separated by 10-15% SDS-PAGE gels, and 
transferred to 0.2 ~m nitrocellulose membrane for 3 hr at 0.75 A. Membranes were 
blocked in 5% skim milk powder in TBS-T (TBS plus 0.5% Tween 20) or in 3% BSA 
in TBS-T (for 4GIO) for 2 hr at room temperature and then incubated ovemight at 4°C 
with primary antibody. Antibodies used were as follows: anti-phospho(Ser473) Akt 
(1: 1000; Cell Signaling Technology, Beverly, MA); anti-Akt (1: 1000; Cell Signaling 
Technology); anti-phospho- (Thr183/Tyr185) ERK (1 :2500; promega), anti-ERK 
(1:5000; Santa Cruz Biotechnology), anti-cleaved caspase 3 (1:1000; Cell Signaling 
Technology), anti-cyclin E (cycE) (2 ~g/ml; Upstate Biotechnology, Lake Placid, 
NY), anti-cyclin-dependent kinase 2 (cdk2) (1:1000; Santa Cruz Biotechnology), anti-
neuronal-specifie enolase (1 :2000; Polysciences, Warrington, PA), anti-neurofilament 
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medium (1:1000; Chemicon), anti-glial fibrillary acidic prote in (GFAP) (1:2000; 
Dako, High Wycombe, UK), anti-phosphotyrosine (4G 1 0; 1: 100; Upstate 
Biotechnology), and anti-TrkB and TrkC (1 :500; Santa Cruz Biotechnology). After 
washing with TBS-T, membranes were incubated with secondary antibodies, HRP-
conjugated goat anti-mouse or anti-rabbit (1:10,000; Boehringer Mannheim),' in 
blocking solution for 2 hr at room temperature. Detection was perfonned using the 
ECL chemiluminescence reagent (Amersham Biosciences, Arlington Heights, IL) and 
XAR x-ray films (Eastman Kodak, Rochester, NY). Membranes were subsequently 
stripped with stripping buffer (70 mM Tris, pH 6.8, 2% v/v SDS, and 0.7% v/v ~­
mercaptoethanol) for 5-10 min at 55°C, were extensively washed with Milli-Q water 
(Millipore, Bedford, MA), reblocked, and reprobed as described above. For 
immunoprecipitations, FGF2 was washed out for 1 hr from cortical progenitors (2 
DIV), and both cortical progenitors and neurons were stimulated for 10 min with 100 
ng/ml NGF, BDNF, NT-3, or NT-4. Equal amounts ofprotein were incubated with 3 
~l of the pan-Trk antibody (203b) (Hempstead et al., 1992) for 2 hr at 4°C and then 
incubated for the same time period with 25 ~l of protein A-Sepharose (Sigma). The 
precipitated proteins were collected by centrifugation, washed three times with TBS 
lysis buffer, boiled with sample buffer, and loaded on a 7.5% SDS-PAGE gel. 
RNA extractions and reverse transcription-PCR analysis. Extraction of RNA from 
cultured cortical progenitors (1 DIV), neurons (6 DIV), or sympathetic neurons 
(Wartiovaara et al., 2002) was perfonned using TRIZOL (Invitrogen) according to the 
protocol of the manufacturer. Total samples were then treated with DNase (Promega) 
for 30 min at 37°C. The absence of genomic DNA contamination was assessed by 
perfonning PCR for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Farah et 
al., 2000). RNA (5-10 ng) was reverse transcribed using Moloney murine leukemia 
virus reverse transcriptase (Fennentas, Hanover, MD) and oligo-dT (Promega) 
following the protocol of the manufacturer. The primers used and amplification 
conditions were as described previously (Benoit et al., 2001). PCR products were 
separated on a 1.5% agarose gel and sized with a 100 bp DNA ladder (Promega). 
105 
VII. Figures and figures legends 
Figure 3.1. Mouse-derived cortical progenitor cells express BDNF, NT-3, TrkB, and 
TrkC. a, TUNEL analysis of cortical progenitors plated at decreasing cell density. 
Progenitors were plated at varying dilutions in the presence of FGF2 (40 ng/ml) and, 2 
d later, were analyzed for apoptosis. *p<0.05; **p<O.OI; ***p<O.OOI (ANOVA). 
Error bars indicate SDs. b,c, RT-PCR analysis for the presence of the rnRNAs (b) for 
the neurotrophins BDNF, NT-3, and NGF ( c), for the neurotrophin receptors TrkB 
and TrkC in cortical progenitors (CP), postmitotic cortical neurons (PM), mouse EI5 
brain (EI5 Br), mouse adult brain (Ad Br), and cultured sympathetic neurons (SCG). 
GAPDH was used as a loading control in all cases. Similar results were obtained with 
three independent cortical progenitor cell RNA preparations (1 or 2 DIV; in the 
presence of 40 ng/ml FGF2). d, Immunocytochemical analysis for TrkB in cyc1ing 
cortical progenitors (cultured with 40 ng/ml FGF2) and postrnitotic cortical neurons. 
The top three panels are photographs of the same field and represent immunostaining 
for TrkB (left, red), the proliferation marker Ki67 (middle, green), and the merge of 
these two panels (right), along with a Hoechst counterstain (blue) toshowall nuc1ei in 
the field (left and right). The bottom three panels are photographs ofthesamefield and 
represent immunostaining for TrkB (left, red), the late neuronal marker MAP2 
(middle, green), and the merge of these two panels (right), along with Hoechst (blue, 
left and right). Scale bar, 50 /lm. e, Western blot analysis for TrkB and TrkC. 
Cortical progenitors (CP) cultured for 4hr with 40 ng/ml FGF2 or postmitotic cortical 
neurons (PM) were harvested and immunoprecipitated with an antibody that 
recognizes all full-Iength members of the Trk family (lP: Pan-Trk) , and then the 
immunoprecipitates were analyzed byWestern blot analysis for TrkB (le ft) or TrkC 
(right). Arrow indicates the immunoreactive Trk receptor bands, and size markers are 
indicated on the right. 
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Figure 3.2. Cortical progenitors are responsive to exogenous and endogenous 
neurotrophins. a, Left, Cortical progenitors cultured for 2 d (CP) with 40 ng/ml 
FGF2, postmitotic cortical neurons (PM) were washed and then stimulated for 10 min 
with one of the four neurotrophins, NGF, BDNF, NT-3 or NT-4 and 
immunoprecipitated with an antibody to all Trk receptors (IP: Pan-Trk), and the 
immunoprecipitates were then analyzed by Western blot analysis with an antibody to 
phosphotyrosine (Probe: P-Tyr). The arrow indicates the phosphotyrosine-positive 
band migrating at the size of the Trk receptors. BDNF, NT-3, and NT-4, but not 
NGF, induce Trk tyrosine phosphorylation. Right, Cortical progenitors (CP; 2 DIV) 
cultured with FGF2 (40 ng/ml) and postmitotic cortical neurons (PM) were analyzed 
for endogenous Trk receptor activation, as described above, without washing or 
exogenous neurotrophin stimulation. b, Cortical progenitor cells, cultured for 4 hr 
(without FGF2), were acutely stimulated with NGF, BDNF, NT-3, or FGF2 and 
analyzed by Western blot for the activation of Akt and ERKs, using phosphorylation-
specifie Akt (P-Akt) and ERK (P-ERK) antibodies. The same blots were then 
reprobed for total Akt and ERK prote in as a loading control. BDNF, NT-3, and FGF2 
all caused increased Akt and ERK phosphorylation, relative to cells that were either 
unstimulated (CTL) or stimulated with NGF. c, Western blot analysis for Akt and 
ERK activation in cortical progenitors cultured for 18 hr in the presence of FGF2 (40 
ng/ml) and antibodies specifie for BDNF (anti-BDNF; 20 )..tg/ml), NT-3 (anti-NT-3; 
20 )..tg/m!), or control anti-chicken IgY (Ctl-IgY; 40 )..tg/ml). Western blots were first 
probed for the activated, phosphorylated forms of Akt and the ERKs (P-Akt and P-
ERKs) and then reprobed for total Akt and ERK protein as a control for equal 
amounts of protein. 
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Figure 3.3. Inhibition of endogenous neurotrophins decreases cortical progenitor 
cell survival, proliferation, and differentiation into neurons. Cortical progenitor 
cells cultured in the presence of FGF2 (40 ng/ml) were treated for 2 d with control 
IgY (40 !lg/ml), anti-NT-3 (20 !lg/ml), anti-BDNF (20 !lg/ml), or the combination of 
anti-NT-3 and anti-BDNF (20 ug/ml each). a, Double-label immunücytochemistry for 
the neuronal marker MAP2 (left, red; counterstained with Hoechst in blue) and 
TUNEL (right, green). Cells were treated for 2 d with either anti-NT -3 (bottom 
panels) or control IgY antibody (top panels). b, Double-label immunocytochemistry 
for ~III-tubulin (left, green; cells are counterstained with Hoechst in blue) and the 
Ki67 antigen, a marker for proliferating cells (right, red). Scale bars: a, b, 100 !lm. c, 
Quantitation of three individual experiments (expt.) assessing cellular apoptosis 
performed as shown in a using TUNEL. d, Quantitation of three individual 
experiments assessing cellular proliferation performed as that shown in b using Ki67 
as a marker for dividing cells. e, J, Quantitation of three individual experiments 
assessing neurogenesis performed as those shown in a and b using both the early 
neuronal marker ~III-tubulin and the later neuronal marker MAP2. In c-J, *p<0.05; 
**p<O.Ol; ***p<O.OOl (ANOVA). Error bars indicate SDs. Cd, Control. 
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Figure 3.4. Cortical progenitor cell survival depends on PI3-kinase but not MEK 
activation. a, Western blot analysis to ascertain the efficacy and specificity of 
treatment with the pharmacological inhibitors PD98059 and L Y294002. Progenitors 
were cultured in the presence of FGF2 (40 ng/ml) with DMSO (1%), PD98059 (50 
/lM), or LY294002 (50 -100 /lM) for 4 hr, and lysates were analyzed by Western 
blots for the active, phosphorylated form of Akt or the ERKs (P-Akt, P-ERKs). The 
blots were then reprobed for total Akt and ERK protein as a loading control. b- d, 
Analysis of apoptosis in cortical progenitors (in the presence of 40 ng/ml FGF2) 
treated for 2 d with DMSO, PD98059 (PD50), or L Y294002 (L Y 100), as assessed by 
phase microscopy of living cens ( b) or by TUNEL analysis (c, d). cens were 
counterstained with Hoechst ( c) or combined with the phase picture ( d ) to show an 
nuclei or cens in the field, respectively. Scale bars: c, 100 /lm; d,50 /lm. e, 
Quantitation of three individual experiments (expt.) similar to that shown in c. 
**p<O.Ol; ***p<O.OOl (ANOVA). Error bars indicate SDs. 1, Western blot analysis 
for the active, cleaved form of caspase-3 in cortical progenitors cultured for 1 d in the 
presence of FGF2 (40 ng/ml) with DMSO, PD98059, or LY294002. Two 
independent experiments are shown. The blots were reprobed for total ERK protein as 
a loading control. 
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Figure 3.5. Cortical progenitor cell proliferation is reduced when PI3-kinase, but 
not MEK, is inhibited. Cortical progenitors cultured in the presence of FGF2 (40 
ng/ml) were treated for 2 d with DMSO (1%), PD98059 (50 j.IM; PD50), or 
L Y294002 (100 !lM; L Y100). Q, Immunocytochemical analysis for BrdU (red), after 
an overnight pulse of BrdU immediately before analysis. Cells were counterstained 
with Hoechst (blue). b, Immunostaining for the Ki67 antigen for proliferating cells 
(green). Cells were counterstained with Hoechst (blue). Scale bars: Q, h, 100 !lm. c, 
Quantitation of three individual experiments (expt.) similar to that shown in b. d, 
Western blot analysis for two S-phase markers, cycE and cdk2, in cortical progenitors 
(CP) and postmitotic cortical neurons (PM). The blot was reprobed for total ERK 
protein as a loading control. e, Quantitation of total cell number per field, as assessed 
by Hoechst staining. The number of cells correspond to the average of 15 randomly 
captured fields per treatment per experiment. ***p<O.OOI (ANOVA). Error bars 
indicate SDs. 
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Figure 3.6. Differentiation of neurons but not astrocytes from cortical progenitors is 
dependent on MEK activation. a- e, Cortical progenitors cultured in the presence of 
FGF2 (40 ng/ml) were treated for 2 d with DMSO (1 %), PD98059 (50 !lM; PD50), or 
L Y294002 (100 !lM; L YlOO). a, Immunocytochemical analysis for the early 
panneuronal marker HuD (red). cens were counterstained with Hoechst (blue). b, c, 
Immunostaining for the late panneuronal marker MAP2 (green). cens were 
counterstained with Hoechst (blue) or combined with the phase picture of the field (c). 
Scale bars: a, b, 100 !lm; c, 50 !lm. d, Quantitation of four individual experiments 
(expt.) similar to those shown in a and b, analyzing the proportion of cens expressing 
HuD, MAP2, or ~III-tubulin. **p<O.Ol; ***p<O.OOl (ANOVA). Error bars indicate 
SDs. e, Western blot analysis for the neuronal markers neuron-specific enolase (NSE) 
and neurofilament-medium (NFM) in cortical progenitors differentiated for 2 d (CP) 
and in postrnitotic cortical neurons (PM) as a control. The blots were reprobed for 
total ERK protein as a loading control. J, Western blot analysis for the astrocyte-
specific protein GFAP in cortical progenitors cultured in the presence of FGF2 (40 
ng/ml) with or without CNTF (50 ng/ml) for 3 d in the presence or absence of 50 !lM 
PD98059. Mixed cortical cultures (grown in the absence of cytosine arabinoside), 
which contain both neurons and astrocytes (PM-CA), were used as a positive control. 
The blot was reprobed for total ERK protein as a loading control. 
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Figure 3.7. Inhibition of endogenous neurotrophins, PI3-kinase, and MEK have 
similar effects in the absence of exogenous FGF2. a, Cortical progenitors were 
cultured for 2 d in the presence or absence of exogenous FGF2 (40 ng/ml), before 
analysis of apoptosis by TUNEL staining, proliferation by immunostaining for Ki67, 
or differentiation of neurons by immunocytochemistry for PIII-tubulin or MAP2. h, 
Cortical progenitors were treated with control IgY (40 Ilglml; IgY-Ctl), anti-NT-3 (20 
Ilg/ml), or anti-BDNF (20 Ilg/ml) in the absence of exogenous FGF2 for 2 d before 
analysis similar to that shown in a. Graphs are representative results from one of three 
independent experiments. c, Cortical progenitors were treated with DMSO (1%), 
PD98059 (50 IlM; PD), or LY294002 (50 -100 IlM; LY) for 2 d in the absence of 
exogenous FGF2 before analysis as in a. Graphs are representative results from one 
of three independent experiments. In aIl three panels, **p<O.Ol; ***p<O.OOl 
(Student's t test in a; ANOVA in h and c). Error bars indicate SDs. 
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CHAPTER4 
I. Preface 
While the two previous chapters have focussed on the precursor-to-neuron 
transition, the present chapter aims at defining the molecular mechanism regulating 
the neuronal-to-glial fate switch that occurs during cortex development. Recently, 
intracellular and extrinsic factors regulating gliogenesis have been identifie d, such as 
chromatin modification and gliogenic factors of the cytokine and BMP families 
(reviewed in Sauvageot and Stiles 2002). However, how such factors regulate the 
timing of the onset of gliogenesis was unknown. In this chapter, l hypothesized that 
newly born neurons are the source of gliogenic factors, and that they instruct 
remaining cortical precursors to generate astrocytes only once sufficient amounts have 
accumulated. Such a neuron-based feedback mechanism would ensure that sufficient 
numbers of neurons are generated before the precursor neuron-to-glial fate transition 
occurs. To test this hypothesis, l performed a series of in vitro and in vivo studies to 
address the nature of neuron-derived gliogenic factor(s) and their involvement in 
regulating the onset of gliogenesis during cortex development. 
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II. Abstract 
Precursor cells of the embryonic cortex sequentially generate neurons and then glial 
cells, but the mechanisms regulating this neurogenic to gliogenic transition are 
unclear. Using cortical precursor cultures, which temporally mimic this in vivo 
differentiation pattern, we demonstrate that cortical neurons synthesize and secrete the 
neurotrophic cytokine cardiotrophin-l, which activates the gp130-JAK-STAT 
pathway and is essential for the timed genesis of astrocytes in vitro. Our data indicate 
that a similar phenomenon also occurs in vivo. In utero electroporation of 
neurotrophic cytokines in the environment of embryonic cortical precursors causes 
premature gliogenesis, while acute perturbation of gp 130 in cortical precursors delays 
the normal timed appearance of astrocytes. Moreover, the neonatal cardiotrophin-l-/-
cortex contains fewer astrocytes. Together, these results de scribe a novel neural 
feedback mechanism; newly-born neurons produce cardiotrophin-l, which instructs 
multipotent cortical precursors to generate astrocytes, thereby ensuring that 
gliogenesis does not occur until neurogenesis is largely complete. 
122 
III. Introduction 
Development of the cerebral cortex is achieved through a common pool of precursor 
cells that sequentially generate neurons and glial cells. Remarkably, this precisely 
timed process can be recapitulated in vitro with isolated embryonic cortical stem cells 
(Qian et al., 2000), suggesting that cortical precursors are biased initially to generate 
neurons, and that an undefined mechanism then instructs them to generate astrocytes 
at later timepoints. One potential molecular explanation for this timing mechanism is 
a cell-intrinsic one where, over time, precursor cells themselyes change so they are 
less biased to make neurons and more likely to make glial cells. Such a change could 
occur, for example, as a consequence of dilution of a neurogenic factor(s) such as a 
transcription factor (Nieto et al., 2001; Sun et al., 2001; Ménard et al., 2002; Ross et 
al., 2003; He et al., 2005), by expression of a specific receptor such as EGFR 
(Burrows et al., 1997; Sun et al., 2005), or by demethylation of astrocyte-specific gene 
promoters (Takizawa et al., 2001; Namihira et al., 2004). Another, not mutually-
exclusive, explanation is that cortical precursor cells are prematurely competent to 
generate astrocytes, but that they require an extrinsic gliogenic signal that is not 
present in their environment until later in embryogenesis. Indeed, several exogenous 
growth factors have been shown to be potent gliogenic factors (reviewed in Sauvageot 
and Stiles, 2002). In particular, the interleukin-6 (IL-6) family of neurotrophic 
cytokines, which includes leukaemia inhibitory factor (LIF), ciliary neurotrophic 
factor (CNTF), and cardiotrophin-1 (CT -1) induces premature astrocyte formation in 
cultured cortical precursors via a gp130-JAK-STAT pathway (Bonni et al., 1997; 
Rajan and McKay, 1998; Park et al., 1999; Ochiai et al., 2001), and targeted ablation 
of the genes encoding either gp 130 or its coreceptor LIFR perturbs astrocyte 
formation in vivo (Ware et al., 1995; Koblar et al., 1998; Nakashima et al., 1999c). 
While these latter studies indicate that cytokine signaling is important, the 
finding that the appropriate timing of astrocyte formation can be mimicked in isolated 
clones of precursor cells seems to argue that a cell-intrinsic mechanism regulates the 
onset of gliogenesis (Qian et al., 2000). However, since such clones contain both 
precursors and newly-bom neurons, a second hypothesis consistent with these 
findings is that newly-bom neurons secrete gliogenic factors that feedback to instruct 
multipotent precursors to generate astrocytes. Here, we describe data that support this 
hypothesis. Specifically, we demonstrate that newly-bom neurons secrete the 
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gliogenic cytokine CT -1, which then instructs cortical precursors to generate 
astrocytes at the appropriate time and in the appropriate number. These findings 
therefore support a model where cortical precursors are competent to generate 
astrocytes early during cortical development, but that it is only later in embryogenesis, 
when levels of neuron-secreted CT -1 are sufficiently high, that these precursors 
receive the necessary gliogenic signal to initiate astrocyte formation, thereby ensuring 
that gliogenesis does not commence until neurogenesis is largely complete. 
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IV. Results 
Mixed cortical neuron and precursor cultures in du ce premature astrocyte formation 
from early cortical precursors 
To study the mechanism responsible for the sequential generation of neurons 
and glial cells, we examined primary cultures of murine E 13 cortical precursor cells 
(Toma et al., 2000; Ménard et al., 2002; Barnabé-Heider and Miller, 2003), a system 
we have previously characterized in detail. Upon plating, these cortical precursor 
cells were virtually all dividing, nestin-positive precursors that sequentially generate 
neurons and then glia, as visualized by immunocytochemistry and Western blot 
analysis for the neuronal marker neurofilament-M (NFM; Fig. 4.1 b), the astrocyte 
marker glial fibrillary acidic protein (GFAP; Fig. 4.1a,b) and the oligodendroglial 
markers galactocerebrosidase (GalC) or CNPase (Suppl. Fig. 4.1a). This analysis 
demonstrated that neurons were first observed after 1 day in vitro (DIV) (Fig. 4.1 b; 
data not shown) as we have previously reported (Toma et al., 2000; Ménard et al., 
2002; Barnabé-Heider and Miller, 2003), while astrocytes and oligodendrocytes were 
first se en at 5-6 DIV (Fig. 4.1a,b, Suppl. Fig. 4.1a). The increase in differentiated cell 
types over time was accompanied by a depletion in precursor cells, as shown by a 
reduction in the expression of the undifferentiated cell marker, nestin, and the 
proliferating cell marker, cyc1in-dependent kinase 2 (cdk2, Fig.4.1 b). 
One explanation for why gliogenesis follows neurogenesis in these cultures is 
that newly-born neurons pro duce a gliogenic factor. To test this possibility, we 
exposed newly-plated cortical precursors to medium conditioned by 4 day old cortical 
precursor cultures (4 DIV conditioned medium or CM), which contain only neurons 
and precursors (Fig. 4.1a,b). As a positive control, we used the known gliogenic 
cytokines, CNTF, LIF, and CT-l (Bonni et al., 1997; Rajan and McKay, 1998; Park et 
al., 1999; Ochiai et al., 2001). Immunocytochemical analysis for GFAP revealed that 
at 4 DIV no astrocytes were present in controls, but that cultures treated with CM or 
any of the three cytokines contained astrocytes, the numbers of which increased 
dramatically by 6 DIV (Fig. 4.1a). We confirmed these results by examining CD44 
and S100~, which we demonstrated are expressed in astrocyte precursors/early 
astrocytes and in glial precursors/early astrocytes, respectively, in these cultures 
(Suppl. Fig. 4.1b,c), as previouslyreported (Burrows et al., 1997; Liu et al., 2004). As 
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predicted, cells expressmg these two markers were detected earlier than those 
expressing GF AP (Suppl. Fig. 4.2a,b), but CM still robustly increased their numbers; 
at 4 DIV, CM-treated cultures contained approximately twice as many CD44 and 
S100~-positive cens (Suppl. Fig. 4.2a,b; Fig. 4.4j,k). Western blot analysis at 6DIV 
confirmed these findings and showed that levels of GF AP, but not those of the 
neuron-specific proteins NFM and ~III-tubulin, were increased by CM (Fig. 4.1c,d). 
Since the gliogenic effect of the CM could be inhibited by heat denaturation (Fig. 
4.1 d), we conclude that it is likely due to a secreted protein. 
To ask whether this premature gliogenesis reflected an increase in the number 
of cortical precursor cens that generated astrocytes, we performed clonaI analysis. 
Since survival of cortical precursors is density-dependent (Barnabé-Heider and Miller, 
2003), we seeded E13 EYFP-tagged transgenic cortical precursors at clonaI density on 
untagged E 13 cortical precursor cultures. These cultures were grown for 4 or 5 days 
with or without 4 DIV CM or CNTF; over this time period, single EYFP-positive cens 
proliferated to generate clones (Fig. 4.le,f). Double-label immunocytochemical 
analysis revealed that, in the control cocultures at 4 DIV, the majority of clones 
contained cens expressing the neuronal marker MAP2 or the precursor marker nestin, 
but no clones contained GFAP-positive astrocytes (data not shown, Fig. 4.lg). By 5 
DIV, a very small number of clones contained at least one GF AP-positive cell (Fig. 
4.lg). In contrast, when cells were cultured in the presence of 4 DIV CM, on day 4 
sorne clones contained GFAP-positive cells (Fig. 4.le,g) while on day 5, many more 
clones contained astrocytes (Fig. 4.lf,g). To ask whether CM acts to enhance genesis 
of astrocytes from multipotent precursors versus simply enhancing differentiation of 
previously-determined astrocyte precursors, we also examined the earlier markers 
CD44 and S100~ (Fig. 4.lh). At 4 DIV, 2-3 times as many clones contained CD44 or 
S100~-positive cens when exposed to CM (Fig. 4.1h), arguing that CM promoted 
premature astrocyte genesis. This enhanced gliogenesis was quantitatively similar to 
that seen when cultures were exposed either to CNTF or CT-l (Fig. 4.1g,h). In 
contrast, neither CM nor CNTF affected the number of clones that contained MAP-2-
positive neurons or nestin-positive precursors (Fig. 4.lf; data not shown). Thus, a 
factor(s) secreted by the mixed precursor/neuron cultures directs cortical precursors to 
generate astrocytes. 
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Purified embryonic cortical neurons secrete factors that are sufficient to direct early 
cortical precursors to generate astrocytes 
To identify the source of the gliogenic factors contained in CM, we isolated 
purified embryonic cortical neurons, taking advantage of the K6 line of TaI :nlacZ 
transgenic mice, which expresses nuclear ~-galactosidase from the neuron-specific 
TaI a-tubulin promoter (Gloster et al., 1994; 1999). E15-17 transgenic cortical cells 
were labelled with the vital dye fluorescein di-p-D-galactopyranoside (FDG), sorted 
by fluorescence activated cell sorting (F ACS), and then cultured for 5 days. 
Immunocytochemical analysis demonstrated that 99.5% of the cultured cells 
expressed the neuronal marker PIII-tubulin, the vast majority ofwhich also expressed 
MAP2 (Fig. 4.2a), while no cells expressed glial markers (data not shown). 
Conditioned medium was collected from these isolated embryonic cortical neurons, 
and applied to newly-isolated cortical precursors for 5 days. Double-label 
immunocytochemical analysis for MAP2 and GF AP revealed that the control cultures 
contained many neurons with only the rare astrocyte, while the cultures grown in 
neuron-conditioned medium contained both neurons and astrocytes (Fig. 4.2b). 
Quantitation of the se experiments revealed that pure neuron CM was similar to 
exogenous CNTF in its ability to promote premature astrocyte formation (Fig. 4.2c). 
Embryonic cortical neurons express neurotrophic cytokines that activate 
downstream cytokine signaling pathways in cortical precursors 
CNTF, CT-l and other IL-6 family member cytokines promote astrocyte 
differentiation from cortical precursors via activation of the JAK-STAT pathway 
(Bonni et al., 1997; Rajan and McKay, 1998; Nakashima et al., 1999b; 1999c; Park et 
al., 1999; Yanagisawa et al., 1999; Ochiai et al., 2001). To determine whether the 
gliogenic factor(s) secreted by newly-born cortical neurons was a cytokine, we 
performed semi-quantitative RT-PCR. This analysis revealed that the mRNAs for ( 
CNTF, LIF and CT -1 were present and all increased as the precursor cultures 
increased in age, coincident with increasing numbers of neurons (Fig. 4.2d), with the 
highest levels in purified postmitotic cortical neurons that were isolated at E15 and 
cultured for 5 DIV (Fig. 4.2d). We also confirmed, using RT-PCR and Western blot 
analysis, that both the gp130 receptor (required for actions of aIl the cytokines) and 
LIFR (required for actions of LIF, CNTF and CT-l) were expressed in cortical 
precursor cultures at timepoints ranging from 0 to 8 DIV (Fig. 4.2e; data not shown). 
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These data indicated that newly-born cortical neurons produce cytokines that 
could regulate the timing and extent of astrocyte formation. To confirm this 
conclusion, we asked whether exposure to CM induced the JAK-STAT pathway, 
which is used by cytokines to signal gliogenesis. Initially, we characterized the basal 
level of activation of the JAK-STAT pathway in precursor cultures. Western blot 
analysis revealed that JAK1, JAK2 and STAT3 were all expressed from 1 to 6 DIV 
(Fig. 4.2g), and immunocytochemistry revealed that STAT3 was enriched in cortical 
precursor ceUs relative to newly-born neurons (Fig. 4.2f). Interestingly, Western blots 
using antibodies specifie for the phosphorylated, activated forms of these proteins 
revealed that the basal activation of JAKs 1 and 2 was increased at 4-6 DIV, 
coincident with the predicted onset of endogenous gliogenic signaling (Fig. 4.2g). To 
ask whether CM activated this same pathway; 4 DIV precursor cultures were washed, 
exposed for 15 minutes to CM from embryonic cortical neurons or 4DIV precursor 
cultures, and analyzed by Western blots. Results demonstrated that CM from either 
source induced activation of both JAK2 and STAT3 (Fig. 4.2h), as did 50 ng/ml 
CNTF. The CM and CNTF also acutely activated a second cytokine signaling 
pathway, the MEK-ERK pathway, as assayed with an antibody specifie for 
phosphorylated ERKs (Fig. 4.2h). Thus, newly-born cortical neurons secrete 
cytokines that activate appropriate signaling pathways in multipotent cortical 
precursors. 
Cytokine signaling through the JAK-STAT pathway, but not through MEK, is 
necessary for cortical neurons to in duce premature gliogenesis 
Cytokines are thought to mediate gliogenesis from cortical precursors by 
activation of the JAK-STAT, but not the MEK-ERK pathway (Bonni et al., 1997; 
Rajan and McKay, 1998; Park et al.,1999), which is instead thought to promote 
neurogenesis in cortical precursors (Ménard et al., 2002; Barnabé-Heider and Miller, 
2003). We therefore assessed the role of these two pathways in CM-mediated 
gliogenesis, using AG490 and PD98059, which specifically inhibit JAK and MEK, 
respectively. We ascertained the specificity and efficacy of these two inhibitors by 
culturing precursor cells for 3 DIV, at which point the peak of neurogenesis is over, 
and then adding either 50 /lM PD98059 or 5 /lM AG490 for two additional days in the 
presence of CNTF or 4 DIV CM. Western blot analysis revealed that PD98059 
inhibited long-term ERK phosphorylation, but had no effect on activation of the JAK-
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STAT pathway (Fig. 4.3c, data not shown), and that AG490 had the converse effect 
(Fig.4.3d). We then asked whether either ofthese two inhibitors affected gliogenesis. 
Immunocytochemical analysis revealed that inhibition of the JAK-STAT pathway 
with AG490 decreased the gliogenic effect of 50 ng/ml CNTF, and completely 
abolished astrocyte formation induced by CM (Fig. 4.3a,e). In contrast, PD98059 had 
no effect on gliogenesis, and neither AG490 nor PD98059 had any effect on the 
numbers of MAP2-positive neurons (Fig. 4.3a,e), as would be predicted since most 
neurons were born by the time the inhibitors were added. Western blot analysis for 
GFAP and for ~III-tubulin confirmed these findings (Fig. 4.3c,d). This inhibitory 
effect of AG490 could not be attributed to an effect on survival or proliferation, since 
total ceIl numbers were similar in the presence or absence of this inhibitor; CM-
treated cultures had 1028±135 ceIls per field with DMSO, 975±88 ceIls with AG490, 
and 1017±117 cells with PD98059. Moreover, when AG490 was applied at 7 DIV, 
after astrocytes were already born, it had little or no effect on astrocyte number (Fig. 
4.3b), arguing that it specifically affected gliogenesis. 
These data indicated that the JAK-STAT, but not the MEK-ERK pathway was 
essential for the gliogenic effect of CM. To confirm this conclusion, we inhibited the 
JAK-STAT pathway genetically, using siRNA for STAT3. To demonstrate the 
efficacy of the STAT3 siRNA vector, we cotransfected it with an EGFP-expression 
plasmid into NIH-3T3 cells. Although the transfection efficiency was only 30-50%, 
Western blot anaysis demonstrated that STAT3 levels were significantly decreased at 
timepoints ranging from 2 to 6 days posttransfection (Fig. 4.4a, data not shown). We 
then asked whether STAT3 siRNA knockdown would inhibit gliogenesis. Cortical 
precursors were cotransfected immediately after plating, were cultured in the presence 
of 4 DIV CM or CNTF, and were analyzed after 5 days. The efficacy of the siRNA 
was demonstrated by immunostaining the cells for GFP and STAT3 (Fig. 4.4b); 85% 
of GFP-positive control cells versus 29% of STAT3 siRNA-transfected cells were 
immunoreactive for STAT3. To assess effects of this knockdown on precursor cell 
differentiation, similar cultures were immunostained for GFP and GF AP or MAP2. 
This analysis (Figs. 4.4c,d) revealed that STAT3 siRNA reproducibly decreased by 2 
to 3-fold the number of astrocytes generated in either CM or CNTF. Interestingly, 
STAT3 knockdown also enhanced the number of neurons by approximately 2-fold 
(Fig. 4.4c,d). Thus, CM directs cortical precursors to generate astrocytes via 
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activation of the JAK-STAT pathway, and inhibition of this pathway prevents 
gliogenesis while enhancing neurogenesis. 
These findings indicate that newly-born neurons secrete factors that promote 
gliogenesis via the JAK-STAT pathway. To determine whether these factors are 
cytokines, we decreased levels of the cytokine receptor, gp 130, on cortical precursors 
using a mixed-pool of siRNA oligonuc1eotides. The efficacy of these oligonuc1eotides 
was demonstrated by transfecting NIH-3T3 ceUs; Western blot analysis demonstrated 
a significant knockdown of gp 130 levels relative to either control cells or cells 
transfected with a scrambled oligonuc1eotide (Fig. 4.4e), in spite of a transfection 
efficiency of only 30-50%. We then cotransfected cortical precursors with GFP and 
gp 130 siRNA at 1 day after plating, and maintained them for 4 additional days in 4 
DIV conditioned medium or CNTF. This protocol effectively reduced gp 130 levels 
(Fig. 4.4f); 82% of control cells versus 26% of gp130 siRNA transfected cells were 
immunoreactive for gp130. We then analyzed these cells for three different astrocyte 
markers, GFAP, S100~, and CD44. This analysis revealed that, relative to the 
scrambled oligonuc1eotide, gp 130 knockdown dramatically reduced the number of 
ceUs expressing all three of these astrocyte precursor/astrocyte markers in response to 
CM (Fig. 4.4g-k). The endogenous gliogenesis that occurs in control cultures was 
also highly reduced (Fig. 4.4j,k). Interestingly, gp130 knockdown also increased the 
number of MAP2-positive neurons by approximately 2-fold (Figs. 4.4g). Thus, the 
gliogenic factor(s) in CM is a cytokine(s), and a reduction in gp130 signaling in 
cortical precursors inhibits gliogenesis and promotes neurogenesis. 
Cortical precursor cells in the early embryonic ventricularlsubventricular zone are 
competent to generate astrocytes in response to premature neurotrophic cytokine 
expression 
Our findings suggest that cortical precursors may be competent to make 
astrocytes earlier in development, but that they do not do so because of low cytokine 
levels in their environment. To test this idea, we expressed the cytokine CNTF in the 
embryonic telencephalic ventricularlsubventricular zone (VZ/SVZ) by performing in 
utero electroporation with a plasmid encoding a myc-tagged, secreted form of CNTF 
(Jiang et al., 2003). As predicted, transfection of this plasmid into COS ceUs led to 
the secretion of CNTF into the medium (Suppl. Fig. 4.3c). We then transfected 
cultured cortical precursors with this plasmid, and demonstrated that after 5 DIV more 
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than 30% of the cells in these cultures expressed GFAP, and that the JAK-STAT 
pathway was robustly activated (Suppl. Fig. 4.3a-c). Importantly, many of the 
nontransfected cells were GFAP-positive (Suppl. Fig. 4.3a), as would be predicted if 
CNTF was secreted by the transfected cells. 
Having established the efficacy of this approach, we performed in utero 
electroporation; plasmids encoding a nuc1ear-targetted GFP and CNTF or empty 
vector were coelectroporated following injection into the E15 lateral ventric1es, 
embryos were reimplanted, and then analyzed 1-3 days later. One day following 
electroporation, only cells in the VZ/SVZ of the telencephalon were transfected (data 
not shown) , as previously reported (Ohtsuka et al., 1999). Three days following 
electroporation, at E18, many cells were still in the VZ/SVZ, but many had also 
migrated into the cortical plate (Fig. 4.5a). The vast majority of the transfected cells 
that expressed GFP coexpressed the myc-tagged CNTF plasmid (Fig. 4.5d). 
Immunocytochemistry demonstrated that virtually no GF AP-positive cells were 
detected in the control-transfected E18 cortex, (Fig. 4.5a, left panels) but that many 
astrocytes were present in the CNTF-transfected cortical VZ/SVZ (Fig. 4.5a, right 
panels). Confocal microscopic analysis revealed that approximately 20% of GFP-
CNTF positive cells in the SVZ adopted an astrocytic fate (Fig. 4.5b,c). Moreover, 
many non-transfected cells also expressed GF AP (Fig. 4.5b) as was se en in the culture 
experiments (Suppl. Fig. 4.3a). 
To ask how early cortical precursors were competent to generate astrocytes in 
vivo, we performed the same electroporation experiment at the earliest feasible 
timepoint, E13.5. Immunocytochemical analysis of the se brains 2.5 days later, at E16, 
revealed abundant GFAP-positive cells within the VZ/SVZ of CNTF-transfected, but 
not control-transfected animaIs (Fig. 4.5g), results similar to those se en at the later 
timepoint. Immunohistochemistry for SI OOp revealed a similar enhancement in the 
CNTF-transfected VZ/SVZ (data not shown), arguing that CNTF promoted the 
premature genesis of aStrocytes, and not just their differentiation. . 
We also asked how early cortical precursors were competent to respond to the 
cytokine(s) in CM; cortical precursors were cultured from the EI1.5 cortex and 
exposed to CM or CNTF. Immunocytochemical analysis revealed that at 5 DIV (the 
earliest timepoint examined), many SlOOp and GF AP-positive astrocytes were present 
under both of these conditions (Fig. 4.5e), while none were present in control cultures 
until 7 DIV (Fig. 4.5t). Thus, early cortical precursors are competent to respond to 
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cytokines both in culture and in vivo, arguing that E13-EI5 cortical precursor cells do 
not normally produce astrocytes because of the limited availability of gliogenic factors 
in their environment. 
The appropriate onset of gliogenesis in vivo requires cytokine signaling in cortical 
precursor cells 
While these findings argue that cortical precursors are competent to respond to 
cytokines during embryogenesis, they do not demonstrate that cytokines directly 
regulate the appropriate ons et of gliogenesis. To address this issue, we acutely 
perturbed cytokine signaling in cortical precursors using gp130 siRNA. As previously 
reported (Calegari et al., 2002; 2004), plasmids and siRNA oligonuc1eotides can be 
efficiently coelectroporated into the developing cortex and remain stably expressed 
(data not shown). We therefore coelectroporated a nuc1ear-targetted GFP plasmid 
with either scrambled or gp130 siRNA oligonuc1eotides into the E14/l5 
telencephalon. The animaIs were reimplanted, born and then analysed at post-natal 
day 3 (P3) or P4. Immunocytochemistry for GFP and for GFAP or for neuron-
specific NeuN revealed that, in control animaIs, almost aIl of the GF AP-positive cells 
were localized to the SVZ (Fig. 4.6a), while, as predicted, the vast majority of NeuN-
positive neurons were in the cortical plate (Fig. 4.6d). Quantitative confocal analysis 
demonstrated that, at P3, GFAP was expressed in 5-10% of the GFP-positive control-
transfected cells, but in virtually none of the gp130 siRNA-transfected ceIls (Fig. 
4;6b,c). By P4, 20-30% of the control, GFP-positive ceIls expressed GFAP, while 
only approximately 5% of the gp130 siRNA-transfected ceIls were GFAP-positive 
(Fig. 4.6b,c). In contrast, gp130 siRNA knockdown led to a smaIl but significant 
increase in the number of transfected neurons in the cortical plate (Fig. 4.6d,e), 
consistent with the culture data. Thus, the appropriate onset of astrocyte formation 
requires the cytokine coreceptor, gp130, in embryonic cortical precursor ceIls. 
Cardiotrophin-l is produced by newly-born cortical neurons and is responsible for 
the gliogenic effects of conditioned medium 
Our RT-PCR analysis (Fig. 4.2d) demonstrated that developing cortical 
neurons express at least three gliogenic cytokines, CNTF, LIF and CT-l. Since 
CNTF-/- mice have no reported astrocytic phenotype, we focussed upon CT-l, which 
is expressed in the embryonic cortex (Oppenheim et al., 2001) and LIF, which is 
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expressed in neurons throughout the adult brain (Lemke et al., 1996). Initially, we 
characterized expression of CT-l and LIF in vivo. RT-PCR analysis of the cortex 
from E12 to E17.5 revealed that CT-1 was barely detectable at E12 or E13, but was 
readily detectable by E17.5 (Fig. 4.6f), confirming earlier analyses (Sheng et al., 1996; 
Oppenheim et al., 2001). In contrast, LIF mRNA was not detectable in the embryonic 
cortex at either timepoint (Fig. 4.6f). To ask what cells expressed CT-1 in vivo, we 
performed immunocytochemistry on the E 18 cortex, and demonstrated that CT -1 was 
enriched in HuD- and NeuN-positive neurons in the cortical plate region, but was not 
detectably expressed in the VZ/SVZ (Fig. 4.6h; Suppl. Fig. 4.3d). The specificity of 
this immunostaining was demonstrated by preabsorbing the antibody with CT-1 
(Suppl. Fig. 4.3d). To further confirm that embryonic cortical neurons synthesize and 
secrete CT-l, we cultured neurons or cortical precursors for 4 DIV, and used these 
cultures to generate conditioned medium for a further 1 DIV. Western blot analysis of 
the concentrated CM demonstrated that a CT -1 immunoreactive band was just 
detectable in medium generated from wild-type, but not CT-1-/- cortical precursors, 
and that this same immunoreactive protein was present at much higher levels in CM 
from cortical neurons (Fig. 4.6g). Thus, CT -1 is highly enriched in newly-born 
cortical neurons in vivo and in vitro. 
To ask whether CT-l or LIF, both of which are expressed in cultured 
developing cortical neurons (Fig. 4.2d) were responsible for the gliogenic effect of 
CM, E13 precursor cell cultures were incubated with 4 DIV CM in the presence or 
absence offunction-blocking antibodies to either CT-1 (Chen and von Bartheld, 2004) 
or LIF (Mi et al., 2001). Immunocytochemical analysis for GFAP and for CD44 (Fig. 
4.7a and data not shown) 4 days later demonstrated that anti-CT-1 almost completely 
blocked the gliogenic effects of CM, while anti-LIF had no effect. In contrast, neither 
antibody affected the numbers of MAP2-positive neurons (Fig. 4.7a). Western blot 
analysis confirmed that anti-CT -1 dramatically inhibited GF AP, but not ~III-tubulin, 
expression in CM-treated cultures (Fig. 4.7b). As further confirmation, we cultured 
cortical precursors from CT-I-/- versus CT-1+/- embryos (Oppenheim et al., 2001), 
collected CM from these cultures at 4 DIV, and then treated wild-type cultures with 
these different conditioned media. Immunocytochemical and Western blot analyses 4 
days later revealed that the number of astrocytes, but not neurons, was significantly 
reduced in cultures treated with CT-1-/- versus CT-1+/- CM (Fig. 4.7c,d). Together 
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these data indicate that CT -1 is produced by neurons and is a major CM gliogenic 
factor. 
Neuron-derived cardiotrophin-l is essential for normal gliogenesis both in culture 
and in vivo 
These data suggest that neuron-derived CT -1 provides a feedback mechanism 
essential for the genesis of astrocytes. One prediction of this model is that loss of CT -
1 should lead to a delay and/or reduction in endogenous astrocyte formation. To test 
this prediction, we cultured cortical precursors from CT-l-/- versus CT-1+/- or CT-
1+/+ littermates and analyzed them at 6 DIV. Immunocytochemical and Western blot 
analyses revealed a dramatic reduction in the numbers of GF AP-positive astrocytes in 
these cultures, with no significant effect on the numbers of neurons (Fig. 4.7e-g). 
Confirmation that the deficit in astrocyte formation in CT-l-/- cultures was due to the 
absence of CT -1 was obtained by analysing wildtype precursors cultured in the 
presence of the function-blocking CT -1 antibody. Immunocytochemical analysis and 
Western blots demonstrated that anti-CT -1 blocked the endogenous genesis of cens 
expressing both GFAP and CD44 in these cultures (Fig. 4.7h,i; data not shown) 
without affecting neurogenesis. Thus, endogenous CT -1 is essential for 
astrogliogenesis in culture. 
We then asked whether CT -1 was also important in vivo by analysing the 
cortex ofneonatal CT-l-/- mice, utilizing both GFAP and CD44 as astrocytic markers. 
To confirm that CD44 was expressed in early cortical astrocytes in vivo as we had 
demonstrated in vitro (Suppl. Fig. 4.lb,c), we performed double-label 
immunocytochemistry for CD44 and GFAP. As predicted by the culture data, at Pl 
the large majority of CD44-positive cens were present in the VZ/SVZ, and almost an 
of them were GFAP positive (Fig. 4.8a). Conversely, many of the GFAP-positive 
cens in the SVZ were CD44-positive. We then performed Western blot analysis for 
CD44 and GFAP in the PO or Pl CT-l-/- versus CT-1+/+ cortex. This analysis 
revealed greatly reduced levels of both of these astrocyte precursor/astrocyte proteins 
in the absence of CT-l, while no differences were observed in the levels ofNFM (Fig. 
4.8b). To further characterize this specific reduction in astrocytic proteins, we 
performed GFAP immunocytochemistry in the CT-l-/- cortex at P3 and P7, and 
quantitated the immunofluorescence signal in a defined region of the dorsal SVZ 
(region 1, Fig. 4.8c-f). This analysis demonstrated a 50-75% reduction in GFAP 
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signal throughout the CT-1-/- SVZ at both of these timepoints (Fig. 4.8d), in good 
agreement with the Western blot data (Fig. 4.8b). In contrast, a similar analysis of the 
dorsal SVZ ofP3 LIF-/- animaIs showed no reduction in OFAP fluorescence intensity 
(Fig. 4.8d). Finally, to confirm that this decrease in astrocytic proteins reflected a 
decrease in astrocyte numbers, we quantitated the density of OF AP-positive cells in 
two defined regions of the cortical SVZ (Fig. 4.8c) using DAB 
immunohistochemistry. This analysis revealed that the density of OF AP-positive 
astrocytes in the P3 CT -1-/ - cortex was decreased 50-75% relative to the CT -1+/+ 
cortex (Fig. 4.8g). Thus, neuron-derived CT -1 but not LIF is essential in vivo for 
appropriate gliogenesis in the developing cortex. 
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v. Discussion 
The results presented here support three major conclusions. First, our culture studies 
indicate that newly-bom cortical neurons express gliogenic cytokines that instruct 
multipotent cortical precursors to generate astrocytes, thereby regulating the temporal 
ons et of gliogenesis. Second, our in vivo work indicates that early cortical precursors 
are competent to produce astrocytes, but that they fail to do so because they require 
gliogenic cytokine signaling that only occurs late during embryogenesis. Third, our 
studies demonstrate that the cytokine CT -1 is highly enriched in embryonic cortical 
neurons, and this neuron-derived CT -1 is essential for the normal genesis of astrocytes 
both in culture and in vivo. Together, these findings support a novel developmental 
mechanism, where cortical precursors first generate neurons that produce and secrete 
the cytokine CT -1, which then provides a feedback loop to direct the parent cortical 
precursors to start making astrocytes. Such a mechanism provides an unanticipated 
level of cross-talk between these different developing cellular populations, and 
ensures that astrocytes are only made after sufficient numbers of neurons are 
generated. 
Our in utero electroporation data argue that a substantial proportion of cortical 
precursors in the VZ/SVZ are competent to generate astrocytes in response to 
exogenous cytokines as early as E13/E14 in vivo and from E11.5 in vitro. The fact 
that they do not normally do so argues that cytokine levels in their endogenous 
environment are limiting, in spite of the recent finding that two cytokines, 
neuropoietin and cardiotrophin-like cytokine, are expressed in embryonic mouse 
neuroepithelia (Uemura et al., 2002; Derouet et al., 2004). Consistent with this 
conclusion, Morrow et al. (2001) demonstrated that the postnatal, but not embryonic 
cortex, contained environmental cues that would direct embryonic cortical precursors 
to become astrocyes. Our data indicate that this difference in cortical environment is 
at least partially due to neuron-derived CT -1. These findings do not, however, 
exclude the possibility that prior to E13/E14, cortical precursors undergo an intrinsic 
change that allows them to respond to cytokines. For example, STAT binding sites on 
the GF AP promoter are demethylated around this time, something that may weIl be a 
necessary prerequisite (Takizawa et al., 2001). Moreover, our data do not rule out the 
possibility that other intrinsic alterations between E13/E14 and birth may render 
cortical precursors more responsive to low levels of environmental cytokines. For 
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example, premature expression ofEGFR in rat precursors at E15 enhances the genesis 
of astrocytes (Burrows et al., 1997), and the JAK-STAT pathway may become more 
responsive as a consequence of interactions with HLH proteins and/or the Notch 
signaling pathway (Kamakura et al., 2004; He et al., 2005). Nonetheless, our data 
strongly argue that neuron-derived CT -1 provides a key extrinsic signal for 
determining when and how many astrocytes are generated in the late embryonic and 
neonatal cortex. 
The idea that cytokines are important for astrogliogenesis is well-supported by 
previous studies. Cytokines, including CNTF, LIF and CT -1 have been shown to 
promote gliogenesis in cultured precursors via a gp130-JAK-STAT pathway (Bonni et 
al., 1997; Rajan and McKay, 1998; Nakashima et al., 1999a; Park et al., 1999; 
Yanagisawa et al., 1999). In addition, while mice lacking individual cytokines such as 
CNTF and LIF do not display glial deficits in the developing cortex (Masu et al., 
1993; Bugga et al., 1998; Oppenheim et al., 2001), mice lacking gp130 or LIFR have 
significantly reduced numbers of CNS astrocytes (Ware et al., 1995; Koblar et al., 
1998; Nakashima et al., 1999c). Here, we demonstrate that neuron-derived CT-l is a 
key player in a novel feedback mechanism regulating the switch from neurogenesis to 
gliogenesis in the cortex. Since a similar developmental switch occurs throughout the 
developing CNS, and since the deficits in astrocyte number are widespread in the 
gp130-/- and LIFR-/- mice, then such a neuron-based feedback mechanism may be 
important throughout the embryonic brain and spinal cord. Moreover, if neurons 
pro duce cytokines like CT -1 into adulthood, then this might explain why precursors 
transplanted into the postnatal brain or to an injured CNS environment generate 
virtually exclusively glial cells (Morrow et al., 2001; Vroemen et al., 2003). 
The deficit in astrocyte formation demonstrated here is very dramatic in 
precursor cultures in which CT -1 is depleted, and astrocyte numbers are reduced 50-
75% in the cortex ofneonatal CT-l-/- mice. However, while this is a robust decrease, 
it is not as dramatic as that se en in the LIFR-/- or gp130-/- mice (Ware et al., 1995; 
Koblar et al., 1998; Nakashima et al., 1999c). This difference may be due to the 
synthesis of other cytokines by developing neurons, as we demonstrate here. In this 
regard, since in vivo expression of both LIF and CNTF commences postnatally, and 
since adult LIF-/- mice have reduced numbers of hippocampal astrocytes (Koblar et 
al., 1998), then we propose that these other cytokines may well provide 
compensatory/additional neuron-derived cytokines, particularly in a CT-l-/-
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background. Moreover, astrocytes themselves (Lillien et al., 1988) can produce 
gliogenic cytokines, suggesting that once the first astrocytes are made, they may 
themselves participate in determining the ultimate astrocytic density. 
One of the surprising results reported here is that cytokines signal via the 
gp130-JAK-STAT pathway not just to promote gliogenesis, but to also inhibit 
neurogenesis. These findings are reminiscent of our recent work showing that growth 
factors that promote neurogenesis from cortical precursors, like neurotrophins and 
PDGF, do so via a MEK-CIEBP pathway that at the same time inhibits gliogenesis 
(Ménard et al., 2002; Bamabé-Heider and Miller, 2003). Similarly, neurogenic bHLHs 
bias neural stem cells towards neurogenesis and against gliogenesis via two distinct, 
but concurrent mechanisms (Sun et al., 2001). Together, these findings argue that 
growth factors in the embryonic neural environment do not simply promote 
differentiation into a given phenotype, but that they actually switch precursors to be 
strongly biased to one fate versus another (i.e. instructive rather than permissive), in 
this case astrocytes versus neurons. Similarly, in the PNS, GGF produced by neurons 
is thought to bias neural crest precursors towards a Schwann cell and against a 
neuronal cell fate (Shah et al., 1994). 
The idea of developmental timers is well-established, but in most cases the 
underlying mechanism is thought to be a cell-intrinsic clock that is tied to the cell 
cycle. For example, the Raff laboratory has characterized a cell-intrinsic timer that 
determines when oligodendrocyte precursor cells exit the cell cycle and terminally 
differentiate (reviewed in (Raff et al., 2001; Tang et al., 2001). This timer is thought 
to involve both transcription factors and cell cycle regulators. As a second example, 
the strict temporal regulation of vertebrate somitogenesis is thought to depend upon an 
intrinsic segmentation clock in presomitic cells, and this clock is thought to involve 
the regulation of cell division and crosstalk at the transcriptional level (Dale and 
Pourquie, 2000; Bessho et al., 2003; Bessho and Kageyama, 2003). Here, we present 
a different developmental mechanism for regulating the onset of cell genesis, one that 
involves an extrinsic feedback loop where one class of daughter cells, neurons, alters 
the environment of the parent precursors to favour production of a second class of 
daughter cells, astrocytes. 
In summary, we conclude that the accumulation of gliogenic CT -1 produced 
by newly bom neurons acts as a novel developmental feedback mechanism to instruct 
the remaining cortical precursor cells to generate a second wave of differentiated cells, 
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astrocytes. These findings not only provide insights into cortical development, but 
also raise the possibility that similar mechanisms may underlie the sequential genesis 
of cell types in other developing systems. 
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VI. Experimental procedures 
Cortical precursor and FA CS purified neuron cultures 
Cortical precursors and post-mitotic neuron cultures were performed as previously 
described; (Ménard et al., 2002; Pozniak et al., 2002; Barnabé-Heider and Miller, 
2003). Briefly, cortical tissue, obtained from CDl mice, actin:EYFP transgenic mice 
(Hadjantonakis et al., 1998), K6 Tal:nlacZ transgenic mice (Gloster et al., 1994; 
1999), or CT-l-/- mice (Oppenheim et al., 2001) was dissected in ice-cold Hank's 
balanced salt solution (Gibco BRL) and then transferred into Neurobasal media 
(Gibco BRL) containing 500 !lM glutamine, 2% B27 supplement and 1% penicillin-
streptomycin (Gibco BRL), and, for precursors, 40 ng/ml FGF2 (Collaborative 
Biomedical Products). The tissue was mechanically triturated with a plastic pipette 
then plated in 6 weIl tissue culture dishes (Nunc Inc.) or chamber slides precoated 
with laminin and poly-D-Iysine (Collaborative Biomedical Products). The original 
cell density was about 200,000 ceIls/mL, with the exception of clonaI cultures which 
were seeded at 1500 ceIls/mL of transgenic ceIls, and approximately 200,000 cells/ml 
of the control cells. For sorted neuronal cultures, cortical tissue from aged-matched 
K6 and CDl embryos (as a negative control) were dissociated with papain as 
previously described (Schinelli et al., 1994) prior to labelling with propidium iodide 
(20ng/mL, Sigma) and fluorescein di-~-D-galactopyranoside (FDG, Molecular 
Probes) according to the manufacturers protocol. The cells were sorted using Dako 
Cytomation MoFIo, and then cultured as described above. CM was collected from 
precursors or neurons by filtration through 0.22Jlm pores, and was supplemented with 
B27, glutamine, and FGF2 for addition to freshly isolated precursor cells at 90% (50% 
for heat denatured medium). Exogenous cytokines used were CNTF, CT-l (both 
Cedarlane Laboratories), and LIF (Sigma), aIl at 50ng/mL. 
Inhibitor treatments and transfection ofprecursor cultures 
The inhibitors AG490 5JlM (Calbiochem) and PD98059 50JlM (BIOMOL Research 
Laboratories) in 1 % DMSO (final concentration) were added after 3 DIV, and cultures 
were then analysed 2 days later. CT -1 or LIF function blocking antibodies or the 
control goat IgG were added at the time of plating (5 Jlg/ml, R&D Systems) in either 
control or conditioned media. Alternatively, CM was depleted for LIF by incubation 
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ovemight at 4° with a rabbit LIF antibody (5 )lg/ml, Santa Cruz), then 30 )lI ofprotein 
A sepharose beads (Sigma) were added for 1 hour and precipitated by centrifugation. 
The recovered CM was added to freshly isolated cells. Similar results were obtained 
with both approaches. For transfection studies, plasmids used were the pSilencer 
vector (Ambion) with or without a STAT3 siRNA sequence (5' 
TCAGGTTGCTGGTCAAATT 3'), or the pCAGGS expression vector with or 
without a rat CNTF sequence engineered to contain a mouse macrophage colony 
stimulating factor signal peptide and a myc epitope tag (the kind gift of Dr. Miyazaki 
(Jiang et al., 2003), and pEGFP (Clonetech). Three hours after plating, cortical 
precursors were transfected using the Fugene6 transfection reagent (Roche). Briefly, 
0.33 Ilg ofpEGFP (Clonetech) and 0.66 Ilg of the STAT3 siRNA or CNTF plasmids 
were mixed with 1.5 III ofFugene6 in 100111 ofOptiMEM medium (Invitrogen). After 
30 minute of incubation the mixture was added dropwise to the cells and the wells 
were gently mixed. For experiments using synthetic siRNA oligonuc1eotides, 
precursors were transfected at IDIV with 60 pmol of siRNA oligonuc1eotides targeted 
to the gp130 sequence (proprietary mixture of 4 siRNAs from Dharmacon) or a non-
specifie scrambled sequence (5' AAAGGTTAGCCTACATTACAG 3') (Dharmacon, 
Lafayette, CO) along with 2 I-lg of pEGFP using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer's directions. Similarly, Cos cells and NIH-3T3 cells 
were transfected using Lipofectamine 2000. We used CY3-labelled siRNA and 
pEGFP plasmid to demonstrate that co-transfected plasmid and siRNA 
oligonuc1eotides are co-expressed in more than 80% of the cells. 
In utero electroporation 
The GFP plasmid used for in utero electroporation encoded an elongation factor 1 
(EFI) promoter driving expression ofa nuc1ear-Iocalized GFP (the kind gift of Dr. R. 
Kageyama). The CNTF expression plasmid and gpl30 siRNA oligonuc1eotides are 
described above. In utero electroporation was performed largely as described 
(Ohtsuka et al., 1999). Briefly, CDl pregnant mice were deeply anesthetized with 
isoflurane and nitrous oxyde, a midline incision was performed and about I)lL of 
DNA solution was injected into E13.5-15 lateral ventric1e. The solution contained 
either GFP (5)lg/)lL) with siRNA (20 pMol) or a 1:3 ratio ofGFP:pCAGGS (5)lg/)lL) 
and 0.05% trypan blue as a tracer. At this ratio, virtually all GFP positive cells co-
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expressed the other plasmid after 1 to 7 days post-electroporation. After injection, 
electroporation was performed using a square electroporator CUY21 EDIT (TR Tech, 
Japan) to deliver five 50ms pulses of 50V with 950ms intervals per embryo. 
Embryonic or neonatal brains were subsequently harvested, fixed in 4% PF A at 4°C 
ovemight, cryoprotected in 30% sucrose at 4°C ovemight, and embedded in OCT 
compound. The brains were kept at -80°C until cryosectioned coronally at 16J.lm. 
Immunocytochemistry and quantitation 
For immunocytochemistry, cells were washed and fixed in 4% PFA for 5-10 minutes, 
then treated as previously described (Toma et al., 2000; Bamabé-Heider and Miller, 
2003). For immunostaining of tissue sections, sections were warmed and washed, 
post-fixed with 4% PFA for 10 minutes, blocked and permeabilized with 10% BSA 
and 0.3% Triton-X. The M.O.M. blocking kit (Vector Laboratories) was then used 
according to the manufacturer's protocol. Sections were incubated with primary 
antibodies at 4°C ovemight, then incubated with secondary antibodies at room 
temperature for 1 hour, conterstained with Hoechst 33258 (1 :2000, Sigma-Aldrich) for 
2 minutes and mounted with GelTol (Fisher). Primary antibodies used were rabbit 
anti-GFAP (1:800, Chemicon), rabbit anti-GalC (1:500, Chemicon), mouse anti-
CNPase (1:500, Chemicon), rat anti-CD44 (1:200, Chemicon), mouse anti-S100~ 
(1: 1000, Sigma), mouse anti-GFP (1: 1000, Molecular Probes), rabbit anti-GFP (1 :500, 
Chemicon), mouse anti-MAP2 (1:400, Sigma-Aldrich), rabbit anti-~III-tubulin 
(1:1000, Covance), rabbit anti-STAT3 (1:500,Cell Signaling Technology), mouse 
anti-nestin (1 :400; Chemicon), rabbit anti-gp130 (1:500, Santa Cruz), mouse anti-
NeuN (1:200, Chemicon), rabbit anti-myc (1:1000, Upstate) and goat-anti-murineCT-
1 (1:200, R&D systems). As a specificity control, anti-CT1 was preabsorbed with an 
excess (1 :5ng) of purified CT -1 prior to incubation on sections. Secondary antibodies 
used were indocarbocyanine (Cy3)-conjugated goat anti-mouse or anti-rabbit IgG 
(1 :600), FITC-conjugated anti-mouse or anti-rabbit IgG (1 :200, Jackson 
ImmunoResearch Laboratories), Cy3-conjugated donkey anti-goat IgG (1:300, 
Jackson ImmunoResearch Laboratories), Alexa Fluor 555 gaot anti-rat (1:1000, 
Molecular Probes), DTAF -conjugated streptavidin (1 :2000) . and CY3-conjugated 
streptavidin (1:2000, Jackson ImmunoResearch Laboratories). 
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For quantitation of immunocytochemistry on cultured celIs, 6 to 8 random 
fields of each treatment (per experiment)were captured and processed. For 
quantitation of OF AP immunohistochemistry from neonatal CT -1-/- and LIF -/ - mice 
(Sendtner et al., 1996; Oppenheim et al., 2001), tissue sections were selected from 
identical rostro-caudal levels of -/-, +/- and +/+ littermates. Adjacent sections were 
either stained for OF AP using DAB immunohistochemistry or for OF AP and Hoechst 
using fluorescence immunohistochemistry. CeIl counts were made from weIl defined 
regions on sections processed using DAB. To obtain unbiased measurements of total 
OF AP fluorescence, Hoechst-labelIed fields were used to trace the clearly demarcated 
subventricular zones, and fluorescence from the traced area was automaticalIy 
captured from the corresponding OF AP image. Digital image acquisition and analysis 
was performed with the Northem Eclipse software (Empix Inc.) using a Sony XC-
75CE CCD video camera. For electroporated brains, sections were analyzed using a 
Zeiss Pascal confocal microscope and the manufacturer's software. 2 to 3 pictures per 
coronal section were taken with a 20X objective and a total of four sections per animal 
were analyzed. In aIl graphs, error bars indicate the Standard Error of the Mean 
(SEM), and the statistics were either performed using one way ANOV A with the 
Student-Newman-Keuls post-hoc test or the Students t-test as mentioned in the figure 
legends. 
Western blot analysis and biochemistry 
For biochemical analysis, cortical precursors were harvested at 2 to 9 DIV in RIPA 
buffer (50mM Tris (pH 7.2), 150mM NaCI, 2mM EDTA, 1% NP40, 1% Na 
deoxycholate, and 0.1 % SDS) supplemented with protease inhibitor cocktail 
(Boehringer Mannheim) and 1.5 mM sodium vanadate. For acute stimulation 
experiments, precursor ceIls were washed with fresh medium for 1 hour, stimulated 
with either CNTF (50 ng/mL) or conditioned medium for 15 minutes, then harvested. 
For PO-Pl CT-I knockout brain analysis, meninges were removed, cortices were 
isolated by microdissection and the tissue was homogenized in RIPA buffer. Lysates 
were analyzed by SDS-PAOE exactly as previously described (Bamabé-Heider and 
Miller, 2003). For CT-1 expression in conditioned medium, CT-I-/- or +/+ precursors 
or cortical neurons were grown in 6 weIl plates for 4 days (as described above) and 
then switch to pure optiMEM (1 mL/weIl; Invitrogen) for 24 hours. An equal volume 
of CM per sample was concentrated using iCON concentrator filters (9kD cut off; 
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Pierce) according to the manufacturer protocol and analyzed by SDS-PAGE. 
Membranes were blocked in 5% skim milk powder, or in 3% BSA for phospho-JAK2, 
CD44, and CT -1 antibodies. In addition to primary antibodies listed above, we used 
rabbit anti-neurofilament medium (NFM) (1: 1000, Chemicon), rabbit anti-cyclin-
dependent kinase 2 (cdk2) (1:1000, Santa Cruz Biotechnology), rabbit anti-
phospho(Thr183/Tyr185) ERK (1:2500, Promega), rabbit anti-ERK (1:5000, Santa 
Cruz Biotechnology), rabbit anti-phospho(Tyr705) STAT3 (1: 1000, Cell Signaling 
Technology), rabbit anti-phospho(Tyr1022/1023) JAK1 (1:1000, Chemicon), rabbit 
anti-JAK1 (1:1000; Chemicon), rabbit anti-phospho(Tyr1007/1008) JAK2 (1:1:500, 
Chemicon), rabbit anti-JAK2 (1:10,000, Chemicon), and rabbit anti-CNTF (1:500, 
Santa Cruz). After washing, membranes were incubated with secondary antibodies, 
HRP-conjugated goat anti-mouse or anti-rabbit (1: 10,000, BioRad) or HRP-
conjugated rabbit anti-goat (1 :2000, Chemicon) or HRP-conjugated goat anti-rat 
(1:2000, Jackson ImmunoResearch Laboratories) in blocking solution for 1-2 hours at 
room temperature. Membranes were subsequently stripped with stripping buffer 
(70mM Tris (pH 6.8), 2% SDS, 0.7% p-mercaptoethanol) for 5-10 minutes at 55°C, 
then were extensively washed, reblocked and reprobed as described above. 
RT-PCR analysis 
RNA was extracted from precursor cells (0, 3 and 6DIV) or post-mitotic neurons 
(6DIV) using Trizol reagent according to the manufacturer's directions (Invitrogen). 
The isolated nucleic acid was treated with DNase (Fermentas) for 30 min at 37°C. 
Any remaining genomic contamination was determined by performing PCR for 
glyceraldehyde-3-phosphate dehydrogenase (Farah et al., 2000). cDNA was 
synthesized from 300-1000 ng of RNA using murine leukemia VIruS reverse 
transcriptase (Fermentas) according to the manufacturer's directions. After reverse 
transcription, 1 III of each mixture was subjected to PCR using Taq polymerase 
(Fermentas) under the following conditions: 95°C for 9 min, 40 cycles of 94°C 20 s, 
60°C 20 s,72°C 30 s and 72°C 5 min. Primers for gp130 were 5' TGT CAG CAC 
CAA GGA TTT GGC 3'(forward), 5' GTA GCT GAC CAT ACA TGA AGT G 
3 '(reverse), for LIFRp 5' TCC TGG AAT CTC GGT CGA TAG 3' (forward), 5' 
GAA TCA AGA ATT GCC TGG AAT TG 3' (reverse) (Yanagisawa et al., 1999), for 
LIF 5' ATG GCA GCG CCA ATG CTC GC 3' (forward), 5' ACA GAC GGC AAA 
GCA CAT TGC 3' (reverse) (Nakashima et al., 1999c), for CT-l 5' CGG CAA CAG 
144 
CAC TGC AGG CATC 3' (forward), 5' AAG CTC CCT GCA GAG AGG AGA GC 
3' (reverse) (Ochiai et al., 2001), and for CNTF 5' TCG CTG GAG TGA GAT GAC 
3' (forward), 5' CCC TGG GGA ACT ACT GAT A 3' (reverse, nuc1eotides 424-
896). 
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VII. Figures and figures legends 
Figure 4.1. (a-d) Conditioned medium from mixed neuron and precursor cultures 
induces premature astrocyte formation. (a) Photomicrographs of cultures 
immunostained for the astrocyte marker GF AP (red) at 2, 4 and 6 DIV in the presence 
of 50 ng/ml CNTF, LIF or CT -1 or in 4 DIV CM. Scale bar = 100 microns. (b) 
Western blot analysis of cortical precursors after 2 to 9 DIV for nestin, the 
proliferation marker cdk2, NFM, and GFAP. (c,d) Western blot analysis of cortical 
precursors cultured for 6 days in 50 ng/ml CNTF or (c) in two separate preparations of 
4 DIV or 6 DIV CM (expt. 1 and expt. 2) or (d) in a third batch of 4 DIV CM that was 
or was not heat-denatured (CM-4 and CM-4-heat). Blots were probed for neuronal 
(NFM and ~III-tubulin) or astrocytic (GFAP) markers, and reprobed for total ERK 
levels as a loading control. (e-h) Clonai analysis demonstrates that conditioned 
medium recruits multipotent cortical precursors to generate astrocytes. (e,f) E13 
EYFP transgenic-derived cortical precursors were cultured at clonaI density with age 
matched CDl precursor cens. Cultures were grown in CM for 4 (e) or 5 (f) days, and 
analysed for coexpression of EYFP (green) and GFAP (red, e and f top panels) or 
MAP2 (red, f, bottom panels). Photomicrographs show individual clones and arrows 
indicate examples of double-Iabened cens. Scale bar = 50 and 100 microns in e and f, 
respectively. (g,h) Quantitation of the number of clones containing cens expressing 
(g) GFAP, (h) CD44 or SIOO~ in cultures grown in CNTF (g), CT-l (h) or CM versus 
control medium (g and h). CMI-4 refers to 4 independent preparations of CM. In 
panels a, e, and f, cens were counterstained with Hoechst 33258 (blue) to show an 
cells in the field. 
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Figure 4.2. (a-c) Embryonic cortical neurons secrete a factor(s) that directs 
multipotent cortical precursors to generate astrocytes. (a) Immunocytochemical 
analysis for ~III-tubulin (green) or MAP2 (red) in embryonic cortical neurons purified 
by F ACS and cultured for 5 days. (b) Cortical precursors were cultured for 5 days 
without (top panels) or with (bottom panels) neuron CM and double stained for GFAP 
(red) and MAP2 (green). Scale bar = 100 microns for a,b. (c) Quantitation of the 
percentage of GF AP cells in experiments similar to that shown in b using two 
independent preparations of neuron CM (K6-CMl-2), in comparison to 50 ng/ml 
CNTF. ***p<O.OOl relative to control medium (ANOVA). Error bars indicate the 
SEM. (d-h) Embryonic cortical neurons express cytokines and neuron conditioned 
medium activates cytokine signaling in cortical precursor cells. (d) RT-PCR 
analysis for CNTF, LIF and CT-l in RNA from precursor cells extracted immediately 
after dissection (0), after 3 or 6 DIV, or from embryonic cortical neurons (CN). 
GAPDH was used as a loading and genomic DNA contamination control in all cases. 
(e) RT-PCR (left panel) and Western blot analysis (right panel) for expression of 
gp130 and LIFR in cortical precursor cultures at timepoints from 0 to 8 DIV. (f) 
Double-label immunocytochemistry for STAT3 and nestin (top panels) or STAT3 and 
MAP2 (bottom panels) in cortical precursor cultures at 4 DIV. Each pair of panels 
shows the same field, and the arrows den ote the same cells. Scale bar = 50 microns. 
(g) Western blot analysis of cortical precursor cultures at timepoints from 2 to 6 DIV 
for STAT3, JAKI and JAK2, and for their phosphorylated, activated forms (pSTAT3, 
pJAKl and pJAK2). (h) Western blot analysis for the activated, phosphorylated 
forms of STAT3, JAK2 or ERKs (pSTAT3, pJAK2, pERKs) in 4 DIV cortical 
precursors following a 15 minute stimulation with CM from 4 DIV precursor cultures 
(CM-4DIV) or from cortical neurons (CM-CN). As a positive control, cells were 
stimulated with 50 ng/ml CNTF. Blots were also probed for total STAT3, JAK2, or 
ERKs as loading controls. In panels a, b, and f, cells were counterstained with 
Hoechst 33258 (bIue). 
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Figure,4.3. Inhibition of the JAK-STAT pathway, but not the MEK pathway, 
prevents conditioned medium-induced astrocyte formation. (a) 
Immunocytochemistry for GF AP in cortical precursors cultured for 3 days, and treated 
for 2 additional days with 4DIV CM in the presence or absence of 5 !lM AG490, 50 
!lM PD98059 (PD), or DMSO. 50 ng/ml CNTF was used as a positive control. (b) 
Immunocytochemistry for GF AP in cortical precursors cultured for 7 days and then 
treated with AG490, as in a. In a and b, cells were counterstained with Hoechst 
33258 (blue). Scale bar = 100 microns. (c,d) Western blot analysis of cortical 
precursor cultures treated as in panel a, with either 50 !lM PD98059 (c) or 5 !lM 
AG490 (d). Blots were probed with antibodies to phosphorylated ERKs, ST AT3 and 
JAK2, as well as with antibodies for total ERKs, STAT3 and JAK2. Blots were also 
probed for GFAP and ~III-tubulin. (e) Quantitation of one representative experiment 
of 3 that were performed similar to that shown in panel a. ***p<O.OOl, **p<O.Ol 
relative to the DMSO controls (ANOV A). Error bars indicate SEM. 
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Figure 4.4. A knockdown of cytokine signaling using siRNA for STAT3 or gp130 
inhibits the ability of conditioned medium to direct cortical precursors to generate 
astrocytes. (a) Western blot analysis for STAT3 in NIH 3T3 cens transfected for 2 or 
4 days with the empty control vector (pSilencer) or with the STAT3 siRNA vector. 
The same blot was reprobed for ERK as a loading control. (b) Double-label 
immunocytochemistry for GFP and STAT3 in cortical precursor cens cotransfected 5 
days earlier with either GFP and STAT3 siRNA plasmids (ST AT3 siRNA, bottom' 
panels) or with GFP and the empty control vector (pSilencer, top panels). Arrows and 
arrowheads represent transfected cells. (c) Double-label immunocytochemistry for 
GFP and GFAP (top panels) or GFP and MAP2 (bottom panels) in cortical precursors 
cotransfected as in b, and treated with 4DIV CM. The top two panels were transfected 
with the empty vector, while the bottom two were transfected with STAT3 siRNA 
plasmid. Arrows and arrowheads denote transfected cells that do or do not express the 
relevant marker protein, respectively. (d) Quantitation of experiments similar to those 
shown in panel c. As a positive control, cells were treated with 50 ng/ml CNTF. For 
each condition at least 300 cells were counted in each of three independent 
experiments (Expt. 1,2, and 3). ***p<O.OOI, **p<O.OI, *p<0.05 relative to the empty 
vector-transfected cells (Students t-test). (e) Western blot analysis ofNIH 3T3 cells 
transfected with gp130 or scrambled (scr) siRNA oligonucleotides for 4 or 6 days. 
Untransfected cells (cont) were run as a control. The same blot was reprobed for total 
ERK protein as a loading control. (t) Double-label immunocytochemistry for GFP 
and gp130 in cortical precursor cens cotransfected 5 days earlier with either the GFP 
plasmid and gp130 siRNA oligonucleotides (gp130 siRNA, top panels) or with GFP 
and the scrambled oligonucleotide (control, bottom panels). Arrowheads represent 
transfected cells. (g) Quantitation of cortical precursors that were cotransfected, 
treated with 4 DIV CM for 5 days, and then immunocytochemically analyzed for GFP 
and GF AP or GFP and MAP2. As a positive control, cells were treated with 50 ng/ml 
CNTF. For each condition at least 300 cells were counted in each of three 
independent experiments (Expt. 1,2, and 3). ***p<O.OOI, **p<O.OI, *p<0.05 relative 
to the scrambled oligonucleotide-transfected cells (Students t-test). Error bars indicate 
SEM. (h,i) Immunocytochemical analysis of cortical precursors treated as in panel g, 
and then double-Iabelled for GFP and CD44 (h) or GFP and S100~ (i). Arrowheads 
denote cells expressing both proteins. G,k) Quantitation of experiments similar to 
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those shown in panels h and i. For each condition at least 300 cens were counted in 
each of two independent experiments (Expt. l, and 2). ***p<O.OOI, **p<O.Ol, 
*p<0.05 relative to the scrambled oligonuc1eotide-transfected cens, or, for the control 
groups joined by black bars, between the control and CM-treated cens (Students t-
test). Error bars indicate SEM. In panels b,c,f, h and i, cells were counterstained with 
Hoechst 33258 (blue), and the sc ale bar = 100 )lm. 
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Figure 4.5. Embryonic cortical precursors are competent to respond to CNTF with 
premature gliogenesis in vivo. (a-d) In ufera electroporations ofprecursor cells in the 
EI5 telencephalic VZ/SVZ with plasmids encoding either GFP and myc-tagged CNTF 
or with GFP and the empty vector. Three days after electroporation, coronal sections 
of the embryonic telencephalon were analyzed by immunocytochemistry either for 
GFP and GFAP (a-c) or for GFP and the myc tag (d). (a)Photomicrographs taken on 
a light microscope of sections spanning the ventricle (V) to the meninges (M) through 
EI8 cortices of embryos transfected with the empty vector (left 3 panels) or with the 
CNTF plasmid (right 3 panels). In each set of 3 panels, the top shows the GFAP 
immunostaining, the middle the GFP immunostaining, and the bottom the merge. 
SVZ=subventricular zone, CP=cortical plate. Scale bar = 200 microns. (b) Confocal 
microscopic analysis of GFP (green) and GF AP (red) expression in the SVZ of 
sections similar to those shown in a. Scale bar = 100 microns. Arrows den ote 
transfected, and arrowheads nontransfected GF AP-positive cells. (c) Quantitation of 
sections similar to those shown in. b. Transfected cells within the SVZ of three 
littermate pairs, four sections per embryo, were counted to obtain these numbers. 
***p<O.OOI relative to vector-transfected sections (Student's t-test). Error bars 
indicate SEM. (d) Photomicrographs of a section from an EI8 brain that was 
cotransfected with plasmids encoding GFP and myc-tagged CNTF, and then 
immunostained for GFP and myc. Arrows indicate double-Iabelled cells (yellow). 
Scale bar = 200 microns. (e,f) Photomicrograph ofEI1.5 cortical precursors cultured 
either (e) for 5 DIV in the presence of CM and immunostained for GF AP (red) and 
S100~ (green) or (f) in control medium for 7 days and immunostained for GFAP (red). 
The cells were counterstained with Hoechst 33258. Scale bar = 50 microns. (g) 
Coronal sections of EI6 cortices that were electroporated at E13.5 with either an 
empty vector or a CNTF plasmid and analysed by immunocytochemistry for GFAP. 
V indicates the ventricles and the arrows regions of GF AP immunoreactivity. Scale 
bar = 100 microns. 
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Figure 4.6. (a-e) Cytokine signaling in cortical precursors is essential for the 
appropriate onset of astrocyte formation in the neonatal brain. A plasmid encoding 
GFP was coelectroporated with either scrambled or gp130 siRNA oligonuc1eotides 
into the E14/15 telencephalic VZ/SVZ, brains were collected 1 week later at P3 or P4, 
sectioned coronally, and analyzed by immunocytochemistry for expression of GFP 
and GFAP (a-c) or GFP and NeuN (d,e). (a) Photomicrographs taken on a light 
microscope of sections spanning the ventric1e (V) to the meninges (M) through the P4 
cortex of animaIs transfected with the scrambled oligonuc1eotides (scrambled, top 3 
panels) or with the gp130 siRNA oligonuc1eotides (gp130, bottom 3 panels). In each 
set of 3 panels, the left shows GF AP, the middle GFP, and the right the merge. 
Indicated are the lateral ventric1e (V), the meninges (M), the cortical plate (CP) and 
the subventricular zone (SVZ) regions. Scale bar = 200 microns. (b) Confocal 
microscopie analysis of GFP and GF AP expression in the SVZ of a P4 cortex 
transfected with the scrambled oligonuc1eotides. Arrows show examples of double-
labelled celIs, while arrowheads point to a GFP positive-GF AP negative cell. Scale 
bar = 50 microns. (c) Quantitation of sections similar to those shown in b. 
Transfected cells within the SVZ of 4 scrambled and 4 gp130 siRNA electroporated 
animaIs (four sections per brain) were counted to obtain these numbers. **p<O.OI 
relative to scrambled oligonuc1eotide transfected sections (ANOV A). Error bars 
indicate SEM. (d) Confocal microscopie analysis of GFP and NeuN in the cortical 
plate of a P4 cortex transfected with the scrambled oligonuc1eotides. Arrows show an 
example of double-Iabelled celIs, while arrow heads point to a GFP positive-NeuN 
negative cell. Scale bar = 50 microns. (e) Quantitation of sections similar to those 
shown in d. Transfected cells within the CP were quantitated as in c. *p<0.05, 
**p<O.Ol relative to the scrambled oligonuc1eotide controls (ANOVA). Error bars 
indicate SEM. (f-h) Cardiotrophin-l is expressed by developing cortical neurons. (f) 
RT-PCR analysis for CT-l and LIF in RNA extracted from whole cortices at E12, E13 
or E17.5, or from cultured cortical neurons. GAPDH was used as a loading and 
genomic DNA contamination control. (g) Western blot analysis for CT-l in 4 DIV 
CM obtained from cultured CT-l-/- (KO) and +/+ (WT) cortical precursors, or from 
pure cortical neuron cultures (CN). After 24 hours of conditioning, an equal volume 
of medium from each sample was concentrated and analyzed. Purified murine CT-l 
was used as a control either directly (10 ng, 5 ng) or after concentration in control 
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medium ([lOng]). The asterisks point to a band which is enriched in CN and which 
can be c1early detected in WT after a longer exposure time (data not shown) but which 
is absent from the KO conditioned medium. (h) Immunocytochemistry on El8 
coronal sections for CT-I and the neuronal marker HuD. CT-I is enriched within the 
neurons of the cortical plate (CP) and weakly or not expressed within the 
subventricular zone (SVZ). M = meninges, V = ventric1e, sc ale bar = IOO)lm. 
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Figure 4.7. Cardiotrophin-l hut not LIF is essential for appropriate 
astrogliogenesis in culture. (a) Precursor cells were grown for 5 days in 4 DIV CM 
with or without a control goat IgG, CT-l function blocking antibody, or LIF function 
blocking antibody (expt. 2). Alternatively, CM was depleted for LIF by 
immunoprecipitation using a different LIF antibody prior to addition to the cells (expt. 
1). The cells were analyzed by immunocytochemisty for GF AP and MAP2. 
***p<O.OOI, ANOV A. (b) Precursors were grown for 5 days in control medium, or in 
4 DIV CM together with CT -1 function blocking antibody or with control goat IgG 
and analysed by Western blots for GFAP, ~III-tubulin, and total ERKs as a loading 
control. (c,d) Wildtype precursor cells were grown for 4 days with either normal 
medium or with 4 DIV CM from CT-I-/- (KO) or CT-l+/- (Het) precursor cultures. 
(c) Western blot analysis for GFAP, NFM and total ERKs as a loading control. (d) 
Quantitation of the percentage of cells immunoreactive for GF AP or MAP2 in these 
cultures. *p<O.05, KO versus no CM and Het versus KO, ANOV A. Representative 
results from one of three experiments are shown in panels b-d. (e-g) Cortical 
precursor cells were isolated from CT-l-/- (KO), +/- (Het) or +/+ (WT) embryos, 
cultured for 6 days and analyzed by (e) Western blots for GFAP, ~III-tubulin, and 
total ERKs as a loading control or (f,g) immunocytochemically for astrocytic and 
neuronal markers. (f,g) Quantitation of the number of cells immunoreactive for GF AP 
(f,g), HuD (t) or MAP2 (g) in CT-l-/- versus +/- cultures. Panels fand g derive from 
independent experiments. ***p<O.OOI, ANOVA (t) and Student's t-test (g). (h,i) 
Wildtype cortical precursor cells were grown for 6 days in control medium 
supplemented with either goat IgG (control) or anti-CT -1 function blocking antibody 
(anti-CT-l). (h) Quantitation of the number of cells immunoreactive for GFAP or 
MAP2 in these cultures. ***p<O.OOI, Student's t-test. Representative results from one 
ofthree experiments are shown. (i) Western blot analysis for GFAP, ~III-tubulin, and 
ERKs as a loading control. 
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Figure 4.8. Cardiotrophin-l but not LIF is essential for proper cortical 
astrogliogenesis in vivo. (a) Photomicrograph of a coronal section through the 
neonatal cortical SVZ double-Iabelled for CD44 (red) and OF AP (green) and 
counterstained with Hoechst to show all the cells in the field (blue). The merge shows 
just the CD44 and OF AP fluorescence. Scale bar = 50 J..Lm. (b) Cortices were isolated 
from either PO (left panel) or Pl (right panel) CT-I -/- (KO) or +/+ (WT) mice and 
analyzed by Western blot for CD44, OFAP, NFM or the ERKs as a loading control. 
(c-f) P3 or P7 CT-I or P3 LIF-/- (KO), +/- (Het) and +/+ (WT) brains were analyzed 
immunocytochemically for expression of OFAP. (c) Depiction of the quantified 
regions of the caudal cortical subventricular zone (boxed areas). (d) Quantitation of 
OF AP fluorescence intensity per defined area from sections similar to those shown in 
panel e through the caudal cortex SVZ region l (see Experimental Methods). (e,f) 
OF AP immunofluorescence (red) in the caudal cortical SVZ region l (e) and region 2 
(f) of P3 CT-I +/- (Het) versus -/- (KO) mice. For total fluorescence measurements, 
the cortical SVZ was identified and traced using Hoechst labelling (blue) as a guide. 
Arrows highlight regions of reduced OF AP staining in the knockouts versus the 
heterozygotes. Scale bars = 100 (e) or 50 (f) J..Lm. (g) Quantitation of OF AP-positive 
cell density in P3 CT-I-/- (KO) or +/+ (WT) cortex as analyzed by DAB 
immunocytochemistry of coronal sections through the cortical regions defined in 
panel c. 
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SUPPLEMENTARY FIGURES 
Supp.Figure 4.1. (a) Precursor cells start making oligodendrocytes after 6 to 8 
DIV, Immunocytochemistry for the oligodendrocyte markers GalC (green) and 
CNPase (red) of cultures after 6 and 8 DIV under control conditions. The cens were 
counterstained with Hoechst 33258 (blue) to show an nuclei in the field. Scale bar = 
100 microns. (b,c) S100p and CD44 are expressed in astrocyte precursor cells. 4-6 
DIV precursor cens were immunostained for a combination of markers and 
counterstained with Hoechst 33258 (blue). (b) Immunostaining for S100~ (red) and 
the neural precursor marker Nestin (green, upper panel) or the early neuronal marker 
a-intemexin (green, bottom panel). Note that an the S100~ positive cells are positive 
for Nestin but negative for a-intemexin. (c) Immunostaining for CD44 (red) and 
S100~ (green, upper left panel), Nestin (green, upper right panel), the late neuronal 
marker MAP2 (green, bottom left panel) and the astrocyte marker GF AP (green, 
bottom right panel). Note that CD44 positive cells are positive for S100~ and Nestin 
and partially for GF AP, but are negative for MAP2. Arrows indicate double-Iabened 
cells and arrow heads indicate cens positive for only one marker. Scale bar = 50 
microns. 
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Supp.Figure 4.2. Conditioned media prematurely induce astrocyte precursor 
formation in cortical precursor cultures. Cortical precursor ceUs were grown under 
control conditions or with 4 DIV CM. After 4 days, the ceUs were analyzed by 
immunocytochemistry for (a) the astrocyte marker GFAP (red) and the astrocyte 
precursor/early astrocyte marker S100~ (green) or (b) the astrocyte precursor/early 
astrocyte marker CD44 (red). The ceUs were counterstained with Hoechst 33258 
(blue) to show aU nuc1ei in the field. Scale bar = 100 microns. 
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Supp.Figure 4.3. (a-c) A secreted CNTF plasmid induces astrocyte formation in 
cortical precursor cultures. (a) Immunocytochemical analysis for precursor cells that 
were cotransfected for 5 days with plasmids encoding GFP and either a myc-tagged, 
secreted form of CNTF, or with an empty vector. Cells were immunostained for GFP 
and GF AP or for GFP and the myc tag. Arrows show examples of double-Iabelled 
cells, while arrowheads point to either a GFP positive-GF AP negative cell (left 
panels) or a GFAP positive non-transfected cell (GFP negative, middle panels. Scale 
bar = 50 microns. (b) Quantitation of a representative experiment similar to that 
shown in a. ***p<O.OOI relative to the empty vector control, Student's t-test. Error 
bars are the SEM. (c) Western blot analysis of (left panel) conditioned medium from 
Cos cells or (right panel) cellular lysates of cortical precursor cells transfected with 
either a plasmid encoding myc-tagged, secreted CNTF, or with empty vector. Cos cell 
conditioned medium was analyzed 2 days after transfection with antibodies specifie to 
CNTF or to the mye tag, while precursor cells were harvested 5 days post-transfection 
and analyzed for the activation of STAT3 (PSTAT3) and the presence of astrocytes by 
GF AP. The membrane was reprobed for ERK and ~III-tubulin levels as loading 
controls. (d) Cardiotrophin-l is expressed in developing cortical neurons in vivo. 
Double-label immunocytochemistry on E18 coronal telencephalic sections for CT-l 
(red) and NeuN (green). As a specificity control, CT -1 antibody was preabsorbed 
with an excess of purified CT -1 before staining. M = meninges, V = ventricle, SVZ = 
subventricular zone, CP = cortical plate. Scale bar = 100 !lm. 
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CHAPTER 5: General discussion 
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1. Summary of findings 
The major aim of the experiments presented in this thesis was the elucidation 
of the cellular and molecular mechanisms by which the embryonic cortex develops. 
Specifically, the results describe the role of specific transcription factors, cell cycle 
regulators, and secreted factors and their downstream signaling pathways in the 
regulation of cortical precursor cell proliferation, survival and differentiation. 
The series of experiments in Chapter 2 demonstrated that two distinct protein 
families, the negative cell cycle regulator pRb, and the tissue-specific bHLH 
transcription factors, collaborate to coordinate cell cycle withdrawal and neuronal 
gene expression during the cortical precursor-to-neuron transition. Our data indicated 
that an important function of pRb during the process of neuronal differentiation is the 
inactivation of the dominant negative HLH protein Id2, providing a molecular link 
between the temporally coupled events of cell cycle exit and the induction of neuronal 
gene expression. 
Chapter 3 described the role of an endogenously produced growth factor 
family, the neurotrophins, and the distinct functions of their downstream signaling 
pathways during cortical precursor neuronal differentiation. It is shown that cortical 
precursors themselves express the neurotrophins BDNF and NT-3 and their preferred 
Trk receptors, TrkB and TrkC, and function-blocking experiments further 
demonstrated that these endogenously produced neurotrophins are crucial 
autocrine/paracrine regulators of cortical precursor survival, proliferation and 
neuronal differentiation. These effects are mediated by distinct downstream signaling 
pathways, with neurotrophin-induced activation of the PI3-KlAkt and MEKIERK 
cascades selectively controlling cortical precursor survival and neuronal 
differentiation, respectively. 
Finally, data presented III Chapter 4 described how newly bom cortical 
neurons supply the signaIs that instruct cortical precursors to switch from 
neurogenesis to gliogenesis. It is demonstrated that newly generated cortical neurons 
express the cytokine CT -1, which induces astrocyte differentiation of cortical 
precursor cells via activation of the gp130/JAKISTAT pathway. These results were 
further confirmed in vivo, where inhibition of gp 130 signaling or CT -1 expression led 
to decreased astrocyte formation, whereas activation of this pathway accelerated the 
onset of astrocyte differentiation of cortical precursor cells. 
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II. Model for embryonic cortical development 
Based on the findings presented in this thesis and several studies perfonned by 
others, l propose a model, shown in Figure 1, which identifies sorne of the key events 
during the sequential generation of neurons and astrocytes in the developing cerebral 
cortex. Early during development, cortical precursor cells proliferate in response to 
mitogenic factors, such as FGF2, and high levels or activity of Id2 maintains these 
precursor cells in an undifferentiated and mitotically active state. Neurotrophin and 
FGF2 signaling through the PI3-KlAkt pathway support precursor cell survival. At 
the onset of neurogenesis, activity of Id2 is reduced concomitant with increased levels 
or activity of the pro-neuronal bHLHs and pRb which can then cooperatively induce 
pan-neuronal gene expression and cell cycle withdrawal. This precursor-to-neuron 
transition is also regulated by extracellular factors, such as the neurotrophins and 
PDGF, which induce the MEKIERK signaling cascade and target the phosphorylation 
of transcription factors, such as CIEBPs. Activated CIEBPs collaborate with bHLH 
proteins to induce the expression of neurogenic genes. The pool of cortical precursor 
ce Ils is maintained by lateral inhibition and activation of the Notch pathway, and they 
undergo developmentally associated intracellular changes, such as DNA 
demethylation and expression of gliogenic cascade components. Toward the end of 
the neurogenic period, cytokines, primarily CT-l, produced by newly generated 
neurons reach sufficient levels to instruct the remaining precursor cells to switch from 
neurogenesis to gliogenesis and to produce astrocytes. Cytokine stimulation induces a 
positive feedback mechanism resulting in increased expression and activation of the 
gliogenic cascade components JAKISTAT. Moreover, newly generated astrocytes 
also secrete cytokines which further participate in promoting astrogliogenesis. While 
most of the oligodendrocyte precursor cells originate from the ventral telencephalon, 
locally produced factors, such as Shh and expression of the oligodendrocytic bHLH 
genes Oligl-2 regulate oligodendrocyte differentiation after birth. 
III. Coordinate regulation of cell cycle exit and induction of 
neuronal gene expression during the precursor-to-neuron transition 
The data presented here suggest that Id2 is the molecular link enabling 
coordinate exit. from the cell cycle and induction of neuronal gene expression. 
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Specifically, our data suggest that as pRb becomes increasingly de-phosphorylated, it 
is able to bind and sequester both the E2F family (resulting in cell cycle exit) and Id2 
(allowing pro-neuronal bHLHs to induce neuronal gene expression). In our 
experiments, overexpressed Id2 inhibited neuronal differentiation, leading to apoptosis 
of cortical precursor cells, which is reminiscent of the pRb knockout phenotype. 
These effects of Id2 overexpression were rescued by overexpressing activated 
(hypophosphorylated) pRb, even though loss or overexpression of pRb does not by 
itself affect early pan-neuronal gene expression (Slack et al., 1998; Toma et al., 2000). 
While we used an ectopic expression system, concurrent work has validated our 
findings by showing that ablation of Id2 was sufficient to rescue the neuronal 
apoptosis observed in the pRb knockouts (Lasorella et al., 2000). These findings 
surprisingly place Id2 as a prime target of pRb during normal neuronal development. 
However, it also raises the question of why early pan-neuronal gene expression is not 
compromised in pRb deficient cells, which theoretically have prolonged Id2-mediated 
inhibition of the proneuronal bHLHs. It is conceivable that the endogenous Id2 is not 
sufficient to inhibit aIl pro-neuronal bHLH activity, and/or that additional 
transcription factor families can compensate for the reduced bHLH activity. One such 
family may be the C/EBP transcription factors, which have recently been shown to 
directly regulate cortical precursor neuronal differentiation. Inhibition of C/EBP 
activity leads to a marked reduction of neuron formation both in vitro and in vivo 
(Paquin et al., in press; Ménard et al., 2002). This raises the possibility that both 
neurogenic bHLHs and CIEBP proteins collaborate to induce neuronal specifie gene 
expression. Although only few target genes of these neurogenic transcription factors 
are presently known, one can speculate that they induce the expression of 
complementary sets of genes. For example, pro-neuronal bHLHs induce the 
expression of the Notch ligand Delta and of the downstream differentiating bHLHs, 
while CIEBPs positively regulate the promoter of early pan-neuronal and growth-
associated genes such as TaI a-tubulin (Bertrand et al., 2002; Ménard et al., 2002; 
Nadeau et al., 2005). Moreover, inhibition of bHLHs by Id2 leads to apoptosis while 
CIEBP inhibition does not (Ménard et al., 2002), suggesting a more specific 
interaction of bHLH proteins with the pRb family. Furthermore, CIEBPs but not 
proneural bHLHs have been shown to be positively regulated via phosphorylation 
during cortical precursor differentiation, with the exception of xenopus NeuroD which 
can be negatively regulated by GSK3-p phosphorylation (Paquin et al., in press; 
173 
Moore et al., 2002). This suggests a specific role for C/EBPs as sensors or integrators 
of the precursor environment. Interestingly, in liver cells, C/EBP regulates the 
transcriptional activity of one of the ATF family members (Shuman et al., 1997), one 
ofwhich, ATF5, has been shown to keep cortical precursor cells in an undifferentiated 
state (Angelastro et al., 2003; Angelastro et al., 2005; Mason et al., 2005). Beside 
these functional and regulatory differences, it is also unclear whether bHLHs and 
C/EBPs act in concert or in a cascade during cortical precursor cell neurogenesis. 
While ngn2 expression is in part regulated by the early patteming protein, Pax6 
(Scardigli et al., 2003), very little is known about the regulation of C/EBP expression 
during cortex development. The questions of whether C/EBPs are part of the 
neurogenic pro gram induced by pro-neuronal bHLHs, or vice versa, and whether they 
can functionally substitute or compensate for each other, could be answered in part by 
detailed analysis of pre-existing knockout animaIs. 
While the precursor-to-neuron transition involves coordinated cell cycle 
withdrawal and induction of neuronal gene expression in most of the CNS (Gloster et 
al., 1999), it is intriguing to note that PNS neuroblasts express differentiated neuronal 
markers while still proliferating (Memberg and Hall, 1995). This suggests that these 
two neural lineages rely on distinct mechanisms regulating the cell cycle. 
Interestingly, pRb knockout embryos display increased apoptosis in both the CNS and 
the PNS, although CNS apoptosis is rescued in the absence of p53, while caspase3 
deficiency rescues PNS neurons (Macleod et al., 1996; Simpson et al., 2001). This 
cell cycle regulation difference may relate to our finding that CNS and PNS neurons 
use different mechanisms to maintain the post-mitotic state of neurons. 
Overexpression of the neuroblastoma-associated oncogene N-myc in sympathetic 
neurons induces S-phase re-entry, via inactivation ofpRb through either direct binding 
or upregulation of Id2 (Lasorella et al., 2000; Wartiovaara et al., 2002). In contrast, 
N-myc or Id2 overexpression in cortical neurons does not affect their post-mitotic 
status (Toma et al., 2000; Wartiovaara et al., 2002). Further studies will be needed to 
better understand the differences between mechanisms that regulate the final division 
of CNS and PNS neuronal precursors, and how those mechanisms prevent CNS and 
PNS neurons from re-entering the cell cycle. 
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IV. Endogenously produced extracellular signais during cortical 
cell differentiation 
Stimulation with exogenous PDGF or the neurotrophin NT -3 was shown to 
promote increased neuronal differentiation of precursor cells (Ghosh and Greenberg, 
1995; Williams et al., 1997; Park et al., 1999; Lukaszewicz et al., 2002). Although 
PDGF is not endogenously produced by these cells, we reported here that 
endogenously produced neurotrophins, BDNF and NT-3, are essential for proper 
cortical precursor development, where inhibition of either one leads to massive 
apoptosis and consequently, inhibits precursor proliferation and neuronal 
differentiation. This profound effect of neurotrophins on cortical precursor cells in 
culture has not been reported in vivo to date, although several cortical neuron 
maturation and survival defects have been identified in TrkB and BDNF knockouts 
(Jones et al., 1994; Gates et al., 2000; ltami et al., 2000; Xu et al., 2000). One 
potential explanation is that compensatory mechanisms exist within the developing 
cortex of these knockouts, which are absent in culture or do not develop in time upon 
acute neurotrophin inhibition. Therefore, a detailed cortical precursor analysis in the 
existing TrkB/TrkC or BDNF/NT-3/NT-4 double and triple knockouts should be 
performed (Minichiello and Klein, 1996; Liu and Jaenisch, 2000). Overexpression 
studies suggest that neurotrophin signaling is not saturated in cortical precursor cells 
in culture or in the adult brain in vivo, where exogenous neurotrophin treatment 
promotes neurogenesis of neural precursor cells (Ghosh and Greenberg, 1995; Zigova 
et al., 1998; Benraiss et al., 2001). For example, transgenic animaIs overexpressing 
BDNF in neural precursor cells display ectopic neuron accumulation in specific zones 
and impaired neuronal migration within the developing cortex, which could also be 
explained by survival, proliferation and neuronal differentiation effects of 
neurotrophins on cortical precursor cells (Ringstedt et al., 1998; Alcantara et al., 
2005). This alternative explanation was proposed but not further investigated by the 
authors of these studies. 
In addition to showing that endogenously produced neurotrophins regulate 
cortical precursor survival, proliferation, and neuronal differentiation, the data 
presented here also show that endogenously produced gp 130-dependent cytokines 
instruct the precursor neuronal-to-glial fate switch. While a large body of work has 
shown that exogenous cytokine and BMP stimulation induces precocious astrocyte 
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formation in cortical precursor cell cultures, by whom, when and where these 
gliogenic factors are produced was sti11largely unknown (Johe et al., 1996; Bonni et 
al., 1997; Rajan and McKay, 1998; Mabie et al., 1999; Nakashima et al., 1999b; Park 
et al., 1999; Yanagisawa et al., 1999; Yanagisawa et al., 2000; Ochiai et al., 2001; 
Takizawa et al., 2001a; Uemura et al., 2002). Two pieces of data indirectly suggest 
the presence of endogenously secreted gliogenic signaIs in cortical precursor cells: 
comparison between low and high density cultures showed that astrocyte formation 
only occurs in the latter one along with a marked increase in basal STAT activation 
(Rajan et al., 2003), and precursor cells cultured five to ten times more dense than 
normal give rise to precocious astrocyte differentiation (FBR and FDM, unpublished 
observations). Endogenous production of cytokines in cortical precursor cultures was 
further supported by the observation that cultured gp 130 knockout precursors fail to 
produce astrocytes even in long-term cultures (Nakashima et al., 1999a). We found 
that, while several cytokines are expressed in mixed cultures of precursors and 
neurons, including LIF and CNTF, CT-1 is specifically enriched in cortical neurons 
and its expression levels increase as newly generated neurons accumulate. In the 
absence of CT -1, cortical astrocyte formation is significantly reduced both in culture 
and in the perinatal cortex. Rowever, the greater loss of astrocytes in the gp 130 and 
LIFR knockout brains suggests that there is compensation and redundancy among the 
cytokines expressed within the developing cortex (Ware et al., 1995; Koblar et al., 
1998; Nakashima et al., 1999c; Nakashima et al., 1999a). Moreover, although BMPs 
can promote astrocyte formation from LIFR knockout precursors in vitro (Koblar et 
al., 1998), endogenous BMPs are unable to substitute for a lack of cytokine signaling 
in vivo. Interestingly, one of the IL-6 cytokine family members, neuropoietin, is 
expressed notably earlier in the developing cortex, at E11 prior to the onset of 
neurogenesis and is downregulated by E 15 prior to the onset of gliogenesis (Derouet 
et al., 2004). While its effect on gliogenesis has not yet been addressed, stimulation 
with exogenous neuropoietin was shown to induce proliferation of embryonic 
telencephalon derived neurospheres (Derouet et al., 2004). Therefore, cytokines 
might be regulating different aspects of cortical precursor cells depending on their 
developmental status, with early precursors proliferating in response to neuropoietin 
and late precursors undergoing astrocyte differentiation in response to CT -1. The 
observation that gliogenesis follows neurogenesis during nervous system 
development, and that the aStrocyte defects in the gp130 and LIFR knockouts are 
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widespread within the late embryonic brain, also suggests a broader role of neuron-
derived astrocyte-inducing mechanisms (Ware et al., 1995; Koblar et al., 1998; 
. Nakashima et al., 1999c). Indeed, a similar mechanism of neuron-derived glial fate 
induction has also been described in the developing PNS, where neuron produced 
GGF instructs neural crest precursors to become Schwann cells (Shah et al., 1994). 
How do extracellular signaIs converge on or interact with intracellular 
machinery to regulate cortical precursor development? Endogenously produced 
neurotrophins activate the MEKIERK pathway, which we have recently shown 
regulates cortical precursor neuronal differentiation through phosphorylation of 
C/EBP proteins (Ménard et al., 2002). This cascade is further supported by recent in 
vivo experiments showing that either overexpression of a dominant negative form of 
MEK or a Rsk phosphorylation-site mutant of C/EBP~ inhibits neuronal 
differentiation in the developing cortex (Paquin et al., in press). Similarly, FGF2 has 
been shown to indirectly potentiate STAT activity during cortical precursor 
astrogenesis, where FGF2 treatment promotes chromatin modifications allowing 
STAT mediated transcription of astrocyte specific genes (Song and Ghosh, 2004). 
Intracellular neurogenic factors can also regulate precursor responsiveness to their 
environment. For example, neurogenic bHLH proteins have been shown to be 
essential for proper neurotrophin receptor expression, where Trk expression is lost in 
the developing inner ear of NeuroD knockouts and the sensory ganglion of ngn1l2 
knockouts (Ma et al., 1999; Kim et al., 2001). It will thus be interesting to investigate 
Trk expression and neurotrophin responsiveness of cortical precursor cells from pro-
neuronal bHLH knockouts, as reduced neurotrophin signaling could be one cause of 
cortical neuron loss observed in these animaIs (Fode et al., 2000). 
One striking property of the cortical precursor culture system is that the in vivo 
differentiation patlern is precisely maintained in serum-free conditions (Qian et al., 
2000). This suggests that cultured cortical precursor cells preserve in vivo-like 
intrinsic and extrinsic differentiation mechanisms. While most studies have focused 
on the effects of exogenously applied factors, the present thesis has paid particular 
attention to endogenous mechanisms and factors regulating precursor fate, and the 
results underscore the importance of endogenously produced and secreted signaIs, 
acting in an autocrine/paracrine fashion, during both cortical precursor neuronal and 
glial differentiation. Although this thesis did not address oligodendrocyte 
differentiation of cortical precursor cells, evidence also exists for endogenous 
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oligodendrocyte-inducing factors. Shh is produced by cortical precursor cells and its 
inhibition decreases oligodendrocyte fonnation (Qian et al., 2000; Alberta et al., 2001; 
Tekki-Kessaris et al., 2001). Moreover, we have observed that cortical neuron 
conditioned media similarly affects astrocytes and oligodendrocytes: it induces 
precocious oligodendrocytogenesis of cortical precursor cells via a pathway distinct 
from the cytokine induced astrogliogenic one (JAW, FBH, and FM, unpublished 
observations). Taken together, these results highly encourage further study of the 
endogenous signaIs regulating neural precursor biology. 
v. Integration of extracellular signais during cortical development 
Precursor cells within the developing cortex are exposed to a variety of 
extrinsic factors. How are these signaIs integrated and transduced into specific 
cellular responses? The results presented here proposed that distinct intracellular 
signaling pathways subserve distinct functions, where the PI3-KlAkt pathway 
supports survival, the MEKIERK pathway promotes neurogenesis, and the JAKISTAT 
pathway induces astrogliogenesis of cortical precursor cells. These pathways are 
common downstream mediators of different secreted factor families. For example, 
PDGF, neurotrophins, FGF2 and cytokines aIl activate the MEKIERK pathway 
although they mediate distinct cellular responses, such as differentiation, proliferation 
and survival (Ghosh and Greenberg, 1995; Bonni et al., 1997; Rajan and McKay, 
1998; Ménard et al., 2002; Barnabé-Heider and Miller, 2003). This can be explained 
in several ways. 
First, the expression pattern of these factors; the expression of neurotrophins 
is detectable prior to the onset of neurogenesis while cytokines are enriched in cortical 
neurons and high levels of expression are detected at the onset of gliogenesis 
(Maisonpierre et al., 1990; Fukumitsu et al., 1998; Barnabé-Heider and Miller, 2003; 
Barnabé-Heider et al., in press). Downstream signaling components can also be 
regulated temporaIly, such as the RTK adaptor protein ShcC which replaces ShcA 
during neuronal differentiation of neural precursor cells and promotes both survival 
and neuronal differentiation, and the JAKIST AT pathway components which are 
upregulated in later precursor cells (Conti et al., 2001; He et al., 2005). 
Second, factors can differentially activate downstream signaling cascades, such 
as acute or sustained activation of MEK, which has been shown to result in distinct 
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cellular resp.onses (Marshall, 1995). Indeed, FGF2 and neur.otr.ophin stimulati.on .of 
precurs.or cells leads t.o different levels .of MAPK ph.osph.orylati.on in c.ortical 
precurs.or cens (Gh.osh and Greenberg, 1995). M.odulati.on .of gene expressi.on kinetics 
by different fact.ors has als.o been recently prop.osed, where comparis.on .of PDGF and 
CNTF -stimulated c.ortical precurs.or cens revealed that the sets .of genes induced by 
these fact.ors differ m.ostly in their expressi.on kinetics and n.ot nature (Sauvage.ot et al., 
2005). 
Finally, c.ompetiti.on .or availability .of c.omm.on d.ownstream signaling 
c.omp.onents .or transcripti.onal c.o-activat.ors can regulate cellular resp.onse t.o gr.owth 
fact.ors. F.or example, FGFRI and TrkA b.oth utilize the adaptor protein FRS2 t.o 
activate the MEKIERK pathway. H.owever, FRS2 is recruited differentially by these 
tw.o RTKs in an activity-independant and dependent manner respectively, providing a 
direct m.odulat.ory mechanism between FGF and neur.otr.ophin signaling (Ong et al., 
2000). Similarly, at the transcripti.onallevel, ngn and STAT proteins c.ompete f.or the 
same binding site .on the c.o-activat.or p300/CBP (Sun et al., 2001), while Smad 
pr.oteins bind t.o a different site and were sh.own t.o directly p.otentiate ST AT 
transcripti.on (Nakashima et al., 1999b). Since CIEBPs als.o utilize the same 
p300/CBP c.o-activat.ors (Bl.obel, 2000), a scenari.o can be pr.op.osed where during 
neur.ogenesis, bHLHs and PDGF/neur.otr.ophin-activated CIEBPs sequester p300/CBP 
and transactivate neur.onal genes, while preventing transcripti.on .of astr.ocytic genes. 
Later in devel.opment, when the activity .of these neur.ogenic factors is reduced and 
intrinsic changes have .occurred such as DNA demethylati.on and upregulati.on .of JAK-
ST AT pathway c.omp.onents, cyt.okine-activated ST AT pr.oteins can then induce 
astr.ocyte specific genes. This is c.onsistent with the .observati.ons that PDGF induced 
neur.ogenesis is d.ominant .over CNTF induced astrogli.ogenesis in early c.ortical 
precurs.or cens (Park et al., 1999). By anal.ogy t.o p300/CBP bridging .of STAT and 
Smad, transcripti.onal p.otentiati.on .of bHLH and CIEBP proteins by Smad c.ould 
explain the neur.ogenic p.otential .of BMPs in early c.ortical precurs.or cens, but 
astrogli.ogenic p.otential later in c.ortical devel.opment (Li et al., 1998; Mabie et al., 
1999). A similar process may underlie the distinct effects .of .other fact.ors at different 
devel.opmental stages. F.or example, Wnt/p-catenin signaling has been sh.own t.o b.oth 
prom.ote the expansi.on .of precurs.or cens, as sh.own by nestin prom.oter-driven P-
catenin .overexpressi.on, and neur.ogenesis by Wnt stimulati.on .ofE13.5, but n.ot EIO.5, 
c.ortical precurs.or ceIl cultures (Chenn and Walsh, 2002; Hirabayashi et al., 2004). 
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Interestingly, ~-catenin has been shown to positively regulate both the promoters of 
Id2 and ngnl in colon carcinoma and cortical precursor cells, respectively (Rockman 
et al., 2001; Hirabayashi et al., 2004), which could promote either precursor cell state 
or neuronal differentiation depending on the cortical precursor environment. 
Likewise, Notch signaling has been shown to promote the maintenance of the 
precursor cell state and astrocyte differentiation. Barly in cortex development, Notch-
induced inhibition of neurogenic bHLH activity, via Hes proteins, leads to reversible 
inhibition of neuronal differentiation (Mizutani and Saito, 2005). In a gliogenic 
environment later in development, Notch signaling promotes astrogliogenesis by both 
inhibiting neurogenic bHLHs and potentiating the cytokine-induced JAKISTAT 
pathway (Ge et al., 2002; Sakamoto et al., 2003; Kamakura et al., 2004). 
VI. Biological and clinical implications of the presented findings 
How can elucidation of molecular mechanisms regulating cortical precursor 
development be use fuI in a broader biological and clinical context? The results 
presented in this thesis identify key cell-intrinsic and extrinsic regulators required for 
the proper developmental proliferation, differentiation and survival of neural precursor 
cells. One important fmding from these studies is that both cell-intrinsic and 
environmental changes occur that increasingly bias neural precursors to generate glial 
rather than neuronal progeny as development proceeds. These changes may relate to 
the finding that neural precursor cells transplanted either into the postnatal brain or the 
normal or damaged adult spinal cord mostly undergo astrocyte differentiation (Cao et 
al., 2001; Morrow et al., 2001; Ge et al., 2002; Sakamoto et al., 2003; Vroemen et al., 
2003; Kamakura et al., 2004). This phenomenon can be at least partially explained by 
the presence of high levels of cytokines in the postnatal and adult CNS or following 
tissue injury. Along the same lines, neural precursor cells expanded in culture as 
neurospheres have been shown to progressively gain gliogenic potential at the expense 
of neuronal production (Seaberg et al., 2005). This neuron-to-glia switch can be 
explained by at least two things: expansion in the presence of FGF2 facilitates 
transcription of astrocyte specifie genes (Song and Ghosh, 2004), and the presence of 
cytokine-producing differentiated cells, such as neurons and astrocytes, within the 
spheres. Finally, adult neural stem cells that persist within the adult brain are thought 
to express an astrocyte-like phenotype, such as GFAP expression, and neurons are 
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only generated within the SVZ of the lateral ventricles (destined for the olfactory 
bulb) and in the dentate gyms of the hippocampus (Cameron and McKay, 1998; 
Kempermann et al., 2004). In order to recover neuronal potential from neural 
precursors in other brain regions, one could propose the enforced expression of 
neuronal transcription factors, such as proneuronal bHLHs and C/EBPs, or inhibition 
of cytokine signaling, as both approaches were shown to induce cortical precursor 
differentiation into neurons at the expense of astrocytes (Paquin et al., in press; 
Bamabé-Heider et al., in press; Sun et al., 2001). Further studies aimed at 
understanding the normal biology of these cells should continue to be a high priority, 
particularly as the use of neural precursor cells to improve neurodegenerative diseases 
and injured neural tissues has gained considerable attention. 
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VII. Figures and figure legends 
Figure 5.1 A model for early cortical development. The major findings presented 
in this thesis are shown, where Id2, pRb and bHLHs cooperatively regulate the 
precursor-to-neuron transition, neurotrophins act in an autocrine/paracrine fashion to 
regulate precursor survival and neuronal differentiation, and accumulating levels of 
neuron-derived CT -1 regulate the neuronal-to-glial fate transition of cortical precursor 
cells. 
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